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Abstract 
In muscle and fat cells, insulin stimulates the translocation of GLUT4 from 
unique intracellular storage site(s) to the cell surface. In type II diabetes this 
translocation is impaired. The translocation of GLUT4 in response to insulin is an 
example of regulated membrane trafficking.  
Membrane trafficking involves the fusion of vesicles with specific target 
membranes and is mediated by SNARE proteins. The SNARE proteins involved in 
the intracellular trafficking of GLUT4 are poorly understood. Stx 16 is a t SNARE 
located in the TGN which has been proposed to have a role in GLUT4 trafficking. 
Previous work has shown that expression of the cytosolic domain of stx 16 
significantly slows the reversal of insulin stimulated glucose transport and 
depletion of stx 16 using morpholino antisense oligonucleotides reduces glucose 
transport over a range of insulin concentrations. Stx 16 knockdown also reduces 
total cellular levels of GLUT4. It has been suggested that stx 16 has a role in 
sequestration of GLUT4 in its storage site(s). In this thesis the role of stx 16 in 
GLUT4 trafficking was further investigated. 
First of all, stx 16 expression was stably depleted in 3T3 L1 adipocytes using a 
shRNA approach. Knockdown of stx 16 reduced the total GLUT4 cellular levels by 
20% and the majority of GLUT4 appeared to be lost from fractions which 
included GSVs. Stx 16 depletion also resulted in a reduction in stx 6 levels and 
reduced recruitment of mVps45 to the membrane.  Also, assays were developed 
to investigate GLUT4 trafficking kinetics using 3T3 L1 adipocytes expressing HA 
GLUT4 GFP. 
Stx 16 is phosphorylated under basal conditions and insulin stimulation decreases 
this phosphorylation. It is thought that this dephosphorylation regulates an 
important membrane trafficking event in GLUT4 sorting. Potential 
phosphorylation sites have been previously identified. Screening of 
phosphorylation site mutants in yeast suggested that stx 16 may be 
phosphorylated at Ser 95. Unfortunately it was not possible to confirm this in 
3T3 L1 adipocytes.  
In summary the data in this thesis suggests that stx 16 has a role in sorting 
GLUT4 to its storage site(s). The precise role of stx 16 will need to be further 
examined to determine the how stx 16 depletion affects GLUT4 trafficking 3 
kinetics. The work presented in this thesis also suggests that stx 16 may be 
phosphorylated at Ser 95. This will need to be confirmed in 3T3 L1 adipocytes 
and the effect of stx 16 phosphorylation on GLUT4 trafficking examined.  4 
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Chapter 1 Introduction 
1.1 Insulin resistance and diabetes 
Diabetes mellitus is a global epidemic affecting approximately 150 million 
people worldwide, a figure which will double by the year 2025 (Zimmet et al., 
2001). The majority (90%) of these cases are of the type II form. Type II diabetes 
is a chronic disease characterised by defective insulin action, a condition known 
as insulin resistance, and/or abnormally high insulin secretion. Insulin resistance 
places a greater demand on the pancreas to produce insulin leading to 
hyperinsulinaemia. Insulin resistance also leads to dysfunctional glucose uptake 
into muscle and adipose tissue as well as increased release of glucose by the 
liver. Both of these processes result in hyperglycaemia. Type II diabetes is 
strongly associated with obesity and as the levels of obesity rise, the incidence 
of this condition, particularly in the younger population is increasing rapidly. 
Insulin resistance and type II diabetes are associated with many health 
complications. These include blindness, nerve damage, kidney failure and 
cardiovascular disease. Type II diabetes is one of the primary causes of 
cardiovascular disease. Overall type II diabetes can lead to increased risk of 
premature death. Although diabetes is a treatable condition, there is as yet no 
cure so it is important that the molecular mechanisms underlying this disease 
are more fully understood. 
 
1.2 GLUT4 
GLUT4 (glucose transporter 4) is a facilitative glucose transporter. It transports 
glucose down its concentration gradient into the cell in an energy independent 
manner. It is a membrane protein with 12 transmembrane domains. There are 13 
known members of the GLUT family of proteins (GLUT1 13) which can be divided 
into 3 classes. Class I includes GLUTs 1 4, class II includes GLUTs 5, 7, 9 and 11 
and class III includes GLUTs 8, 10, 12 and the proton myoinositol 
symporter H
+  myo inositol cotransporter (HMIT1) (Joost and Thorens, 2001). 
GLUT4 is expressed primarily in striated muscle and adipose tissue and is the 
major insulin responsive GLUT isoform.  Nicola S Hamilton, 2010    Chapter 1, 19 
GLUT4 has been shown to be important for glucose homeostasis. Disruption of 
GLUT4 expression in all tissues of mice leads to insulin resistance (Stenbit et al., 
1997). Also, genetic ablation of the GLUT4 gene specifically in muscle tissue 
results in insulin resistance and glucose intolerance in mice as young as eight 
weeks old (Zisman et al., 2000). Disruption of GLUT4 specifically in adipose 
tissue results in impaired glucose uptake and hyperinsulinaemia (Abel et al., 
2001). In addition, the adipose tissue shows insulin resistance and impaired 
glucose tolerance.  Interestingly, liver and muscle tissue also develop insulin 
resistance, despite the fact that GLUT4 is only ablated in adipose tissue. Also 
insulin stimulated glucose transport was markedly reduced in muscle tissue, 
even though the levels of GLUT4 expression in this tissue were normal (Abel et 
al., 2001). These data suggest that perturbation of GLUT4 expression levels in 
specific tissues may be a contributing factor in insulin resistance and type II 
diabetes. In fact it has been shown that GLUT4 expression is reduced in 
adipocytes from obese subjects and those with impaired glucose tolerance and 
type II diabetes (Garvey et al., 1991). It has also been shown that overexpression 
of GLUT4 ameliorates diabetes in the db/db mouse model (Brozinick, Jr. et al., 
2001). 
 
1.3 Insulin 
1.3.1 Role in glucose homeostasis 
Insulin is an important hormone involved in metabolism. It has a role in cell 
growth, differentiation, and the storage of substrates in fat, muscle and the 
liver. One of its most important roles is in whole body glucose homeostasis 
(Saltiel and Kahn, 2001). At high plasma glucose concentrations, for example 
after eating a meal, insulin stimulates the uptake of glucose by adipose and 
muscle tissue and inhibits glucose production by the liver. Insulin stimulates 
glucose uptake in adipocytes by stimulating the translocation of GLUT4 
molecules from unique intracellular storage site(s) to the cell surface which 
results in an increase in glucose uptake into the cell. This returns glucose 
concentrations to their normal levels. In insulin resistance and type II diabetes 
this normal response to insulin is impaired. Nicola S Hamilton, 2010    Chapter 1, 20 
1.3.2 Signalling regulating GLUT4 translocation 
In the 1980s it was first demonstrated that insulin stimulates the translocation of 
glucose transport activity (Suzuki and Kono, 1980;Cushman and Wardzala, 1980). 
Insulin binds to a surface receptor on muscle and adipose cells and triggers a 
cascade of signalling events.  Two independent signalling pathways have been 
shown to be involved in insulin regulated GLUT4 translocation (Kanzaki, 
2006;Leney and Tavare, 2009), a phosphatidylinositol 3 kinase (PI3K) dependent 
pathway (Okada et al., 1994) and a c Cbl dependent pathway (Baumann et al., 
2000) (Fig. 1.1). In both these pathways insulin binds to its heterotetrameric 
receptor composed of two a and two b subunits. This results in a conformational 
change in the receptor, which leads to activation of its tyrosine kinase domains 
in the intracellular portion of the b subunits. The receptor is then able to 
phosphorylate several potential substrates.  
 
In the PI3K  dependent pathway (Okada et al., 1994), the insulin receptor 
phosphorylates insulin receptor substrate (IRS)1 (White, 1998). IRS1 recruits PI3K 
to the plasma membrane where it catalyses the production of 
phosphatidylinositol 3, 4, 5 phosphate (PI(3,4,5)P3). PI(3,4,5)P3 recruits kinases 
including protein kinase B (PKB)/Akt via their pleckstrin homology (PH) domain 
(Stokoe et al., 1997). This brings PKB/Akt in close proximity to the kinase 
phosphoinositide dependent kinase 1 (PDK1) which phosphorylates PKB/Akt on 
Thr 308 and activates it (Alessi et al., 1997). PKB is also activated by 
phosphorylation on Ser 473 by TORC2 (target of rapamycin complex 2) (Hresko 
and Mueckler, 2005;Sarbassov et al., 2005). PDK1 also phosphorylates the 
atypical protein kinase C (PKC)s, PKCl on Thr 402 and PKCz on Thr 410 (Chou et 
al., 1998;Le Good et al., 1998).  
 
PKB/Akt phosphorylates several substrates in the cell. One downstream target of 
PKB/Akt which is thought to be important in GLUT4 translocation is Akt substrate 
of 160 kDa (AS160) (Sakamoto and Holman, 2008). AS160 is a protein with Rab 
GAP (GTPase activating protein) activity (Kane et al., 2002). It is thought that 
PKB/Akt phosphorylation of AS160 inhibits its Rab GAP activity towards Rabs 
associated with GLUT4 storage vesicles (GSVs) which leads to translocation of 
GLUT4 (Sano et al., 2003b;Zeigerer et al., 2004). Further work has shown that 
AS160 is important for intracellular retention of GLUT4 under basal conditions Nicola S Hamilton, 2010    Chapter 1, 21 
(Eguez et al., 2005;Larance et al., 2005). The membrane association of AS160 
seems to be important in this process (Stockli et al., 2008). PKB/Akt also 
phosphorylates TBC1D1 (tre 2/USP6,BUB2,cdc16 domain 1 family member 1) 
(Taylor et al., 2008) and Ser 318 of PIKfyve (phosphoinositide kinase, FYVE finger 
containing) (Berwick et al., 2004). TBC1D1 is a protein related to AS160 and is 
mostly expressed in fast twitch muscle fibres. TBC1D1 is likely to play an 
important role in the stimulation of muscle glucose uptake in response to insulin, 
contraction and AMPK activation (Taylor et al., 2008). Phosphorylation of 
PIKfyve by PKB/Akt, activates the kinase which phosphorylates 
phosphatidylinositol 3 phosphate (PI(3)P) to yield phosphatidylinositol 3, 5 
bisphosphate (PI(3,5)P2) on intracellular membranes. This may be important for 
intracellular trafficking of GLUT4 (Berwick et al., 2004). 
 
In the c Cbl dependent pathway (Baumann et al., 2000), the insulin receptor 
phosphorylates APS (adapter protein containing a PH and SH2 domain) which 
binds to the receptor. Phosphorylated APS then recruits c Cbl to the insulin 
receptor (Liu et al., 2002;Ahn et al., 2004). c Cbl in a c Cbl/CAP complex is 
phosphorylated by the insulin receptor (Ribon and Saltiel, 1997). This stimulates 
the movement of the c Cbl CAP complex into lipid rafts (Ribon et al., 1998). The 
tyrosine phosphorylated c Cbl recruits a complex of an adaptor protein, CrkII 
and C3G, a guanine nucleotide exchange factor (GEF). C3G then activates TC10 
(Chiang et al., 2001), which is a Rho family GTPase (Murphy et al., 1999). TC10 
is an actin regulator, (Kanzaki et al., 2002) which may be important for GLUT4 
translocation (Kanzaki and Pessin, 2001;Chang et al., 2007). However, the 
precise mechanism by which TC10 stimulates GLUT4 translocation is yet to be 
described. Nicola S Hamilton, 2010    Chapter 1, 22 
 
 
 
Figure 1.1. Insulin signalling pathways regulating GLUT4 translocation (Leney 
and Tavare, 2009).  
Insulin binding to the insulin receptor (IR) activates both PI3K dependent (shown 
in black) and c Cbl dependent (shown in grey) signalling pathways leading to 
translocation of GLUT4 vesicles to the plasma membrane.  
In the PI3K dependent pathway, the insulin receptor phosphorylates IRS1. 
Phosphorylated IRS1 recruits PI3K to the plasma membrane which catalyses the 
production of PI(3,4,5)P3. The increase in PI(3,4,5)P3 results in recruitment of 
PH domain containing proteins, PDK1 and PKB/Akt. Once recruited to the plasma 
membrane, PKB/Akt is activated by phosphorylation by PDK1 and TORC2. PDK1 
also phosphorylates the atypical PKCs, PKCl and PKCz. PKB/Akt phosphorylates 
several substrates including AS160, TBC1D1 and PIKfyve. PKB/Akt 
phosphorylation of AS160 inhibits its RabGAP activity against a number of Rab 
proteins thought to be associated with GLUT4 storage vesicles. In adipocytes 
AS160 acts on Rab 10 whereas in muscle cells it acts on Rabs 8A and 14. TBC1D1 
is a protein related to AS160 and is mostly expressed in fast twitch muscle 
fibres. PKB/Akt also phosphorylates and activates PIKfyve which phosphorylates Nicola S Hamilton, 2010    Chapter 1, 23 
PI(3)P to yield PI(3,5)P2 on intracellular membranes which may be important for 
intracellular trafficking of GLUT4. 
In the c Cbl dependent pathway, the adaptor protein APS binds to and is 
phosphorylated by the IR. Phosphorylated APS recruits c Cbl to the IR. C Cbl in a 
c Cbl/CAP complex is phosphorylated by the IR. Then the c Cbl/CAP heterodimer 
dissociates from the IR and is recruited into lipid raft domains. Lipid raft 
associated, phosphorylated c Cbl recruits a signalling complex containing CrKII 
adaptor protein and C3G GEF. C3G activates TC10 which is a Rho family GTPase. 
TC10 is an actin regulator which may be important for GLUT4 translocation.  
See main text for further details. 
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The PI3K dependent pathway and the c Cbl dependent pathway of insulin 
signalling have both been clearly defined and their role in GLUT4 translocation 
demonstrated. The two pathways have been shown to be independent. 
Disruption of CAP by expression of the N terminal domain did not affect PI3K 
dependent signalling (Baumann et al., 2000). Also disruption of lipid raft 
domains in adipocytes inhibited TC10  activation without affecting PI3K 
signalling (Watson et al., 2001). The roles of the individual proteins in each 
pathway have been determined using several methods including: using the PI3K 
inhibitor wortmannin (Okada et al., 1994); truncation mutants (Baumann et al., 
2000;Ahn et al., 2004); phosphosite mutants (Kane et al., 2002;Sano et al., 
2003a;Berwick et al., 2004); kinase assays (Alessi et al., 1997;Chou et al., 
1998;Le Good et al., 1998;Hresko and Mueckler, 2005); and RNA intereference 
(RNAi) (Eguez et al., 2005;Larance et al., 2005;Hresko and Mueckler, 2005;Sano 
et al., 2007;Larance et al., 2008). 
 
However the exact nature and function of the downstream effectors which 
mediate GLUT4 translocation need to be further investigated. In particular the 
target Rabs of AS160 need to be clearly defined. In vitro the GAP domain of 
AS160 acts on Rabs 2A, 8A, 10 and 14 (Miinea et al., 2005). Rabs 8A and 14 seem 
to be the targets of AS160 in muscle cells (Ishikura et al., 2007). However, in 
adipocytes AS160 acts on Rab10 (Sano et al., 2007;Sano et al., 2008). This may 
indicate that there are cell specific differences in the insulin signalling pathways 
regulating GLUT4 translocation. 
  
Also the sites of insulin action on GLUT4 translocation need to be better 
understood. The main effect of insulin is on the exocytosis of GLUT4 (Satoh et 
al., 1993). However exocytosis involves several steps each of which could be 
regulated by insulin (Holman and Sandoval, 2001;Zaid et al., 2008). Insulin could 
regulate budding of vesicles from the GLUT4 storage compartment or the 
trafficking of these vesicles to the plasma membrane (Thurmond and Pessin, 
2000;Xu and Kandror, 2002).  
More recent data seems to suggest that insulin’s main effect is on the docking 
(Lizunov et al., 2005) and/or fusion of GLUT4 vesicles with the plasma 
membrane (Koumanov et al., 2005;Bai et al., 2007;Huang et al., 2007;Jiang et 
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microscopy (TIRFM) to analyse the later stages of HA GLUT4 GFP in primary rat 
adipose cells. Their data showed that under basal conditions, GLUT4 vesicles 
moved rapidly along a microtuble network under the plasma membrane, only 
stopping occasionally and only briefly and loosely. In contrast under insulin 
stimulated conditions, GLUT4 vesicles were much less mobile and were tethered 
to the plasma membrane in clusters and then slowly fused with the plasma 
membrane (Lizunov et al., 2005).  
Several other studies have used TIRFM to analyse fusion of GLUT4 vesicles (Bai et 
al., 2007;Huang et al., 2007;Jiang et al., 2008). Bai et al. used time lapse TIRFM 
to observe the movement of vesicles containing GLUT4 EGFP in 3T3 L1 
adipocytes and did a quantitive analysis of the docking, priming and fusion of 
the vesicles with the plasma membrane and the transition kinetics between 
these steps. The authors showed that preparation of GSVs for fusion competence 
after docking is a key step regulated by insulin. They also showed that docking 
of GSVs is PI3K  and AS160 dependent. This suggests that alternative Akt 
substrates or alternative signalling pathways downstream of docking are a key 
site of insulin regulation (Bai et al., 2007). In another study, Huang et al. used 
TIRFM to track vesicles containg GLUT4 EGFP in 3T3 L1 adipocytes and 
developed  a computer program to analyse docking/fusion kinetics. They showed 
that insulin increased the frequency of fusion of GLUT4 vesicles by 
approximately four –fold. Also insulin decreases the duration of docking prior to 
fusion. This suggests that insulin signalling accelerates the transition from 
docking to fusion with the plasma membrane (Huang et al., 2007). Finally, Jiang 
et al. developed a novel dual coloured probe to monitor the translocation of 
3T3 L1 adipocytes. The probe was made up of the PH sensitive fluorescence 
protein PHluorin attached to the luminal terminus of IRAP and the red 
fluorescence protein TDimer2 to the cytosolic end of IRAP. PHluorin will be 
located in the lumen of the GSVs, which is acidic prior to fusion and will be 
exposed to the extracellular medium, which is neutral upon fusion. This will 
cause a brightening of PHluorin fluorescence. This allowed easy identification of 
fusion of single GSVs and also allowed tracking of the GSVs prior to fusion. The 
authors used TIRFM to visualise single Tdimer2 IRAP PHluorin vesicles.The study 
showed that insulin stimulation increased fusion of GSVs with the plasma 
membrane by approximately 40 fold (Jiang et al., 2008).  
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In addition an in vitro fusion assay involving mixing GLUT4 vesicles containing 
DyLight647 streptavidin tagged GLUT4 with plama membrane liposome 
containing EU(TMT) showed that the rate of GLUT4 vesicle fusion is stimulated 8 
fold by insulin.  Fusion was determined by analysing the FRET signal. Fusion was 
shown to be Akt dependent and required the recruitment of Akt to the plasma 
membrane (Koumanov et al., 2005).  
Other data suggests that translocation of GLUT4 to the plasma membrane is not 
sufficient for glucose transport into the cell. The authors suggest that insulin 
stimulates the activation of the GLUT4 molecules once they are inserted into the 
plasma membrane (Funaki et al., 2004). 
 
1.4 Intracellular protein trafficking 
Cells are highly organised and contain several different areas and compartments. 
An important aspect of this compartmentalisation is the localisation of proteins 
to specific compartments which ensures that the identity and function of the 
compartment is maintained. The sorting and transport of proteins to the correct 
compartment involves membrane trafficking (Rothman and Wieland, 1996). 
Membrane trafficking and the transport of proteins involves several steps. First 
of all, the cargo proteins to be transported are concentrated in a donor 
compartment or membrane. Transport vesicles, enriched in the cargo molecules 
are then formed from the donor membrane. These vesicles are then translocated 
to the target compartment or membrane. The vesicles then dock and fuse with 
the target membrane.  
Two of the most studied examples of intracellular protein trafficking are the 
secretory pathway and the endocytic pathway.   
1.4.1 Secretory pathway 
In the secretory pathway (van Vliet et al., 2003) newly synthesised membrane  
proteins and soluble proteins are first translocated into the endoplasmic 
reticulum (ER). The proteins are then packaged into vesicles and transported to 
the Golgi. Once at the Golgi, the proteins move through the Golgi cisternae to 
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their final destinations. Proteins in the secretory pathway can be sorted to a 
number of different destinations. Soluble proteins can be secreted from the cell 
or membrane proteins inserted into the plasma membrane by a process known as 
exocytosis, in which an intracellular trafficking vesicle fuses with the plasma 
membrane (Jahn, 2004). Alternatively proteins can be sorted to lysosomes or 
retained in an organelle in the secretory pathway. 
1.4.2 Endocytic pathway 
The endocytic pathway is the process by which membrane proteins, receptor 
associated ligands and solute molecules are delivered to various intracellular 
compartments (Maxfield and McGraw, 2004). First of all the proteins are 
packaged into an endocytic vesicle at the plasma membrane. The vesicle is then 
transported to an early endosome or sorting endosome compartment. From the 
sorting endosome proteins can be delivered to late endsomes and then the 
lysosome for degradation. Proteins can also be recycled back to the plasma 
membrane. Alternatively proteins can be transported from the sorting endosome 
to another part of the early endosome called the endocytic recycling 
compartment (ERC). Proteins in the ERC can either be recycled back to the 
plasma membrane or sorted to the TGN. 
 
1.4.3 Sorting signals in the secretory and endocytic pathways 
There are several signals which regulate the trafficking of proteins between 
compartments. A given protein can have multiple sorting signals, each specifying 
the fate of that protein at successive stages, i.e. whether the protein enters or 
avoids a transport vesicle. This determines the itinerary of the protein in the 
cell. A protein without sorting signals is transported by bulk flow of the 
membrane around the cell. Sorting motifs within the protein sequence can often 
bind to adaptor proteins which in turn bind to coat proteins, providing a link 
between cargo concentration and vesicle formation. Adaptor proteins such as 
APs (adaptor proteins) and GGAs (Golgi localised g ear containing Arf binding 
proteins) have important roles in the sorting of membrane proteins (Robinson, 
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Examples of the sorting signals include; the KDEL or HDEL motif which is 
important for the retrieval of soluble ER resident proteins from the Golgi. 
Soluble ER proteins contain the C terminal KDEL or HDEL sequence. This 
sequence is recognised by the Golgi localised receptor Erd2. Erd2 binds to the 
KDEL/HDEL sequence in the slightly acidic environment of the Golgi and releases 
it on arrival at the ER (Semenza et al., 1990;Lewis and Pelham, 1992). Erd2 
itself contains a dilysine retrieval sequence, K(X)KXX which interacts with the 
COPI coat protein (Cosson and Letourneur, 1994). 
Also, tyrosine based signals are require for the retrieval of Golgi localised 
proteins from the plasma membrane. For example, TGN38 has a SDYQRL motif 
which interacts with the m2 subunit of AP2 (Stephens et al., 1997).In addition, 
CI MPR trafficking is determined by an acidic cluster dileucine motif which binds 
to GGA proteins and by an aromatic residue motif (Chen et al., 1993;Schweizer 
et al., 1997).  
There are other examples of sorting signals regulating the trafficking steps in the 
secretory and endocytic pathway, however many are not yet fully understood. 
 
1.5 Intracellular trafficking of GLUT4 
The translocation of GLUT4 in response to insulin is an example of regulated 
membrane trafficking (Bryant et al., 2002). Under basal conditions, in the 
absence of insulin, GLUT4 is almost completely excluded from the cell surface. 
Insulin acts to greatly increase the exocytosis of GLUT4 containing vesicles to 
the plasma membrane, while only slightly decreasing their endocytosis (Suzuki 
and Kono, 1980;Cushman and Wardzala, 1980). This leads to a 10 to 20 fold 
increase in GLUT4 molecules at the cell surface. This effect of insulin is specific, 
as the plasma membrane level of the transferrin receptor (TfR) is only increased 
approximately two fold. 
1.5.1 Intracellular localisation of GLUT4 
GLUT4 is found in many organelles including the plasma membrane, sorting 
endosome, recycling endosome, TGN (Shewan et al., 2003), in tubulovesicular 
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the cytosol (Slot et al., 1991). It is thought GLUT4 occupies a complex 
tubulovesicular network that is connected to the endosomal –TGN system. GLUT4 
is also thought to reside in a specialised insulin responsive compartment (IRC), 
insulin responsive vesicles (IRVs) or GLUT4 storage vesicles (GSVs). 
1.5.2 GSVs 
The IRC or GSVs have been difficult to define and distinguish from the general 
endosomal system. GSVs are small insulin responsive vesicles which are highly 
enriched in GLUT4 molecules. They also contain vesicle associated membrane 
protein (VAMP)2 and insulin responsive aminopeptidase (IRAP) (Martin et al., 
1996;Ramm et al., 2000). IRAP traffics in concert with GLUT4 in response to 
insulin (Garza and Birnbaum, 2000) and enhances GLUT4 exocytosis in response 
to insulin (Yeh et al., 2007). The GSVs are also lacking in several proteins 
including TfR, cellubrevin (VAMP3) (Hashiramoto and James, 2000), cellugyrin 
(synaptogyrin 2) (Kupriyanova et al., 2002) and cation dependent mannose 6 
phosphate receptor (CD MPR) (Martin et al., 2000). GSVs are segregated from 
the general recycling endosomal system, as shown by chemical ablation of TfR 
containing endosomal compartments (Martin et al., 1996;Livingstone et al., 
1996). 
The precise mechanism by which the GSVs are formed is not fully known. 
Sortillin, a major component of GSVs has been shown to be sufficient and 
essential for GSV formation (Shi and Kandror, 2005). Further work has shown 
that it is the lumenal Vsp10p domain of sortillin which interacts with GLUT4 and 
IRAP and plays an important role in GSV formation (Shi and Kandror, 2007). Also  
GGAs are required for the sorting of GLUT4 (Watson et al., 2004;Li and Kandror, 
2005) and IRAP (Hou et al., 2006) into GSVs. It has been proposed that the 
formation of GSVs is driven by mass action, in which the expression of GLUT4, 
IRAP and sortillin, whose interaction and abundance fill the compartment, 
largely excludes other molecules (Pilch, 2008). Recently it has been shown that 
GSVs self assemble during differention of 3T3 L1 adipocytes and that lumenal 
interactions of GLUT4 and IRAP have an important role in the assembly of GSVs 
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The specialised GSV compartment is thought to be an important mechanism of 
basal intracellular retention of GLUT4 and it is thought that GLUT4 in this 
compartment translocates to the cell surface in response to insulin. 
 
1.5.3 Targeting sequences in GLUT4 
GLUT4 contains several motifs which regulate its localisation and trafficking 
(Lalioti et al., 2001). The majority of these motifs are found in the N  and C 
terminal domains. 
The FQQI motif in the N terminus has been shown to be important for the 
internalisation of GLUT4 from the cell surface (Garippa et al., 1994;Verhey et 
al., 1995). Other studies have found it may be involved in other aspects of 
GLUT4 trafficking. Substitution of Phe (5) for Ser leads to transport of GLUT4 to 
the late endosome/lysosome, where it is degraded (Palacios et al., 2001). FQQI 
is also involved in the entry of newly synthesised GLUT4 into the IRC (Khan et 
al., 2004) and the AS160 dependent exit of GLUT4 from the IRC (Capilla et al., 
2007). Recent work suggests that the FQQI motif may be involved in the basal 
retention of GLUT4 (Blot and McGraw, 2008).  
The LL motif in the C terminus of GLUT4 has also been shown to be important 
for the rapid endocytosis and retention of GLUT4 (Corvera et al., 1994). It is 
thought that the LL motif regulates the transport of internalised GLUT4 out of a 
fast recycling pathway into the retention pathway (Blot and McGraw, 2008).  
The FQQI and LL motifs belong to the aromatic based and dileucine based family 
of trafficking motifs respectively. These motifs regulate intracellular trafficking 
of membrane proteins by interacting with adaptor proteins involved in vesicle 
formation and clathrin recruitment (Bonifacino and Traub, 2003). However the 
proteins which interact with the GLUT4 motifs have not been identified. 
Several other residues and motifs in the C terminus are thought to be important 
for GLUT4 trafficking. These residues and motifs tend to be acidic in nature. The 
last 30 amino acids of the C terminus are sufficient for the correct localisation 
of GLUT4 into the IRC (Verhey et al., 1995). A YXXPDEND motif has been shown 
to be important for the release of GLUT4 from the IRC (Martinez Arca et al., 
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translocation to the plasma membrane (Song et al., 2008). Also a TELEYLGP 
motif regulates sorting of GLUT4 into a post endosomal compartment (Shewan et 
al., 2000;Cope et al., 2000). The TELEY motif is conserved in IRAP (Shewan et 
al., 2000). The post –endosomal compartment has been shown to be a subdomain 
of the TGN enriched with syntaxin(stx) 6 and 16 (Shewan et al., 2003). Recently 
it has been shown that TELEY is required for the full basal retention of GLUT4 
and that the trafficking step it is involved in is regulated by AS160 (Blot and 
McGraw, 2008). Other recent work suggests that the C terminus of GLUT4 is 
required for targeting of GLUT4 to a perinuclear IRV donor compartment but is 
not required for entry into the IRVs (Li et al., 2009).  
In addition to the motifs in the N  and C terminus, other motifs have been 
discovered which regulate GLUT4 trafficking. The large intracellular loop has 
been shown to be important for entry of GLUT4 into the IRC (Khan et al., 2004) 
and also the AS160 dependent exit of GLUT4 from the IRC. This intracellular loop 
also binds to the protein TUG (Tether containing a UBX domain for GLUT4) which 
is required to retain GLUT4 intracellularly in 3T3 L1 adipocytes in the absence of 
insulin (Yu et al., 2007). Also a phosphatidic acid binding motif, SQWL in the 
first intracellular loop of GLUT4 is involved in the insulin stimulated fusion of 
GLUT4 vesicles with the plasma membrane (Heyward et al., 2008).    
1.5.4 Models of GLUT4 trafficking 
There have been several models of GLUT4 trafficking proposed to explain the 
basal exclusion of GLUT4 from the plasma membrane and the high insulin 
responsiveness of GLUT4 translocation (Pessin et al., 1999;Dugani and Klip, 
2005). These models include retention mechanisms, dynamic sorting events and 
packaging GLUT4 into a more stationary population of secretory type vesicles or 
a static specialised compartment (Fig. 1.2). 
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Figure 1.2 Dynamic vs. static models of intracellular GLUT4 retention 
(Larance et al., 2008).  
A. In GLUT4 recycling experiments the intracellular GLUT4 is thought of as one 
pool. B. A dynamic recycling model in which GLUT4 recycles between endosomes 
and GSVs in the basal state. C. An alternative dynamic recycling model in which 
GSVs are an intermediate between the TGN and endosomes (Endo). D. Static 
retention model in which GSVs form a stable pool of GLUT4 which is only 
released to the plasma membrane/endosome cycle in response to insulin (ins). Nicola S Hamilton, 2010    Chapter 1, 33 
The retention model predicts that sequences in GLUT4 specifically target GLUT4 
containing vesicles away from the recycling endosome (Lalioti et al., 2001). 
These sequences bind to retention receptors found in insulin responsive cells, 
for example, TUG (Bogan et al., 2003;Yu et al., 2007). Insulin stimulation or 
competition by retention sequence peptides (Lee and Jung, 1997), disrupts the 
interaction between the GLUT4 sequences and the retention receptors, allowing 
the GLUT4 containing vesicles to enter the recycling endosomal system resulting 
in translocation to the plasma membrane.  
 
In the dynamic recycling model, the entire complement of GLUT4 eventually 
recycles to the plasma membrane in the basal state (Martin et al., 2006). 
GLUT4 containing vesicles undergo a futile cycle of fission and fusion with 
endosomes (Karylowski et al., 2004). Insulin acts to switch the fusion of these 
vesicles to the plasma membrane. Insulin promotes two routes for GLUT4 
mobilisation towards the plasma membrane, a direct route from the GLUT4 
containing vesicles and an indirect one from the GLUT4 containing vesicles via 
the endosomal recycling system (Ramm et al., 2000;Zeigerer et al., 2002). A 
variation of this model is that only a fraction of GLUT4 recycles to the plasma 
membrane in the basal state. Insulin increases the quantity of GLUT4 available 
for translocation via the recycling endosomal system (Coster et al., 2004). There 
also exists a latent pool of GLUT4 molecules which is never mobilised in response 
to insulin (Govers et al., 2004). 
 
In the secretory vesicle model GLUT4 is localised to both small synaptic like 
vesicles as well as larger tubulovesicular compartments. Insulin stimulation 
results in association and fusion of the vesicles with the plasma membrane (Xu 
and Kandror, 2002). Evidence in support of this is the fact that ablation of 
endosomes does not prevent insulin stimulated GLUT4 translocation (Martin et 
al., 1998) and that GSVs share characteristics of small synaptic vesicles. 
  
These models are not mutually exclusive. Recent work has shown that GLUT4 is 
regulated by both static and dynamic retention mechanisms (Muretta et al., 
2008). Also the authors suggest that cell culture conditions can affect GLUT4 
trafficking, for example replating 3T3 L1 cells after differentiation inhibits static 
retention of GLUT4.  Parts of each model can be incorporated into a model (Fig. 
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mechanisms (Bryant et al., 2002). It is proposed that intracellular GLUT4 
occupies two interrelated and overlapping endosomal cycles. The first is a fast 
trafficking cycle involving the plasma membrane and the early endosome. In the 
absence of insulin it is this cycle which internalises GLUT4. Once in the 
endosome, GLUT4 is further sorted into a slow trafficking cycle involving the 
endosome, the TGN and GSVs. It is thought that it is the GLUT4 in these GSVs 
which translocates to the plasma membrane in response to insulin. Recent data 
also supports a model in which basal GLUT4 retention involves two intracellular 
trafficking cycles (Blot and McGraw, 2008). Nicola S Hamilton, 2010    Chapter 1, 35 
 
 
 
Figure 1.3. GLUT4 trafficking model. Modified from (Bryant et al., 2002). 
GLUT4 occupies two intracellular overlapping trafficking cycles. Cycle 1 includes 
the plasma membrane and endosomes. Cycle 2 includes endosomes, TGN and 
GSVs. GLUT4 in the GSVs translocates to the cell surface in response to insulin.  Nicola S Hamilton, 2010    Chapter 1, 36 
1.6 SNAREs and membrane fusion  
The trafficking of GLUT4 involves the fusion of vesicles with specific membranes 
which is mediated by target  (t ) and vesicle  (v ) SNAREs (soluble N 
ethylmaleimide sensitive factor attachment protein receptors) (Hong, 2005). 
During membrane trafficking or vesicle mediated transport, vesicles are formed 
from a donor compartment or membrane. These transport vesicles are then 
translocated to the target compartment or membrane. Then the vesicles dock 
and fuse with the target membrane. SNAREs function in the final docking and 
fusion stages of this process and catalyse the final fusion step (Chen and 
Scheller, 2001). 
 
1.6.1 Classification of SNAREs 
SNAREs are small membrane proteins of around 100 300 amino acids in length, 
which function in membrane fusion. There are three main subfamilies of SNAREs; 
syntaxin (stx), synaptobrevin/ vesicle associated membrane protein (VAMP) and 
synaptosomal associated protein, 25 kDa (SNAP 25)/ light chain subfamily.  
Functionally SNAREs can be classified into v SNAREs that are associated with the 
vesicle and t SNAREs that are associated with the target membrane (Hong, 
2005). A v SNARE consists of a single membrane spanning protein containing one 
SNARE motif, whereas a t SNARE consists of two or three proteins. There are two 
types of t SNARE complex. A heterodimeric t SNARE complex contains one 
member of the stx subfamily, contributing one SNARE motif and a member of the 
SNAP 25 subfamily which contributes two SNARE motifs.  A heterotrimeric t 
SNARE complex consists of one member of the stx subfamily, one SNARE related 
to the N terminal half of SNAP 25 and one SNARE related to the C terminal half 
of SNAP 25, each contributing one SNARE motif.  
SNAREs are also classified structurally as R SNAREs (arginine containing SNARE) 
or Q SNAREs (glutamine containing SNARE) on the basis of a conserved residue in 
their SNARE motif (Fasshauer et al., 1998). All members of the VAMP subfamily 
are R SNAREs, the stx subfamily are Qa SNAREs, SNAREs related to the N 
terminal half of SNAP 25 are Qb SNAREs and SNAREs related to the C terminal 
half of SNAP 25 are Qc SNAREs. Nicola S Hamilton, 2010    Chapter 1, 37 
1.6.2 Membrane fusion 
The mechanism by which SNAREs mediate fusion involves several steps (Fig. 1.4) 
(Jahn and Scheller, 2006). First of all, during vesicle formation, the v SNARE is 
packaged with cargo proteins into the budding vesicle. This ensures that the 
vesicle is competent to fuse with the target membrane. Meanwhile on the target 
membrane the heterodimeric or heterotrimeric t SNARE complex forms. As the 
vesicle arrives at the target membrane, the vesicle is brought to the correct 
location in the membrane by tethering factors, such as Rab proteins. The 
tethering factors facilitate the pairing of the v SNARE with its cognate t SNARE 
complex. The v SNARE binds to its cognate t SNARE complex, docking the vesicle 
to the target membrane. The SNARE motifs of the proteins “zipper up,” starting 
from the membrane distal N terminus to the membrane proximal C terminus, 
leading to the formation of the trans SNARE complex. This involves the 
organisation of the SNARE motifs into a four helix bundle known as the core 
complex. This process brings the two opposing membranes closer together. The 
energy released during the formation of the stable trans SNARE complex 
overcomes the energy barrier to membrane fusion which is created by the 
negative charges of the phospholipid headgroups in the lipid bilayers. The trans 
SNARE complex is thought to directly catalyse fusion of the opposing 
membranes.  
During membrane fusion, as the membranes are brought closer together, the 
outer leaflets of the two membranes start to merge, resulting in hemifusion. 
This follows with breakdown of the inner leaflets to form a fusion pore. The 
fusion pore expands leading to full fusion of the two membranes.  The trans 
SNARE complexes which were formed before membrane fusion are now on the 
same fused membrane and are known as cis SNARE complexes. To allow 
subsequent rounds of vesicle transport, the cis SNARE complex needs to be 
disassembled. This is catalysed by the ATPase N ethylmaleimide sensitive factor 
(NSF) and its cofactor a SNAP (soluble NSF attachment protein). The 
disassembled SNAREs are then sorted back to their correct compartment. Nicola S Hamilton, 2010    Chapter 1, 38 
 
 
 
Figure 1.4. Membrane fusion (Jahn and Scheller, 2006).  
Figure shows the main steps involved in membrane fusion. See main text for 
more details. Nicola S Hamilton, 2010    Chapter 1, 39 
1.6.3 Structure of SNARE complexes 
SNAREs have a highly conserved structure (Brunger, 2005). The majority of 
SNAREs contain three domains, an N terminal domain, a SNARE domain and a 
transmembrane domain (Fig. 1.5). The main feature of these proteins is the 
SNARE domain of around 60 residues, which is found in all SNAREs. The SNARE 
domain consists of heptad repeats which form coiled coil structures. Most 
SNAREs contain an extended N terminal domain with coiled coil regions. The 
structure of the N terminal domain varies and this domain is involved in a 
variety of functions. The N terminal domain of the stx subfamily has a three 
helical bundle consisting of Ha, Hb and Hc regions. These regions can bind to the 
C terminal SNARE domain generating a closed conformation, which needs to be 
opened before assembly into a t SNARE complex. The N terminal domain of the 
stx subfamily can also be involved in interactions with regulators of SNARE 
assembly. For example the N terminus of stx 16 binds to the Sec1/Munc18 (SM) 
protein mVps45 (Dulubova et al., 2002). Finally the N terminal domain can 
direct intracellular targeting of the SNARE, for example the N terminal region of 
VAMP4 targets the SNARE to the TGN by a di leucine motif and an acidic cluster 
(Zeng et al., 2003). Nicola S Hamilton, 2010    Chapter 1, 40 
 
 
 
Figure 1.5. General structure of SNAREs (Hong, 2005).  
General structure of different SNAREs. Upper panel shows the main domains in 
SNAREs. Lower panel shows the different N terminal regions of SNAREs.Nicola S Hamilton, 2010    Chapter 1, 41 
During membrane fusion a trans SNARE complex is formed. The trans SNARE 
complex is composed of a tightly packed parallel four helix bundle, with each 
member of the SNARE subfamilies contributing one or two helices (Fasshauer, 
2003) (Fig.1.6). In the interior of the SNARE bundle the four helices are 
connected by 16 layers ( 7 to +8) of interacting amino acid side chains. These 
residues are mostly hydrophobic in nature and are highly conserved in SNAREs 
(Antonin et al., 2002). In the middle of the bundle (0 layer) there is an unusual 
hydrophilic layer consisting of 3 Glutamine (Gln, Q) and 1 Arginine (Arg, R) 
residues (Fasshauer et al., 1998). This is known as the 3Q:1R or QaQbQcR 
configuration. Mutations have shown that the 3Q:1R configuration is important 
for SNARE function in membrane fusion. However compensatory mutations in the 
0 layer can restore membrane fusion (Fratti et al., 2007). Nicola S Hamilton, 2010    Chapter 1, 42 
 
  
 
Figure 1.6. Structure of an endosomal SNARE complex. Modified from 
(Antonin et al., 2002).  
Schematic view of an endosomal SNARE complex. Endobrevin is shown in blue, 
stx 7 in red, Vti1b in light green and stx 8 in dark green. N and C denote the N  
and C termini of the SNARE complex. Amino acid side chains are shown as sticks. Nicola S Hamilton, 2010    Chapter 1, 43 
1.6.4 Role of SNARE function in membrane fusion 
Several studies suggest that SNAREs have a role in membrane fusion.  Clostridial 
neurotoxins inhibit neurotransmitter release in neurons. Schiavo et al. showed 
that clostridial neurotoxins such as tetanus toxin and botulinum toxin are zinc 
endopeptidases which act specifically on the SNARE synaptobrevin 2 (Schiavo et 
al., 1992). They also showed that blocking of neurotransmitter release in Aplysia 
neurons by injection with tetanus or botulinum B toxin is delayed by the 
presence of synaptobrevin 2 peptides, containing the neurotoxin cleavage site. 
This suggests that tetanus and botulinum B neurotoxins block neurotransmitter 
release by cleaving synaptobrevin 2 and that synaptobrevin 2 plays an important 
role in neurotransmitter release. Another study examined catecholamine 
secretion from bovine adrenal chromaffin cells (Xu et al., 1998). Using flash 
photolysis of caged intracellular calcium to induce exocytosis and capacitance 
measurements and amperometry the authors observed distinct kinetic 
components of vesicle fusion. These components were exocytic burst (which 
represents the fusion of release competent vesicles) and a later slow component 
(which represents recruitment of vesicles to the ready release pool). Botulinum 
A cleaves nine amino acids from the C terminal of SNAP 25. This results in a 
reduction in the fast component of exocytic burst, which suggests that SNAP 25 
is involved in final stage of exocytosis ( i.e. the fusion of docked vesicles with 
the membrane) (Xu et al., 1998). In a further study by Xu et al. it was shown 
that the inital fast component of exocytic burst was inhibited by a blocking 
antibody (specific to SNAP 25A) which prevented the assembly of the ternary 
SNARE complex containing syntaxin 1A, synaptobrevin 2 and SNAP 25A (Xu et al., 
1999).  
 
Genetic studies have also shown the importance of SNAREs in membrane fusion. 
A temperature sensitive paralytic mutation in syntaxin of D. Melanogaster 
rapidly blocks synaptic transmission at non permissive temperatures. The 
mutation (a substitution of Ile for Thr at position 254 in the SNARE domain of 
syntaxin), specifically and selectively decreases binding of syntaxin to 
synaptobrevin and abolishes assembly of the SNARE complex between syntaxin, 
snaptobrevin and SNAP 25. This failure to assemble the SNARE complex results in 
an increase in docked vesicles and leads to a block in synaptic transmission. This 
suggests that syntaxin synaptobrevin interaction and SNARE complex assembly Nicola S Hamilton, 2010    Chapter 1, 44 
are required for exocytosis (Littleton et al., 1998). In a VAMP2 knockout mouse, 
the rate of spontaneous synaptic vesicle fusion was decreased by approximately 
10 fold and the rate of calcium triggered synaptic vesicle fusion was decreased 
by over 100 fold (Schoch et al., 2001). 
 
An In vitro study using a synthetic liposome fusion system has shown that SNAREs 
are both necessary and sufficient for fusion to occur (Weber et al., 1998). The 
SNAREs VAMP 2, syntaxin 1A and SNAP 25 were reconstituted into vesicles. 
Fusion was monitored by measuring lipid mixing. The vesicles containing the v 
SNARE VAMP2 also contained a quenched mixture of fluorescent phospholipids 
NBD PE (N (7 nitro 2, 1, 3 benzoxadiazole 4 yl) phosphatidylethanolamine) and 
rhodamine PE. When the fluorescent “donor” vesicles fused with non fluorescent 
“acceptor” vesicles (containing the t SNAREs syntaxin 1A and SNAP 25) the 
fluorescent lipid was diluted and the quenching decreased, resulting in an 
increase in NBD fluorescence at 538 nm. Fusion was disrupted by pre incubation 
of free SNAREs with botulinum toxin D or with soluble cytoplasmic domains of 
SNAREs. However this disruption did not occur once SNARE complexes have been 
formed. This suggests that SNARE complex assembly is necessary and sufficient 
for fusion. However the rate of fusion in vitro was much slower than in vivo with 
a half time of around 10 minutes, which suggests that although SNAREs are 
sufficient for membrane fusion, other factors are required in vivo to aid fusion.  
 
Despite this large amount of evidence in support of SNAREs as mediators of 
membrane fusion, some studies have suggested that perhaps SNAREs are not 
involved in the fusion process. A yeast study of vacuolar fusion showed that 
disruption of SNARE complexes by a blocking antibody did not affect content 
mixing of vacuoles (Ungermann et al., 1998). Also in fusion of sea urchin egg 
cortical vesicles, calcium ions were found to dissociate SNARE complexes 
without disrupting fusion (Tahara et al., 1998). It has also been suggested that 
proteins other than SNAREs can mediate fusion in vitro which may mediate 
fusion in vivo. (Jahn and Grubmuller, 2002). 
 
More recent papers have focussed on how SNARE assembly leads to membrane 
fusion and whether the energy released during assembly is sufficient to induce 
membrane fusion. 
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Sorensen et al. investigated whether SNARE complex assembly of the SNAREs, 
SNAP 25, syntaxin and synaptobrevin occurs in the N  to C terminal direction 
(Sorensen et al., 2006).Using alanine mutations in the N  and C terminal regions 
of the SNARE complex, they showed that C terminal mutations in SNAP 25 
reduced fusion triggering in embryonic chromaffin cells and lead to unfolding of 
the SNARE complex in vitro. This suggests that the C terminal region of SNAREs 
can assemble /disassemble independently. In contrast N terminal mutations in 
SNAP 25 were without effect on fusion. These results suggest that SNARE 
complex assembly occurs from the N terminal end to the C terminal end. 
 
The linker region between the SNARE domain and the transmembrane domain is 
thought to have important role in transducing the energy from SNARE assembly 
to the membrane, leading to fusion. Two studies have illustrated the importance 
of the linker region in fusion. Introduction of two “helix breaking” proline 
residues in the juxtamembrane region of syntaxin reduced fusion by 50% in a 
liposome fusion assay. Also insertion of a flexible linker to increase the distance 
between the cytoplasmic and transmembrane domain of syntaxin lead to a 50% 
decrease in fusion (McNew et al., 1999). In a further study, replacement of the 
transmembrane domain anchors of VAMP2 and syntaxin 1A with a covalently 
attached phospholipid (phosphatidylethanolamine) completely inhibited fusion in 
a liposome fusion assay (McNew et al., 2000b). 
 
Studies have also investigated the energy produced during SNARE assembly and 
whether this energy is sufficient to fuse membranes. Li et al. used surface forces 
apparatus to determine the energetics and dynamics of SNARE complex 
formation (Li et al., 2007). The authors found that the energy stabilising a single 
SNARE complex (35 KBT) corresponds closely with the energy required to fuse the 
outer leaflet of a lipid bilayer (hemifusion). Sorenson et al. used free energy 
perturbation simulations to determine the effect of mutations in the C terminal 
region of SNAP 25 on the thermodynamic stability of the SNARE complex 
between SNAP 25, syntaxin and synaptobrevin. The DDG for the SNAP 25 L78A, 
L81A, M201A mutant was 45KJ/mol. This suggests that assembly of the C 
terminal end of the SNARE complex may provide substantial energy for 
membrane fusion. 
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A number of studies have also investigated how many SNAREs are necessary for 
fusion of a vesicle with a membrane. Using a permeablised PC12 cell system, the 
effect of an increasing concentration of the soluble domain of VAMP2 on 
membrane fusion was determined. The increased inhibition of fusion with 
increasing concentration of VAMP2 best fit to a model in which three SNARE 
complexes mediate fusion of a single vesicle (Hua and Scheller, 2001). Han et al. 
showed that mutations in the transmembrane domain of syntaxin altered 
neurotransmitter flux through fusion pores and altered pore conductance in 
PC12 cells (Han et al., 2004). The mutations were on the same face of the 
transmembrane alpha helix and lined the fusion pore. This suggested a model in 
which the syntaxin transmembrane domains form a circular arrangement of 5 8 
molecules in the plasma membrane forming a fusion pore. Kinetic analysis of the 
docking and fusion of synaptobrevin containing vesicles with a t SNARE complex 
containing planar membrane in a single vesicle fusion assay using TIRFM, 
suggested a kinetic model in which fusion sites consisted of 8 SNARE complexes 
that each activate a single rate limiting step (Domanska et al., 2009). Electron 
paramagnetic resonance (EPR) and fluorescence analyses also show that at least 
three copies of t SNAREs self assemble through interaction between the 
transmembrane domains (Lu et al., 2008). This multimeric structure serves as a 
scaffold for trans SNARE complex formation leading to hemifusion.   
 
1.6.5 Specificity of membrane fusion and the SNARE hypothesis 
In addition to their function in promoting fusion, SNAREs also have a role in 
ensuring specificity of membrane fusion.  In 1993 Sollner et al. proposed the 
SNARE hypothesis (Sollner et al., 1993). It proposes that each transport vesicle 
has its own v SNARE that pairs up with its unique cognate t SNARE complex in 
the appropriate target membrane, and that this specific interaction docks 
vesicles at the correct membrane. 
 
Several studies support the SNARE hypothesis.  Firstly for most trafficking steps 
there is only one set of SNAREs involved.  Also it has been shown that for 
exocytosis in PC12 cells only specific SNAREs inhibit or rescue this process 
(Scales et al., 2000). In addition several liposome based fusion studies have 
shown specificity in SNARE pairing (McNew et al., 2000a;Parlati et al., 
2002;Paumet et al., 2004).  Nicola S Hamilton, 2010    Chapter 1, 47 
However some SNAREs can function in more than one trafficking step and in 
some cases substitute for other SNAREs (Gotte and von Mollard, 1998). Several 
studies have shown promiscuity of SNARE interactions (von Mollard et al., 
1997;Yang et al., 1999;Fasshauer et al., 1999;Tsui and Banfield, 2000). The 
SNARE hypothesis suggests that SNAREs dock vesicles at the correct membrane. 
However disruption of SNAREs does not seem to affect vesicle docking (Hunt et 
al., 1994;Broadie et al., 1995). SNAREs have a high level of structural 
conservation which may explain their promiscuity. Also SNAREs localise to 
specific membranes and compartments and this may be the mechanism by which 
they mediate specificity of membrane fusion events. It has been suggested that 
in vivo other proteins are required for the docking of vesicles with specific 
membranes (Zerial and McBride, 2001). Recent data suggests that in biological 
membranes SNARE specificity is mediated by both a preference for cognate 
SNAREs in the trans configuration (which may involve proof reading proteins such 
as SM proteins) and lateral segregation of SNAREs at the site of fusion (Bethani 
et al., 2007). 
1.6.6 Regulation of SNARE function 
The action of SNAREs can be regulated by several factors including SNARE 
binding proteins, for example SM proteins and post translational modifications 
such as phosphorylation (Gerst, 2003;Malsam et al., 2008). This regulation 
ensures that functional SNARE complexes and therefore membrane fusion only 
occurs at the right time and place. Regulation is needed to prevent 
inappropriate trans SNARE pairing between cognate SNAREs before they are 
required, to ensure that only SNARE molecules at the site of fusion are activated 
for fusion and to aid catalysis of SNARE assembly. SNARE regulators act by 
maintaining SNARE proteins in conformations which are either well or poorly 
disposed to assembly. 
SM proteins are a family of proteins which have been shown to be essential for 
vesicle trafficking. For example, a temperature sensitive mutant of the yeast SM 
protein Vps45p causes an accumulation of post Golgi vesicles (Piper et al., 
1994). SM proteins bind to stxs and regulate SNARE complex assembly (Toonen 
and Verhage, 2003;Sudhof and Rothman, 2009). They function to positively 
regulate SNARE complex assembly by regulating t SNARE receptivity. SM proteins 
bind to stxs in three different modes (Carpp et al., 2006;D'Andrea Merrins et al., Nicola S Hamilton, 2010    Chapter 1, 48 
2007;Aran et al., 2009;Furgason et al., 2009). In the first mode the SM protein 
binds to the stx in a closed conformation, preventing the formation of SNARE 
complexes (mode A Fig. 1.7). In the second mode (mode B) the N terminal lobe 
of the SM protein binds to the N terminal peptide of the stx. This mode of 
binding allows the t SNARE complex to assemble and then accept the v SNARE, 
forming a trans SNARE complex. SM proteins also bind the trans SNARE complex. 
Interaction of the SM protein with the trans SNARE complex (mode C) stimulates 
membrane fusion and adds specificity to membrane trafficking. 
There is a lot of data to support the binding of SM proteins to the closed 
conformation of stxs. For example, stx 4 lacking the N terminal 36 amino acids 
(Stx 4 –ND) is still able to bind to Munc 18c (Aran et al., 2009). Also Tlg2p ND is 
able to bind to the mutant Vps45p L117R (Furgason et al., 2009). Vps45p L117R 
is a “pocket fill” mutant which is unable to bind the N terminal peptide of 
Tlg2p. Also Tlg2p(37 192), containing the Habc domain and Tlg2p(221 318), 
containing the linker and SNARE motif, are unable to bind Vps45p or compete 
with Tlg2p ND for binding to Vps45p (Furgason et al., 2009). In addition, 
mutation of I285, a residue present in the SNARE motif which should contact  
Vps45p when in the closed conformation, inhibits C terminal binding of Tlg2p to 
Vps45p (Furgason et al., 2009). 
There is also evidence to support binding of the N terminal peptide of stx to SM 
proteins.  The Vps45p L117R “pocket fill” mutation completely abolishes binding 
of Vps45p with Tlg2p (Carpp et al., 2006). In another study, a D3R mutation in 
the N terminal peptide of stx 4 CFP resulted in a 40% reduction in FRET with 
cYFP Munc 18c. In addition D3R mutation in a constitutively open mutant of stx 4 
(stx 4 L173A, E174A) completely eliminated binding to Munc 18c (D'Andrea 
Merrins et al., 2007). Another mutation in the N terminal peptide of stx 4 (L8K), 
significantly reduced binding of Munc 18c to both wildtype and constitutively 
open stx 4 (Aran et al., 2009). The crystal structure of the N terminal peptide 
bound to Munc 18c identified Leu 8 of stx 4 as making a crucial contact with the 
hydrophobic pocket in domain 1 of Munc 18c (Hu et al., 2007). 
Finally, there is some evidence to support the binding of SM proteins to the 
trans SNARE complex. His6 Vps45p interacts directly with the cytosolic domains 
of the Tlg2p and the V SNARE Snc2p. Also this interaction is specific to Vps45p as 
Snc2p does not bind to the SM protein Munc 18c (Carpp et al., 2006). The Nicola S Hamilton, 2010    Chapter 1, 49 
interaction between Snc2p is mediated by its SNARE motif as a version of Snc2p 
lacking its N terminal region (Snc2pD2 19) binds efficiently to Vsp45p. This 
supports a bridging hypothesis, whereby the SM protein forms a bridge between 
t SNAREs and their cognate v SNAREs (Peng and Gallwitz, 2004). 
 In addition to a role in SNARE complex assembly, SM proteins have been 
implicated in stx stabilisation and transport (Bryant and James, 2001;Carpp et 
al., 2007). Nicola S Hamilton, 2010    Chapter 1, 50 
 
 
Figure 1.7. Binding modes of SM proteins (Sudhof and Rothman, 2009). 
A. SM protein binds to the closed conformation of the stx. Inset shows the 
residues of the stx N terminus which interact with the SM protein in this mode. 
B. SM protein binds to the N terminal peptide of the stx. C. SM protein binds to 
the trans SNARE complex. Positions of the SM protein in B and C are arbitrary. Nicola S Hamilton, 2010    Chapter 1, 51 
SNAREs can also be regulated by phosphorylation. It has been shown that 
dephosphorylation of t SNAREs modulates exocytosis and endocytosis in yeast, by 
regulating the assembly of SNARE complexes (Marash and Gerst, 
2001;Gurunathan et al., 2002). Yeast cells lacking Snc1p and Snc2p (snc) are 
defective in exocytosis. This defect can be ameliorated by treatment with 
ceramide which results in dephosphorylation of Ssop t SNAREs and the formation 
of complexes between Ssop and Sec9p t SNAREs. Sso1p has a protein kinase A 
(PKA) phosphorylation site at Ser 79. Mutation of this site to alanine rescues snc 
cells in the absence of ceramide. Also phosphorylation of Sso1p in vitro by Tpk1p 
prevents assembly of Sso1p into complexes with Sec9p (Marash and Gerst, 2001). 
These results suggest that t SNARE phosphorylation by PKA inhibits SNARE 
assembly and subsequent fusion in yeast. The results also suggest a ceramide 
regulated pathway can restore exocytosis in snc cells by dephosphorylating t 
SNAREs.  
Yeast cells lacking the v SNAREs Snc1p and Snc2p and Tlg1p or Tlg2p t SNAREs 
are defective in endocytosis.  Treatment of these yeast cells with ceramide 
restores endocytosis. Ceramide treatment also promotes assembly of Tlg1p and 
Tlg2p into complexes in snc cells. Also mutation of single PKA sites in Tlg1p (Ser 
31) or Tlg2p (Ser 90) to alanine is sufficient to restore endocytosis in snc cells in 
the absence of ceramide. In vitro phosphorylation of Tlg1p and Tlg2p by Tpk1p 
inhibits complex assembly (Gurunathan et al., 2002). These results suggest that 
like exocytosis, endocytosis is regulated by t SNARE phosphorylation in vivo. It is 
thought that phosphorylation regulates the availability of t SNAREs to participate 
in trafficking events. 
 
In addition to the yeast SNAREs Sso1p, Tlg1p and Tlg2p, there are other SNAREs 
which have been found to be phosphorylated. Stx 1 is phosphorylated by several 
kinases including, casein kinase I (CKI) (Dubois et al., 2002), CKII (Bennett et al., 
1993;Hirling and Scheller, 1996;Foster et al., 1998;Risinger and Bennett, 
1999;Dubois et al., 2002), calcium/calmodulin dependent protein kinase II 
(CaMKII) (Hirling and Scheller, 1996;Ohyama et al., 2002) and death associated 
protein (DAP) kinase (Tian et al., 2003). Stx 4 is phosphorylated by CKII (Foster 
et al., 1998;Risinger and Bennett, 1999) and PKA (Foster et al., 1998). SNAP 25 
is phosphorylated by PKC (Shimazaki et al., 1996;Genoud et al., 1999) and PKA 
(Risinger and Bennett, 1999). SNAP 23 is also phosphorylated by PKC (Polgar et Nicola S Hamilton, 2010    Chapter 1, 52 
al., 2003). Finally VAMP2 is phosphorylated by CKII and CaMKII (Nielander et al., 
1995). 
Stx 1 is phosphorylated at Ser 14 by CKII (Bennett et al., 1993). This 
phosphorylation of stx 1 by CKII enhances its interaction with synaptotagmin I 
(Risinger and Bennett, 1999). Phosphorylated stx 1 also associates with SNAP 25 
and localises to discrete domains of axonal plasma membranes which may define 
fusion sites (Foletti et al., 2000). In addition, phosphorylation of stx 1 at Ser 14 
decreases the N terminal interaction of stx 1 with Munc 18 1 at the plasma 
membrane and reduces vesicle mobility and exocytosis (Rickman and Duncan, 
2010). Stx 1 is also phosphorylated by CaMKII at Thr 161 in the linker domain. 
Phosphorylation at Thr 161 by CaMKII does not affect the binding of CaMKII to stx 
1 (Ohyama et al., 2002). Stx 1 is phosphorylated by DAP kinase at Ser 188 in the 
linker domain of stx 1 both in vitro and in vivo in a Ca
2+ dependent manner. Stx 
1 phosphorylation by DAP kinase decreases stx 1 binding to Munc 18 1 (Tian et 
al., 2003). 
The phosphorylation sites of stx 4 for CKII and PKA were not determined (Foster 
et al., 1998;Risinger and Bennett, 1999). However it was shown that 
phosphorylation of stx 4 by PKA disrupted its binding to SNAP 23 (Foster et al., 
1998). The authors suggest that PKA may modulate stx 4 dependent SNARE 
complex formation to regulate exocytosis in non neuronal cells. 
SNAP 25 is phosphorylated at Ser 28, Ser 187 and Thr 29 by PKC (Shimazaki et 
al., 1996;Genoud et al., 1999). Phosphorylation of SNAP 25 at Ser 187 decreases 
binding of SNAP 25 to syntaxin (Shimazaki et al., 1996). Phosphorylation of SNAP 
25 at Ser 187 in vivo increases vesicle recruitment in chromaffin cells (Nagy et 
al., 2002). The authors suggest that the decreased binding of SNAP 25 to 
syntaxin prevents inappropriate SNARE interactions.  SNAP 25 is also 
phosphorylated at Thr 138 by PKA, although this phosphorylation does not affect 
binding to syntaxin (Risinger and Bennett, 1999). However PKA phosphorylation 
at Thr 138 increases the size of the ready releasable pool of vesicles in 
chromaffin cells (Nagy et al., 2004). 
SNAP 23 is phosphorylated at Ser 13/Thr 14 and Ser161 by PKC (Polgar et al., 
2003). The authors could not determine which of Ser 13 or Thr 14 were 
phosphorylated but did show that phosphorylation at these sites inhibits the Nicola S Hamilton, 2010    Chapter 1, 53 
interaction between SNAP 23 and syntaxin. SNAP 23 is also phosphorylated at Ser 
95 and Ser 120 in rodent mast cells (Hepp et al., 2005). This phosphorylation 
occurs after degranulation and after stimulation occurs, essentially all of the 
SNAP23 that is bound to stx 4 and VAMP 2 is phosphorylated.  
VAMP 2 is phosphorylated in vitro at Thr 35 and Ser 61 by CaMKII and at Ser 75 
by CKII (Nielander et al., 1995). As the study was done in vitro the significance 
of these phosphorylations was not determined.   
1.7 SNAREs involved in GLUT4 trafficking 
The SNAREs involved in fusion of GLUT4 containing vesicles with the plasma 
membrane have been well characterised (Thurmond and Pessin, 2001). The v 
SNARE VAMP2 has been found to reside in GSVs (Martin et al., 1996) and has 
been shown to be important for translocation of GSVs to the plasma membrane 
in response to insulin (Martin et al., 1998). VAMP2 forms a complex with the t 
SNAREs stx 4 and SNAP 23 which are highly enriched in the plasma membrane of 
fat and muscle cells. This results in fusion of the GLUT4 containing vesicle with 
the plasma membrane. The assembly of the trans SNARE complex between 
VAMP2, stx 4 and SNAP 23 is regulated by the SM protein Munc18c (Brandie et 
al., 2008). 
In contrast the identity of the SNAREs involved in GLUT4 intracellular trafficking 
remains largely unknown. It has been shown that the t SNARE stx 6 has a role in 
GLUT4 trafficking. Stx 6 colocalises with perinuclear GLUT4 in a subdomain of 
the TGN and is highly enriched in immunoisolated GLUT4 vesicles. Also insulin 
stimulates movement of stx 6 from intracellular membranes to the plasma 
membrane of adipocytes (Shewan et al., 2003).  Overexpression of the cytosolic 
domain of stx 6 in adipocytes increases basal levels of glucose transport and cell 
surface levels of GLUT4, but does not affect insulin stimulated glucose transport 
or GLUT4 translocation (Perera et al., 2003). However reversal of insulin 
stimulated glucose transport and the rate of internalisation of GLUT4 from the 
plasma membrane after insulin withdrawal are significantly slowed in cells 
overexpressing the cytosolic domain of stx 6. Also overexpression of the cytosolic 
domain of stx 6 significantly reduces the amount of GLUT4 reaching the GSV 
compartment after insulin withdrawal (Perera et al., 2003). This data suggests 
that stx 6 may be involved in trafficking of GLUT4 into its storage site. Nicola S Hamilton, 2010    Chapter 1, 54 
 
1.8 Syntaxin 16 
Stx 16 is a member of the stx subfamily of SNAREs (Teng et al., 2001). Its yeast 
homologue is Tlg2p (Struthers et al., 2009). Stx 16 is located in the TGN 
(Simonsen et al., 1998;Tang et al., 1998) and is known to be involved in early 
endosome to TGN transport (Mallard et al., 2002). It is required for the efficient 
retrograde transport of Shiga toxin, cholera toxin, ricin and the mannose 6 
phosphate receptor (Amessou et al., 2007). Stx 16 forms a t SNARE complex with 
stx 6 and Vti1a (Mallard et al., 2002) and also with stx 10 and Vti1a, however the 
latter complex is not formed in murine cells and is specifically required for the 
retrograde transport of mannose 6 phosphate receptor (Ganley et al., 2008). Stx 
16 also binds to the SM protein mVps45 (Dulubova et al., 2002) which regulates 
its assembly into SNARE complexes. 
 
1.9 Role of syntaxin 16 in GLUT4 trafficking 
In addition to its role in retrograde transport, stx 16 is proposed to have a role in 
GLUT4 trafficking. There are data to support a role for stx 16 in GLUT4 
trafficking. The expression of stx 16 is significantly upregulated during adipocyte 
differentiation. It colocalises with GLUT4 in a subdomain of the TGN and is 
highly enriched in GLUT4 vesicles. Also insulin stimulation results in the 
translocation of stx 16 to the cell surface in a similar manner to GLUT4 (Shewan 
et al., 2003). Recently it has been shown that overexpression of the cytosolic 
domain of stx 16 significantly slows the reversal of insulin stimulated glucose 
transport. Depletion of stx 16 using a morpholino antisense oligonucleotide 
reduces insulin stimulated glucose transport over a range of insulin 
concentrations and slows the reversal of glucose transport after insulin 
withdrawal (Proctor et al., 2006).Stx 16 knockdown also reduces the 
translocation of GLUT4 to the cell surface in response to insulin. It was also 
noted in stx 16 depleted cells that total GLUT4 cellular levels were reduced by 
30% which suggests that GLUT4 is missorted to a degradative pathway in these 
cells. The effect of stx 16 is specific to GLUT4 trafficking as there was no effect 
on the delivery of TfR to the cell surface (Proctor et al., 2006). This data 
suggests that stx 16 regulates intracellular trafficking of GLUT4. In particular it Nicola S Hamilton, 2010    Chapter 1, 55 
suggests stx16 has a crucial role in sorting GLUT4 from the fast trafficking 
pathway to the slow trafficking pathway. It has been proposed that stx 16 may 
control sequestration of GLUT4 in its storage site(s). 
Stx 16 is also phosphorylated in the absence of insulin and this phosphorylation 
decreases upon insulin treatment (Perera et al., 2003). It is thought that this 
dephosphorylation may control an important membrane trafficking event in 
GLUT4 sorting.  
 
1.10 Aims of this thesis 
The aim of this thesis was to further investigate the role of stx 16 in GLUT4 
trafficking. The results obtained in this thesis were divided into three chapters 
as follows. 
In chapter three, a shRNA approach was used to knockdown stx 16 expression in 
3T3 L1 adipocytes. The effect of stx 16 knockdown on GLUT4 trafficking was 
investigated. In chapter four, assays were developed to examine the 
translocation and recycling of GLUT4. In chapter five, the phosphorylation site of 
stx 16 was investigated. 56 
Chapter 2 Materials and Methods 
2.1 Materials 
2.1.1 General reagents 
All reagents were ordered from Fisher Scientific UK Ltd, Loughborough, 
Leicestershire, UK or Sigma Aldrich Company Ltd, Gillingham, Dorset, UK unless 
stated below. 
BD Biosciences, Oxford, UK 
Round bottomed flow cytometry tubes 
Syringes 
26 gauge needles 
Beckman Coulter (UK) Ltd, High Wycombe, Buckinghamshire, UK 
Thinwall polyallomer 2.2 ml tubes, 11 x 35 mm 
Thinwall Ultra Clear™ 5 ml tubes, 13 x 51 mm 
Bio-Rad Laboratories Ltd, Hemel Hempstead, Hertfordshire, UK 
Bio Rad protein assay reagent 
Dako UK Ltd, Cambridgeshire, UK 
R Phycoerythrin (RPE) conjugated goat anti mouse antibody 
ForMedium™, Hunstanton, Norfolk, UK 
Agarose 
Amino acid supplements –uracil (Ura) –leucine (Leu) Nicola S Hamilton, 2010    Chapter 2, 57 
Amino acid supplements –Ura –methionine (Met) 
Peptone 
Tryptone 
Yeast extract 
Yeast nitrogen base without amino acids 
GE Healthcare Life Sciences, Little Chalfont, Buckhamshire, UK 
All horseradish peroxidase (HRP) conjugated secondary antibodies 
Cy3 antibody labelling kit 
Invitrogen Ltd, Paisley, UK 
Super optimal broth with catabolite repression (SOC) medium 
Deoxynucleotide triphosphates (dNTPs) 
Kodak Ltd, Hemel Hempstead, Hertfordshire, UK 
X ray film 
Jackson ImmunoResearch Laboratories Inc, West Grove, Pennsylvania, US 
Cy3 conjugated goat anti mouse antibody 
Merck Chemicals Ltd, Nottingham, UK 
Calbiochem
® Proteoextract
® phosphopeptide enrichment TiO2 kit 
Calbiochem
® Proteoextract
® phosphopeptide enrichment SCIMAC (strong cation 
exchange  immobilised metal ion affinity chromatography) kit 
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New England Biolabs (UK) Ltd, Hitchin, Hertfordshire, UK 
Pre stained broad range protein marker 6 175 kilodaltons (kDa) 
T4 deoxyribonucleic acid (DNA) ligase 
1 kilobase (kb) DNA ladder 
Premier Brands UK, Knighton, Adbaston, Staffordshire, UK 
Marvel low fat milk powder 
Promega, Southampton, UK 
All restriction endonucleases 
Pfu DNA polymerase 
Wizard
® Plus SV miniprep kit 
Qiagen, Crawley, West Sussex, UK 
PhosphoProtein purification kit 
QIAfilter Maxi plasmid purification kit 
Roche Diagnostics Ltd, Burgess Hill, UK 
Complete and complete ethylenediaminetetraacetic acid (EDTA) free protease 
inhibitor tablets 
Trypsin (sequencing grade) 
Severn Biotech Ltd, Kidderminster, Worcestershire, UK 
30% weight/volume ratio (w/v) acrylamide/bisacrylamide 
 Nicola S Hamilton, 2010    Chapter 2, 59 
Sterilin Limited, Caerphily, UK 
90 mm petri dishes 
Whatman plc, Maidstone, Kent, UK 
Protran
® nitrocellulose 
2.1.2 Cell culture materials 
ATCC, LGC Standards, Teddington, Middlesex, UK 
NIH 3T3 cell line 
ATCC, P.O. Box 1549, Manassas, Virginia, US 
3T3 L1 cell line 
BD Biosciences, Oxford, UK 
BD Falcon
™ 10 cm plates, 6 well plates, 12 well plates and 96 well plates 
Clontech-Takara Bio Europe, Saint-Germain-en-Laye, France 
EcoPack 2 293 cell line 
Corning B.V. Life Sciences, Schiphol-Rijk, The Netherlands 
75 cm
2 flasks and 150 cm
2 flasks 
GE Osmonics, Minnetonka, Minnesota, US 
0.45 mm cellulose acetate filters 
Invitrogen Ltd, Paisley, UK 
Dulbecco’s modified eagle medium (DMEM) Nicola S Hamilton, 2010    Chapter 2, 60 
Foetal bovine serum (FBS, US origin) 
Lipofectamine™ 2000 
Newborn calf serum (NCS, New Zealand origin) 
Non essential amino acids (NEAA) 
Opti MEM
® reduced serum medium 
Penicillin and streptomycin 
Sodium pyruvate 
0.25 % (w/v) trypsin EDTA 
Roche Diagnostics Ltd, Burgess Hill, UK 
Collagenase 
 
293T cell line was a kind gift of Prof. R. Everett (University of Glasgow). 
2.1.3 Primary antibodies 
Abcam plc, Cambridge, UK 
Green fluorescent protein (GFP) rabbit polyclonal antibody. Catalogue number 
(Cat. No.)  ab290  
mVps45 goat polyclonal antibody. Cat. No. ab52013 
BD Biosciences, Oxford, UK 
Stx 6 mouse monoclonal antibody. Cat. No. 610636 
Vti1a mouse monoclonal antibody. Cat. No. 611220 Nicola S Hamilton, 2010    Chapter 2, 61 
Vti1b mouse monoclonal antibody. Cat. No. 611405 
Cambridge BioScience Ltd, Cambridge, UK 
Covance
® haemagglutinin (HA).11 mouse monoclonal antibody. Cat. No. MMS 
101R 
Invitrogen Ltd, Paisley, UK 
ZYMED
® TfR mouse monoclonal antibody. Cat. No. 13 6800 
Millipore Ltd, Watford, UK 
CHEMICON
® GLUT4 C terminus rabbit polyclonal antiserum. Cat. No. CBL243 
Roche Diagnostics Ltd, West Sussex, UK 
HA rat monoclonal antibody (clone 3F10). Cat. No. 11867423001 
Sigma-Aldrich Company Ltd, Gillingham, Dorset,UK 
Rabbit anti sheep immunoglobulin (Ig)G antiserum. Cat. No. S 1140 
IgG1 isotype control from murine myeloma clone MOPC 21. Cat. No. M 5284 
IgG2b isotype control from murine myeloma clone MOPC 141. Cat. No. M 5534 
Synaptic Systems GmbH, Goettingen, Germany 
SNAP 23 rabbit polyclonal antiserum. Cat. No. 111 202 
Stx 16 mouse monoclonal antibody. Cat. No. 110 161 
Stx 16 rabbit polyclonal antiserum. Cat. No. 110 162  
 
IRAP rabbit antibody was a kind gift of Prof. D. E. James (Garvan Institute of 
Medical Research, Sydney) (Keller et al., 1995). Nicola S Hamilton, 2010    Chapter 2, 62 
Tlg2p rabbit antiserum was purified in house as described in (Bryant and James, 
2001).  
2.1.4 Plasmids 
Clontech-Takara Bio Europe, Saint-Germain-en-Laye, France 
Ribonucleic acid interference (RNAi) Ready pSIREN RetroQ vector. Cat. No. 
631526. Retroviral expression vector designed to express short hairpin RNA 
(shRNA). ShRNA was cloned into the vector using BamH I and EcoR I sites. 
 
HA GLUT4 GFP in the pRRL PGK plasmid and the ViraPower™ packaging mix were 
a kind gift of Prof. C.C. Mastick (University of Nevada) (Muretta et al., 2008). 
HA GLUT4 GFP was constructed by cloning cDNA encoding HA GLUT4 (from Dr 
Samuel Cushman, National Institutes of Health, Bethesda) at the Age I site in 
frame upstream of the GFP reporter of the pRRL PGK GFP lentiviral expression 
vector. The HA tag is in the first exofacial loop of GLUT4 and the GFP tag is at 
the C terminus of GLUT4. The GLUT4 used in the plasmid is human and contains 
the residues 1 509. 
Myc stx 16A in the pShuttle CMV plasmid was made by Dr K. Proctor (University 
of Glasgow) (Proctor et al., 2006). A N terminally myc tagged (EQKLISEEDL) 
version of human stx 16A (residues 1 304) was cloned into the pShuttle CMV 
adenoviral expression vector at the Pme I site.  
pVT102U (Vernet et al., 1987). Yeast expression vector (2m URA3) containing the 
ADH1 promoter. 
pHA TLG2 (Seron et al., 1998). pHA TLG2 was constructed to express a N 
terminally HA tagged (YPYDVPDYA) version of Tlg2p (residues 1 396) under the 
control of the constitutive ADH1 promoter in pVT102U. HA TLG2 was cloned into 
the pVT102U vector at the Xba I site. 
pSGS025 and pSGS036 were made by Dr. S. Shanks (University of Glasgow). 
pSGS025 was constructed to express a N terminally HA tagged (YPYDVP) version Nicola S Hamilton, 2010    Chapter 2, 63 
of human stx 16A (residues 1 304) under the control of the constitutive ADH1 
promoter in pVT102U. HA stx 16A was cloned into the pVT102U vector at the Xba 
I and Xho I sites.  pSGS036 was constructed to express a N terminally HA tagged 
(YPYDVP) version of human stx 4 (residues 1 297) under the control of the 
constitutive ADH1 promoter in pVT102U. HA stx 4 was cloned into the pVT102U 
vector at the Xba I and Xho I sites. 
pSL2099 (Davis et al., 1993). pSL2099 was constructed to express a C terminally 
myc tagged (c-myc 9E10 epitope) version of Ste3p (residues 1 470) under control 
of the GAL1 promoter in pRS315. 
2.1.5 Oligonucleotides 
All oligonucleotides were made by Yorkshire Bioscience Ltd, York, UK. 
Name  Sequence (5’ to 3’) 
Stx16 shRNA1 
5’ 
GATCCGTATGATGTTGGCCGCATTTTCAAGAGAAATGCGGCCAACAT
CATACTTTTTTACGCGTG 
             
Stx16 shRNA1 
3’ 
AATTCACGCGTAAAAAAGTATGATGTTGGCCGCATTTCTCTTGAAAAT
GCGGCCAACATCATACG 
Stx16 shRNA2 
5’ 
GATCCAGGAGAGATCGCAGCATTTTTCAAGAGAAAATGCTGCGATCT
CTCCTTTTTTTACGCGTG 
Stx16 shRNA2 
3’ 
AATTCACGCGTAAAAAAAGGAGAGATCGCAGCATTTTCTCTTGAAAAA
TGCTGCGATCTCTCCTG 
Stx16 shRNA3 
5’ 
GATCCGCATTTAGACGGGCCAGTTATTCAAGAGATAACTGGCCCGTC
TAAATGTTTTTTACGCGTG 
Stx16 shRNA3 
3’ 
AATTCACGCGTAAAAAACATTTAGACGGGCCAGTTATCTCTTGAATAAC
TGGCCCGTCTAAATGCG 
Stx16 shRNA4 
5’ 
GATCCGTGCTACTGTGTGGATTATTTCAAGAGAATAATCCACACAGTA
GCACTTTTTTACGCGTG 
Stx16 shRNA4 
3’ 
AATTCACGCGTAAAAAAGTGCTACTGTGTGGATTATTCTCTTGAAATAA
TCCACACAGTAGCACG 
Stx16 
T90AS94AS95A 
CATTTAAACAGACCCGCCCTGGATGACGCCGCCGAAGAGGAACATGCC Nicola S Hamilton, 2010    Chapter 2, 64 
5’ 
Stx16 
T90AS94AS95A 
3’ 
GCCATGTTCCTCTTCGGCGGCGTCATCCAGGGCGGGTCTGTTTAAATG 
Stx16 
T90DS94DS95D 
5’ 
CATTTAAACAGACCCGACCTGGATGACGACGACGAAGAGGAACATGCC 
Stx16 
T90DS94DS95D 
3’ 
GGCATGTTCCTCTTCGTCGTCGTCATCCAGGTCGGGTCTGTTTAAATG 
Stx16 S94A 5’  CCCACCCTGGATGACGCCAGCGAAGAGGAACATGC 
Stx16 S94A 3’  GCATGTTCCTCTTCGCTGGCGTCATCCAGGGTGGG 
Stx16 S95A 5’  CCCACCCTGGATGACAGCGCCGAAGAGGAACATGC 
Stx16 S95A 3’  GCATGTTCCTCTTCGGCGCTGTCATCCAGGGTGGG 
Stx16 T90D 5’  AAACAGACCCGACCTGGATGACA 
Stx16 T90D 3’  TGTCATCCAGGTCGGGTCTGTTT 
Stx16 S94D 5’  CCTGGATGACGACAGCGAAGAGGAA 
Stx16 S94D 3’  TTCCTCTTCGCTGTCGTCATCCAGG 
Stx16 S95D 5’  CCTGGATGACAGCGACGAAGAGGAA 
Stx16 S95D 3’  TTCCTCTTCGTCGCTGTCATCCAGG 
 
Target sequences in the shRNA oligonucleotides are highlighted in bold and 
underlined. Mutations in the primers for site directed mutagenesis are also 
highlighted in bold and underlined. 
2.1.6 Escherichia coli (E.coli) strains 
Clontech-Takara Bio Europe, Saint-Germain-en-Laye, France Nicola S Hamilton, 2010    Chapter 2, 65 
Fusion Blue™ competent cells                                                                    
endA1, hsdR17 (rK12 , mK12+), supE44, thi 1, recA1, gyrA96, relA1, lac F'[proA+B+, 
lacIqZ M15::Tn10(tetR)] 
Invitrogen Ltd, Paisley, UK 
Stbl3 competent cells  
F– mcrB mrr hsdS20(rB–, mB–) recA13 supE44 ara 14 galK2 lacY1 proA2 rpsL20(Str
R) 
xyl 5 l– leu mtl 1 
 
Top 10 competent cells  
F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(araleu) 
7697 galU galK rpsL (StrR) endA1 nupG 
2.1.7 Yeast strains 
RPY10                                                                                                          
MAT  ura3-52 leu2 3 112 his4 519 ade6 gal2                                                
(Piper et al., 1994) 
NOzY4                                                                                                         
MAT  ura3 52 leu2 3 112 his4 519 ade6 gal2 tlg2D::Kan
r                              
(Bryant and James, 2001)  
SF838 9D 
MAT  ura3-52 leu2 3 112 his4 519 ade6 gal2 pep4 3 
(Rothman and Stevens, 1986) 
 
NOzY3 
MAT  ura3-52 leu2 3 his4 519 ade6 gal2 pep4 3 tlg2D::Kan
r 
(Bryant and James, 2001)                               
 
 
2.1.8 General buffers 
BSA/Gly buffer 
2% (w/v) bovine serum albumin (BSA) in 20 mM glycine (Gly) in phosphate 
buffered saline (PBS) 
BSA/Gly/Sap buffer 
0.1% (w/v) saponin (Sap) in BSA/Gly buffer Nicola S Hamilton, 2010    Chapter 2, 66 
DNA loading buffer (6 x) 
0.25% (w/v) bromophenol blue, 15% (w/v) Ficoll 
HES buffer 
20 mM HEPES(4 (2 hydroxyethyl) 1 piperazineethanesulphonic acid), 225 mM 
sucrose, 1 mM EDTA, EDTA free protease inhibitors, pH 7.4 
High sucrose HES buffer 
20 mM HEPES, 1.12 M sucrose, 1 mM EDTA, EDTA free protease inhibitors, pH 7.4 
Immunoprecipitation (IP) buffer 
50 mM HEPES, 5 mM EDTA, 10 mM sodium pyrophosphate, 10 mM NaF, 150 mM 
NaCl, 2 mM sodium orthovanadate, 50 mM b glycerolphosphate, 1 mM 
dithiothreitol (DTT), 1% volume/volume ratio (v/v) Triton X 100, EDTA free 
protease inhibitors, pH 7.4 
IP wash buffer 
20 mM Tris base, 150 mM NaCl, pH 7.4    
LiTE-Sorb 
0.1 M LiOAc, 10 mM Tris.HCl pH 7.6, 1 mM EDTA, 1.2 M sorbitol 
Phosphate-buffered Saline (PBS) 
136 mM NaCl, 10 mM Na2HPO4, 2.5 mM KCl, 1.8 mM KH2PO4, pH 7.4 
PBS-T 
PBS, 0.01% (v/v) Tween 20 
Recycling assay wash buffer Nicola S Hamilton, 2010    Chapter 2, 67 
150 mM NaCl, 20 mM HEPES, 1mM CaCl2, 5 mM KCl, 1 mM MgCl2, pH 7.2 
Running buffer 
25 mM Tris base, 190 mM glycine, 0.1% (w/v) sodium dodecyl sulphate (SDS) 
S-D –Ura –Leu plates 
0.67% (w/v) yeast nitrogen base without amino acids, 0.075% (w/v) amino acid 
supplements –Ura –Leu, 2% (w/v) (D)  glucose, 2% (w/v) agarose 
 
S-Raf/Gal –Ura –Leu 
0.67% (w/v) yeast nitrogen base without amino acids, 0.075% (w/v) amino acid 
supplements –Ura –Leu, 2% (w/v) galactose (Gal), 2% (w/v) raffinose (Raf) 
S-D –Ura -Met 
0.67% (w/v) yeast nitrogen base without amino acids, 0.075% (w/v) amino acid 
supplements –Ura –Met, 2% (w/v) (D)  glucose 
S-D –Ura -Met plates 
0.67% (w/v) yeast nitrogen base without amino acids, 0.075% (w/v) amino acid 
supplements –Ura –Met, 2% (w/v) (D)  glucose, 2% (w/v) agarose 
SDS-PAGE sample buffer (2 x) 
100 mM Tris.HCl pH 6.8, 20 mM DTT (added immediately before use), 20% (w/v) 
glycerol, 4% (w/v) SDS, 0.2% (w/v) bromophenol blue  
TAE buffer 
40 mM Tris acetate, 1 mM EDTA pH 7.8 
Transfer buffer Nicola S Hamilton, 2010    Chapter 2, 68 
25 mM Tris base, 192 mM glycine, 20% (v/v) methanol 
TWIRL buffer 
8 M Urea, 50 mM Tris.HCl pH 6.8, 10% (w/v) glycerol, 5% (w/v)  SDS, 0.2% (w/v) 
bromophenol blue, 10% (v/v) b mercaptoethanol (added immediately before use) 
2YT 
1% (w/v) yeast extract, 1.6% (w/v) tryptone, 85 mM NaCl 
 
YEPD 
1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) (D) glucose 
 
2.2 Molecular biology methods 
2.2.1 2YT agar plates 
2YT was prepared as described in 2.1.8. 2% (w/v) agarose was added to the 2YT 
and then autoclaved. After autoclaving the mixture was cooled to approximately 
50 
oC prior to addition of antibiotic. Ampicillin was used at a final concentration 
of 100 mg/ml and Kanamycin was used at a final concentration of 50 mg/ml. The 
medium was mixed gently and approximately 25 ml poured into each 90 mm 
petri dish. The plates were left to set at room temperature and then stored at 4 
oC. Unused plates were disposed of one month after preparation. 
2.2.2 Transformation of E. coli 
An aliquot of Top10 (Stbl3 for HA GLUT4 GFP plasmid) competent cells was 
thawed on ice. 1 10 ml of DNA was added to the cells and incubated on ice for 30 
minutes. The cells were then incubated at 42 
oC for 45 seconds to heat shock. 
After heat shock the cells were incubated on ice for 2 minutes. 300 ml of SOC Nicola S Hamilton, 2010    Chapter 2, 69 
medium was added to the cells which were then incubated for 90 minutes at 37 
oC. After incubation, 50 ml and 250 ml was plated on 2YT agar plates (section 
2.2.1) containing the appropriate antibiotic. The plates were inverted and 
incubated overnight at 37 
oC. 
2.2.3 E. coli cultures 
To prepare a small overnight culture (10 ml) a colony of the transformed 
bacteria was picked from the 2YT agar plate (section 2.2.2) using a pipette tip. 
This was put into 10 ml 2YT (section 2.1.8) containing the appropriate antibiotic. 
The culture was incubated overnight at 37 
oC with shaking. 
To prepare a larger culture the small overnight culture was diluted 1:1000 into a 
large volume of 2YT containing the appropriate antibiotic. The culture was 
incubated overnight at 37 
oC with shaking. 
2.2.4 Small-scale preparation of plasmid DNA (Mini-preps) 
Plasmid DNA was purified from bacterial cultures using the Wizard
® Plus SV 
miniprep kit and the buffers therein. A small overnight culture was prepared as 
described in section 2.2.3. 10 ml of bacterial culture was centrifuged at 10,000 x 
g for 5 minutes at 4 
oC and the supernatant removed. The pellet was 
resuspended in 250 ml of cell resuspension solution and transferred to a 1.5 ml 
microcentrifuge tube. 250 ml of cell lysis solution was added to the tube 
followed by 10 ml of alkaline protease solution. The mixture was then incubated 
for 5 minutes at room temperature. Then 350 ml of neutralization solution was 
added. The bacterial lysate was centrifuged at 14,000 x g for 10 minutes. The 
cleared lysate was decanted into a spin column. The spin column was 
centrifuged at 14,000 x g for 1 minute to allow DNA binding. The spin column 
was washed twice with column wash solution and centrifuged at 14,000 x g for 1 
minute. DNA was eluted by adding 100 ml of nuclease free water to the spin 
column (which had been placed into a 1.5 ml microcentrifuge tube) and then 
centrifugation at 14,000 x g for 1 minute. Nicola S Hamilton, 2010    Chapter 2, 70 
2.2.5 Large-scale preparation of plasmid DNA (Maxi-preps) 
Plasmid DNA was purified using the QIAfilter Maxi plasmid purification kit and 
the buffers therein. A 100 ml culture was prepared as described in 2.2.3. 
Bacterial cells were harvested by centrifugation at 6000 x g for 15 minutes at 4 
oC. The pellet was resuspended in 10 ml of chilled P1 buffer. 10 ml of P2 buffer 
was added and the mixture incubated at room temperature for 5 minutes. To 
neutralise the reaction 10 ml of chilled P3 buffer was added to the mixture. The 
lysate was then poured into a capped QIAfilter Maxi cartridge and incubated at 
room temperature for 10 minutes. Meanwhile a QIAGEN tip 500 was equilibrated 
by applying 10 ml of QBT buffer and allowing the column to empty by gravity 
flow. After incubation the cap was removed from the QIAfilter Maxi cartridge 
and a plunger inserted to filter the lysate into the equilibrated QIAGEN tip 500. 
The cleared lysate was then allowed to enter the resin by gravity flow. The 
QIAGEN tip 500 was washed twice with 30 ml of QC buffer. DNA was eluted with 
15 ml of QF buffer. To precipitate the DNA, 10.5 ml of isopropanol was added to 
the eluted DNA. This mixture was then centrifuged at 5000 x g for 60 minutes at 
4 
oC. The pellet was washed with 5ml 70% (v/v) ethanol and centrifuged again at 
5000 x g for 30 minutes at 4 
oC. The pellet was air dried for 10 minutes and then 
resuspended in 250 ml of nuclease free water.  
2.2.6 DNA quantification 
The concentration of a DNA sample was determined by measuring the 
absorbance of a 1:1000 dilution of the sample at 260 nm using a Jenway Genova 
life science analyser (Bibby Scientific Ltd, Dunmow, Essex, UK). An A260 of 1 
corresponds to 50 mg/ml of double stranded DNA. 
2.2.7 Sequencing 
Sequencing reactions were performed at The Sequencing Service, University of 
Dundee. Nicola S Hamilton, 2010    Chapter 2, 71 
2.2.8 Preparation of glycerol stocks of transformed E.coli 
A 10 ml overnight culture was prepared as described in section 2.2.3. 0.75 ml of 
the bacterial culture was placed into a 1.8 ml cryovial. 0.75 ml of 50% (v/v) 
glycerol was then added and mixed. The cryovial was stored at  80 
oC. 
2.2.9 Digestion of DNA with restriction endonucleases 
Restriction digests of DNA were performed to check that a ligation reaction had 
been successful. To check a ligation reaction 5 ml of DNA miniprep (section 
2.2.4) was digested using the appropriate enzymes and buffers in a final volume 
of 10 ml. Control reaction mixtures did not contain any restriction endonuclease. 
Restriction digest reaction mixtures were incubated from 2 hours to overnight at 
37 
oC.  
2.2.10 Agarose gel electrophoresis 
Digested DNA samples were examined using gel electrophoresis. A 1% (w/v) 
agarose gel was prepared by mixing agarose with 1 x TAE buffer (section 2.1.8). 
The agarose was heated until it had melted. 2.5 mg/ml ethidium bromide was 
added and the gel poured into a horizontal gel tank. Once the gel had set 1 x 
TAE was added to the tank. DNA samples were mixed with 6 x DNA loading dye 
(section 2.1.8) and then loaded onto the gel. The gel was then run for 
approximately 30 minutes at 100 V. The DNA fragments were visualised under 
ultraviolet light and their sizes determined by comparison with a 1 kb ladder. 
2.2.11 Site-directed mutagenesis 
Site directed mutagenesis was performed using the QuikChange
® Site Directed 
Mutagenesis Kit. Polymerase chain reaction (PCR) reaction mixtures containing 5 
ml of 10 x Pfu buffer, 50 ng of dsDNA template 125 ng of forward and reverse 
primer, 1 ml of dNTP mix and 1 ml Pfu DNA polymerase were prepared in a total 
volume of 50 ml. Control reaction mixtures did not contain any Pfu DNA 
polymerase. Reactions were cycled in a Proteus thermocycler (Helena 
Bioscience, Gateshead, Tyne and Wear, UK) as described below: 
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  Cycle 1:   95
 oC for 2 minutes 
  Cycle 2 19:  95 
oC for 30 seconds 
      50 
oC for 1 minute 
      68 
oC for 1 minute per kb of plasmid length 
  Cycle 20:  68 
oC for 1 minute per kb of plasmid length 
After themocycling, the PCR products were treated with 1 ml of Dpn1 and 
incubated for 1 hour at 37 
oC.  5 ml of the digested PCR product was then 
transformed as described in section 2.2.2. 
2.3 Mammalian cell culture methods 
2.3.1 Cell maintenance 
2.3.1.1 3T3-L1 
3T3 L1 fibroblasts were cultured in 75 cm
2 flasks in DMEM containing 10% (v/v) 
NCS and 1% (v/v) penicillin and streptomycin. The cells were incubated at 37 
oC 
in a humidified atmosphere of 10% CO2. The medium was replaced every 48 
hours. 
2.3.1.2 NIH 3T3 
NIH 3T3 cells were cultured in 75 cm
2 flasks in DMEM containing 10% (v/v) NCS 
and 1% (v/v) penicillin and streptomycin. The cells were incubated at 37 
oC in a 
humidified atmosphere of 10% CO2. The medium was replaced every 48 hours. 
2.3.1.3 EcoPack 2-293 
EcoPack 2 293 cells were cultured in 150 cm
2 flasks in DMEM containing 10% (v/v) 
FBS, 1 mM sodium pyruvate and 1% (v/v) penicillin and streptomycin. The cells 
were incubated at 37 
oC in a humidified atmosphere of 5% CO2. The medium was 
replaced every 48 hours. Nicola S Hamilton, 2010    Chapter 2, 73 
2.3.1.4 293T 
293T cells were cultured in 10 cm plates in DMEM containing 10% (v/v) FBS, 1 mM 
sodium pyruvate, 1% (v/v) NEAA and 1% (v/v) penicillin and streptomycin. The 
cells were incubated at 37 
oC in a humidified atmosphere of 5% CO2. The medium 
was replaced every 48 hours. 
2.3.2 Cell sub-culture 
When the cells were sub confluent they were sub cultured into 75 cm
2 flasks, 10 
cm, 6 well, 12 well or 96 well plates. The medium was removed by aspiration. 1 
ml of 0.25% (w/v) trypsin EDTA solution was added to the cells to wash them. 
The trypsin solution was removed and a further 2 ml added. The cells were then 
incubated with the trypsin for 5 minutes at 37 
oC. Once the cells had detached 
complete medium was added to the appropriate volume and the cells dispensed 
into new flasks and plates.   
2.3.3 Freezing down and thawing of cells 
To freeze down cells, a freeze medium was prepared by adding 10% (v/v) 
dimethyl sulfoxide (DMSO) to complete medium. Cells were detached from a 75 
cm
2 flask as described in 2.3.2. A small volume of complete medium was added 
to the cells and the cells sedimented by centrifugation at 183 x g for 5 minutes 
at 4 
oC. The cells were then resuspended in 2 ml of freeze medium. A 1 ml 
aliquot was placed into a 1.8 ml cryovial. The cryovials were kept at  80 
oC 
overnight before storing in liquid nitrogen. 
To thaw cells, a cryovial was taken from storage in liquid nitrogen and incubated 
at 37 
oC until the cells had just thawed. The cells were then transferred into 5 
ml of pre warmed complete medium and gently mixed. A further 5 ml of medium 
was added and then mixed. This was to wash the DMSO from the cells. The cells 
were then sedimented by centrifugation at 183 x g for 5 minutes at 4 
oC. The 
cells were resuspended in complete medium and placed into a culture plate. Nicola S Hamilton, 2010    Chapter 2, 74 
2.3.4 Differentiation of 3T3-L1s. 
3T3 L1 fibroblasts in 10 cm plates were allowed to grow to confluency. The 
DMEM containing 10% (v/v) NCS, 1% (v/v) penicillin and streptomycin was 
replaced at confluency. After 48 hours the cells were incubated in DMEM 
containing 10% (v/v) FBS, 1% (v/v) penicillin and streptomycin, 1 mg/ml insulin, 
110 mg/ml isobutylmethylxanthine and 0.25 mM dexamethasone. After a further 
48 hours the medium was replaced with DMEM containing 10% (v/v) FBS, 1% (v/v) 
penicillin and streptomycin and 1 mg/ml insulin. Thereafter the medium was 
replaced every 48 hours with DMEM containing 10% (v/v) FBS, 1% (v/v) penicillin 
and streptomycin. The cells were ready to use between 8 and 12 days post 
differentiation. 
 
2.4 Biochemical methods 
2.4.1 Cell membrane preparation 
3T3 L1 adipocytes were incubated in serum free medium for 2 hours. Then the 
cells were washed twice with 5 ml of ice cold HES buffer (section 2.1.8). The 
cells were then scraped into 0.5 ml HES buffer per 10 cm plate. The lysate was 
passed through a 26 gauge needle twenty times. The lysate was then centrifuged 
at 250 x g for 10 minutes at 4 
oC to pellet debris. The resulting supernatant was 
then centrifuged at 104300 x g for 60 minutes at 4 
oC. The pellet which contains 
the cell membranes was then resuspended in HES buffer. The sample was then 
mixed with 2 x SDS PAGE (SDS polyacrylamide gel electrophoresis) sample buffer 
(section 2.1.8) and incubated at 65 
oC for 15 minutes. 
2.4.2 Subcellular fractionation 
3T3 L1 adipocytes were incubated in serum free medium for 2 hours. Then the 
cells were washed three times with 5 ml of ice cold HES buffer (section 2.1.8). 
The cells from two 10 cm plates were then scraped into 2 ml of HES buffer. The 
lysate was passed through a 26 gauge needle twenty times and then centrifuged 
at 500 x g for 10 minutes at 4 
oC in a bench top refrigerated microcentrifuge to 
pellet debris. The supernatant was placed in a Thinwall Ultra Clear™ tube and Nicola S Hamilton, 2010    Chapter 2, 75 
centrifuged at 6000 x g for 12 minutes at 4 
oC using a TLA 110 rotor in an 
Optima™ ultracentrifuge (Beckman Coulter (UK) Ltd, High Wycombe, 
Buckinghamshire, UK). The pellet contains the plasma membrane (PM) and 
mitochondria and nuclei (M/N) fractions. The supernatant contains the cytosol, 
low density microsome (LDM) and high density microsome (HDM) fractions. 
The pellet which contained the PM and M/N fractions was resuspended in 10 ml 
HES buffer and centrifuged at 6000 x g for 12 minutes at 4 
oC. The resulting 
pellet was resuspended in 1 ml HES, layered over high sucrose HES (section 
2.1.8) in a Thinwall polyallomer tube and then centrifuged at 42000 x g  for 60 
minutes at 4 
oC in a TLS 55 rotor. The resulting pellet contains the M/N fraction 
and was resuspended in 100 ml HES. The PM fraction was collected from a layer 
above the high sucrose HES and placed into a Thinwall Ultra Clear™ tube. Three 
volumes of HES were added to the PM fraction and the mixture was centrifuged 
at 9400 x g for 15 minutes at 4 
oC in a TLA 110 rotor. The resulting pellet 
contains the PM fraction and was resuspended in 100 ml HES. 
The supernatant which contained the cytosol, LDM and HDM fractions was 
further centrifuged at 9400 x g for 17 minutes at 4 
oC in a TLA 110 rotor. The 
resulting pellet contains the HDM fraction and was resuspended in 100 ml HES. 
The supernatant was then centrifuged at 104300 x g for 75 minutes at 4 
oC in a 
TLA 110 rotor. The resulting pellet contains the LDM fraction and was 
resuspended in 100 ml HES. The supernatant contains the cytosol. To recover the 
soluble proteins from the cytosol, 0.1 ml 100% (w/v) trichloroacetic acid was 
added to 1 ml of the cytosol fraction. The mixture was vortexed and then kept 
on ice for 10 minutes. The mixture was then centrifuged at 22000 x g in a bench 
top refrigerated microcentrifuge. The pellet which contains the soluble proteins 
was resuspended in 100 ml HES. The fractions were mixed with 2 x SDS PAGE 
sample buffer (section 2.1.8) and then incubated at 65 
oC for 15 minutes. 
2.4.3 Protein concentration determination 
Protein concentration was determined using the Bio Rad protein assay reagent. 
The standard curve and test samples were placed in a 96 well plate. For the 
standard curve, between 0 and 20 mg of BSA was put into duplicate wells. Water 
was added to the wells to make a total volume of 160 ml. For the test samples Nicola S Hamilton, 2010    Chapter 2, 76 
159 ml of water was put into duplicate wells and 1 ml of sample added. Then 40 
ml of Bio Rad protein assay reagent was added to all the wells and the plate 
incubated at room temperature for 5 minutes. After incubation the colour 
change was determined by measuring the A595 using a FLUOstar OPTIMA 
microplate reader (BMG LABTECH Ltd, Aylesbury, UK). 
2.4.4 SDS-PAGE 
Samples were loaded onto a SDS PAGE gel consisting of a 5% (v/v) stacker gel 
and a 10% (v/v) resolving gel. The molecular weight of the samples was 
determined using a pre stained protein marker. The gel was placed in running 
buffer (section 2.1.8) and run at 120V using a BioRad mini protean 3 system until 
the dye front reached the bottom of the gel.  
2.4.5 Transfer to nitrocellulose 
The gel was removed from the plate and placed onto a nitrocellulose membrane 
soaked in transfer buffer (section 2.1.8). The gel and nitrocellulose membrane 
were placed between filter paper and sponges soaked in transfer buffer and 
placed into a tank. Proteins were transferred to the nitrocellulose membrane at 
200 mAmp for 2 hours. 
2.4.6 Western blotting 
The nitrocellulose membrane was incubated with PBS T (section 2.1.8) 
containing 5% (w/v) low fat milk power for 30 minutes on a roller to block non 
specific binding sites. The membrane was then incubated overnight at 4 
oC with 
primary antibody usually at a dilution of 1:1000 in PBS T containing 1% (w/v) 
low fat milk powder. The next day the membrane was washed five times with 
PBS T for 5 minutes each wash. After washing, the membrane was incubated for 
1 hour at room temperature with a HRP conjugated secondary antibody usually 
at a dilution of 1:2500 in PBS T containing 5% (w/v) low fat milk powder. The 
membrane was washed five times with PBS T for 5 minutes each wash. The 
membrane was then incubated in enhanced chemiluminesence (ECL) solution 
and exposed to blue Kodak film and developed using an X OMAT machine. Blots Nicola S Hamilton, 2010    Chapter 2, 77 
were analysed by densitometry using ImageJ software (National Institutes of 
Health, NIH, Maryland, US). 
2.4.7 Immunoprecipitation 
3T3 L1 adipocytes were incubated in serum free medium for 2 hours. The cells 
were then washed three times with 5 ml of IP buffer (section 2.1.8). After 
washing, the cells from three 10 cm plates were scraped into 1 ml of IP buffer. 
The lysate was passed through a 26 gauge needle ten times and then incubated 
on ice for 30 minutes. After incubation the lysate was centrifuged at 22000 x g 
for 20 minutes at 4 
oC. 1 ml of the clarified lysate was incubated with each 
antibody. For stx 16 immunoprecipitations, 5 mg of stx 16 rabbit polyclonal 
antiserum was added to the lysate. As a control 5 mg of rabbit anti sheep IgG 
antiserum was used. Alternatively 5 mg of stx 16 mouse monoclonal antibody was 
added to the lysate and 5 mg of IgG2b isotype control from murine myeloma 
clone MOPC 141 was used as a control. The lysate was then inverted ten times to 
mix. The lysate was incubated with the antibody for 60 minutes on ice. 
Meanwhile, Protein A agarose slurry was washed three times with 1 ml of IP 
wash buffer (section 2.1.8). For each lysate mixture, 50 ml of slurry was used. 
After washing, the lysate mixtures were added to each tube of Protein A agarose 
and mixed gently. The tubes were rotated overnight at 4 
oC. The next day the 
agarose was sedimented by centrifugation at 22000 x g for 1 minute at 4 
oC.  The 
supernatant was carefully removed and kept as the unbound control. The Protein 
A agarose was then washed twice with wash buffer containing 1% (v/v) thesit 
and again with wash buffer containing 0.1% (v/v) thesit. 50 ml of 2 x SDS PAGE 
sample buffer (section 2.1.8) was added to each IP sample and boiled for 5 
minutes. After boiling the samples were placed on ice for 5 minutes. The 
samples were then centrifuged at 22000 x g for 1 minute at 4 
oC. The 
supernatant containing the immunoprecipitated proteins was then carefully 
transferred to a new microcentrifuge tube. 2 x SDS PAGE sample buffer was also 
added to the unbound controls and the samples boiled as described above.  
2.4.8 Colloidal Coomassie staining 
Samples were separated by SDS PAGE as described in section 2.4.4. After 
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according to the manufacturer’s instructions. First the gel was fixed for one hour 
in 7% (v/v) glacial acetic acid in 40% (v/v) methanol. Meanwhile Brilliant Blue G 
Colloidal working solution was diluted 4:1 with methanol. This solution was then 
used to stain the gel for 2 hours. The gel was de stained with 10% (v/v) acetic 
acid in 25% (v/v) methanol for 30 seconds with shaking. The gel was then rinsed 
with 25% (v/v) methanol and de stained with 25% (v/v) methanol overnight.  
2.4.9 Phosphoprotein purification 
Phosphoproteins were purified from basal and insulin stimulated 3T3 L1 
adipocytes using a PhosphoProtein purification kit. 10
7 cells were lysed in 5 ml of 
PhosphoProtein lysis buffer containing 0.25% (w/v) CHAPS (3 [(3 
Cholamidopropyl)dimethylammonio] 1 propanesulphonate), a protease inhibitor 
tablet and 250 U of Benzonase
® nuclease. The lysate was incubated at 4 
oC for 
30 minutes and vortexed briefly every 10 minutes. After incubation the lysate 
was centrifuged at 10000 x g for 30 minutes at 4 
oC. Meanwhile a PhosphoProtein 
purification column was equilibrated using 4 ml of PhosphoProtein lysis buffer 
containing 0.25% (w/v) CHAPS. The supernatant from the centrifugation was 
harvested and the protein concentration was determined as described in 2.4.3. A 
volume of lysate containing 2.5 mg of protein was diluted to 0.1 mg/ml using 
PhosphoProtein lysis buffer containing 0.25% (w/v) CHAPS. The diluted lysate 
was poured into the PhosphoProtein purification column. The flow through 
fraction was collected for analysis of unphosphorylated proteins. The column 
was then washed with 6 ml of PhosphoProtein lysis buffer containing 0.25% (w/v) 
CHAPS. The phosphorylated proteins were eluted using 5 x 500 ml of 
PhosphoProtein elution buffer containing 0.25% (w/v) CHAPS. The protein 
concentration was determined as described in section 2.4.3 of all eluates to 
determine the most concentrated fraction.  
The most concentrated fractions were then further concentrated using a 
Nanosep ultrafiltration column. Each 500 ml protein fraction was placed into the 
sample reservoir of the column. The column was centrifuged at 10000 x g for 10 
minutes. After centrifugation the concentrated protein sample was removed 
from the retentate chamber, mixed with 2 x SDS PAGE sample buffer (section 
2.1.8) and heated at 65 
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were analysed by SDS PAGE and western blotting as described in sections 2.4.4, 
2.4.5 and 2.4.6 to determine in which fractions stx 16 was present. 
2.4.10 Phosphopeptide purification 
Stx 16 was immunoprecipitated from basal and insulin stimulated 3T3 L1 
adipocytes as described in section 2.4.7 except the samples were not boiled in 2 
x SDS PAGE sample buffer. The immunoprecipitated proteins remained bound to 
the Protein A agarose. The proteins were denatured and digested according to a 
protocol by T.E.Thingholm (Thingholm et al., 2006). The proteins were first 
incubated with 50 mM ammonium bicarbonate, pH 7.8, 10 mM DTT at 37 
oC for 1 
hour to reduce the proteins. After reduction, 20 mM iodoacetate was added and 
the samples incubated at room temperature for 1 hour. The reaction was 
quenched with 10 mM DTT and then digested with sequencing grade trypsin (2% 
v/v) at 37 
oC overnight.    
2.4.10.1 TiO2 method 
Phosphorylated peptides were purified using the Calbiochem
® Proteoextract
® 
phosphopeptide enrichment TiO2 kit. The trypsin digested samples were diluted 
1:4 with TiO2 Phosphobind buffer containing dihydrobenzoic acid to give a final 
volume of 200 ml. The diluted samples were then mixed with 50 ml of TiO2 
Phophobind resin and incubated for 10 minutes at room temperature with gentle 
agitation. After incubation the samples were centrifuged at 2500 x g for 3 
minutes at 4 
oC and the supernatant removed. The samples were washed twice 
with 100 ml of Wash buffer 1 and the samples centrifuged at 2500 x g for 3 
minutes at 4 
oC. The samples were then washed twice with 100 ml of Wash buffer 
2 as described above. 30 ml of Elution buffer was then added to the samples and 
incubated with gentle agitation for 10 minutes at room temperature. The 
samples were then centrifuged at 10000 x g for 5 minutes at 4 
oC and the 
supernatant carefully transferred to a new microcentrifuge tube. The 
supernatant was centrifuged again at 10000 x g for 3 minutes at 4 
oC. The 
supernatant containing the phosphopeptides was sent for phophosite analysis at 
the Fingerprint Proteomics unit at the University of Dundee.    Nicola S Hamilton, 2010    Chapter 2, 80 
2.4.10.2 SCIMAC method 
Phosphorylated peptides were purified using the Calbiochem
® Proteoextract
® 
phosphopeptide enrichment SCIMAC kit. The trypsin digested samples were 
diluted 1:10 with 1 x Phosphobind buffer to give a total volume of 200 ml. 100 ml 
SCX resin was pelleted by centrifugation at 2500 x g for 2 minutes at 4 
oC. The 
resin was then washed three times with 500 ml of 1 x Phosphobind buffer and 
centrifuged at 2500 x g for 3 minutes at 4 
oC. The diluted samples were then 
mixed with the washed resin and incubated at room temperature for 15 minutes 
with gentle agitation. The mixture was then centrifuged at 2500 x g for 3 
minutes at 4 
oC and the supernatant removed. 100 ml of SCX Elute buffer was 
added to the resin and incubated at room temperature for 10 minutes with 
gentle agitation. After incubation, the mixture was centrifuged at 2500 x g for 3 
minutes at 4 
oC. The supernatant was transferred to a new microcentrifuge tube 
and centrifuged again at 10000 x g for 3 minutes at 4 
oC.  The final SCX eluate 
was transferred to a new microcentrifuge tube and 50 ml of 1 x Phosphobind 
buffer was added. 
The diluted SCX eluate was mixed with 50 ml of MagPrep
® Phosphobind particles. 
The mixture was incubated at room temperature for 10 minutes with gentle 
agitation. The mixture was centrifuged at 2000 x g for 1 minute at 4 
oC and the 
supernatant removed. The particles were washed twice with 100 ml of Wash 
buffer 1 and centrifuged at 2000 x g for 1 minute at 4 
oC. Then the particles 
were washed twice with 100 ml of Wash buffer 2 and centrifuged at 2000 x g for 
1 minute at 4 
oC. 25 ml of Elution buffer was added to the particles and 
incubated at room temperature for 10 minutes with gentle agitation. After 
incubation the mixture was centrifuged at 10000 x g for 5 minutes at 4 
oC. The 
supernatant containing the phosphopeptides was sent for phophosite analysis at 
the Fingerprint Proteomics unit at the University of Dundee.    
2.4.11 Cy3 antibody labelling 
HA.11 antibody was labelled with a Cy3 antibody labelling kit. 1 mg of the HA.11 
antibody was dissolved at 1 mg/ml in PBS (section 2.1.8). The antibody solution 
was added to the vial of coupling buffer and mixed thoroughly by inverting ten 
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reactive Cy3 dye and mixed thoroughly. The reaction mixture was incubated at 
room temperature for 30 minutes and mixed every 10 minutes. Meanwhile the 
gel filtration column was equilibrated with 13 ml of elution buffer. The reaction 
mixture was then added to the column. 2 ml of elution buffer was added to the 
column to separate the faster moving pink band of labelled antibody from the 
unconjugated dye. An additional 2.5 ml of elution buffer was added to the 
column to elute the labelled antibody from the column. The molar dye/protein 
ratio was determined by measuring the absorbance at 552 nm and 280 nm using 
the Jenway Genova life science analyser (Bibby Scientific Ltd, Dunmow, Essex, 
UK). The kit produced a dye/protein ratio of approximately 12. 
  
2.5 Virus preparation methods 
2.5.1 Stx16 shRNA retrovirus 
Stx 16 shRNA retrovirus was prepared using the Clontech RNAi Ready pSIREN 
RetroQ Vector system. Stx 16 shRNA target sequences and oligonucleotides were 
designed using Clontech’s online designer tool. Four different shRNA targets 
were designed (see table in 2.1.5). To anneal the oligonucleotides, 100 mM 5’ 
and 3’ strands were mixed at a 1:1 ratio. The mixture was heated in a Proteus 
thermocycler (Helena Bioscience, Gateshead, Tyne and Wear, UK) as described 
below: 
95 
oC for 30 seconds 
72 
oC for 2 minutes 
37 
oC for 2 minutes 
25 
oC for 2 minutes 
Then the annealed shRNA oligonucleotides were ligated into the RNAi Ready 
pSIREN RetroQ vector using a T4 DNA ligase. 1 ml of 0.5 mM annealed shRNA 
oligonucleotide was mixed with 50 ng of linearised pSIREN vector. 1.5 ml of 10 x 
ligase buffer and 0.5 ml of T4 DNA ligase were added to give a final volume of 15 Nicola S Hamilton, 2010    Chapter 2, 82 
ml. As a control 1 ml of negative control annealed shRNA oligonucleotide was 
used. The reaction mixtures were incubated at room temperature for 3 hours. 2 
ml of the ligation reaction mixtures were then transformed into Fusion Blue™ 
competent cells as described in section 2.2.2. Colonies were picked the next day 
and small cultures prepared as described in section 2.2.3. The plasmid DNA was 
purified as described in section 2.2.4. 
In order to identify clones which contained the shRNA target sequence, the DNA 
was digested with Mlu I restriction endonuclease. The Mlu I site had been 
designed into the shRNA oligonucleotide sequence. The restriction digest was 
performed as described in section 2.2.9. Once positive clones were identified a 
large culture was prepared as described in section 2.2.3 and the plasmid DNA 
was purified as described in 2.2.5. 
Next the shRNA plasmids were transfected into EcoPack 2 293 cells using 
Lipofectamine™ 2000. EcoPack2 293 cells were grown to approximately 90% 
confluency in a 150 cm
2 flask. The medium was then replaced with growth 
medium without antibiotics. 60 mg of shRNA plasmid was diluted in 3.75 ml of 
Opti MEM
® reduced serum medium. Then 150 ml of Lipofectamine™ 2000 was 
diluted in 3.75 ml of Opti MEM
® reduced serum medium and incubated at room 
temperature for 5 minutes. After incubation the diluted DNA was mixed gently 
with the diluted Lipofectamine™ 2000 and incubated at room temperature for 20 
minutes. After incubation the DNA and Lipofectamine™ 2000 mixture was added 
to the EcoPack 2 293 cells and medium. The medium was changed after 4 hours 
to complete medium containing antibiotics. 
The supernatant from the transfected EcoPack 2 293 cells containing the shRNA 
retroviral particles was harvested after 24 hours and 48 hours. To remove any 
unwanted debris from the cells the supernatants were centrifuged at 183 x g for 
5 minutes at 4 
oC. The 24 hour and 48 hour supernatants were then combined, 
aliquoted and then stored at  80 
oC. 
The titre of the virus was determined using NIH 3T3 cells. 1 x 10
5 cells were 
seeded into each well of a 6 well plate in 2 ml of complete medium. The next 
day 60 ml of 4 mg/ml polybrene was added to 20 ml of complete medium. The 
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acetate filter. The virus containing medium was then diluted 10 fold by adding 
150 ml to 1.35 ml of complete medium. This diluted virus containing medium was 
then diluted as above a further five times. To infect the NIH 3T3 cells, 1 ml of 
diluted virus containing medium was added to each well. The next day the 
medium on the NIH 3T3 cells was replaced with complete medium containing 2.5 
mg/ml puromycin. The NIH 3T3 cells were grown in puromycin for a week, after 
which the number of colonies present at the highest dilution of the virus 
containing medium was determined. This number was multiplied by the dilution 
factor to give the number of colony forming units (cfu)/ml. 
To infect 3T3 L1 cells, 2 x 10
5 cells were seeded into a 10 cm plate. The next 
day the virus containing medium was thawed and filtered through a 0.45 mm 
cellulose acetate filter. The virus containing medium was added to the cells at a 
multiplicity of infection (MOI) of 50 and polybrene was added to a final 
concentration of 5 mg/ml. The cells were then incubated for 24 hours. After 24 
hours the infected 3T3 L1 cells were sub cultured at a 1 in 10 dilution into new 
10 cm and 12 well plates as described in section 2.3.2. After a further 24 hours 
the medium on the infected 3T3 L1 cells was replaced with complete medium 
containing 1 mg/ml puromycin. The infected cells were grown in puromycin 
containing medium for a least a week to select for cells stably expressing the 
shRNA construct. When the infected 3T3 L1 cells reached confluency they were 
differentiated as described in section 2.3.4.       
2.5.2 HA-GLUT4-GFP lentivirus 
HA GLUT4 GFP lentivirus was prepared using Invitrogen™ ViraPower™ Lentiviral 
systems. 
293T cells were co transfected with the HA GLUT4 GFP plasmid and the 
ViraPower™ packaging mix using Lipofectamine™ 2000. As a negative control 
some 293T cells were transfected without DNA. A reverse transfection procedure 
was employed. 9 mg ViraPower™ packaging mix and 3 mg HA GLUT4 GFP plasmid 
was diluted in 1.5 ml Opti MEM
® reduced serum medium. In a separate tube 36 
ml of Lipofectamine™ 2000 was diluted in 1.5 ml of Opti MEM
® reduced serum 
medium and incubated at room temperature for 5 minutes. After the incubation, 
the diluted DNA and diluted Lipofectamine™ 2000 were mixed gently and Nicola S Hamilton, 2010    Chapter 2, 84 
incubated at room temperature for 20 minutes. During this incubation 293T cells 
were detached from the plates as described in section 2.3.2 and then counted. 
The 293T cells were resuspended at 1.2 x 10
6 cells/ml in growth medium without 
antibiotics. The DNA and Lipofectamine™ 2000 mixture was added to a 10 cm 
plate containing 5 ml of growth medium without antibiotics. Then 5 ml of the 
293T cell suspension (6 x 10
6 total cells) was added to the plate and the cells 
incubated overnight at 37 
oC. The next day the medium was replaced with 
growth medium without antibiotics. Lentivirus –containing supernatants were 
harvested 72 hours after transfection. 
The day before lentivirus harvesting the 3T3 L1 fibroblasts to be infected were 
plated. 3T3 L1 fibroblasts were seeded at 1 x 10
5 cells per well of a 6 well plate. 
The next day the lentivirus containing supernatants were harvested from the 
transfected 293T cells. The supernatants were centrifuged at 183 x g for 15 
minutes at 4 
oC to remove unwanted debris. The viral supernatants were then 
filtered through a 0.45 mm cellulose acetate filter and aliquoted into crovials. 
Any virus not used was then stored at  80 
oC.  To infect 3T3 L1 fibroblasts a 2 
fold serial dilution was used. Viral supernatant and 6 mg/ml polybrene was added 
to the cells and incubated for 24 hours at 37 
oC. After incubation the medium on 
the infected 3T3 L1 fibroblasts was replaced with complete medium and the 
cells were incubated at 37 
oC for a further 48 hours.  After incubation the 
infected 3T3 L1 fibroblasts were sub cultured as described in section 2.3.2 and 
diluted into 10 ml of complete medium. 2.5 ml was plated into a well of a 6 well 
plate and 7.5 ml was plated into a 10 cm plate. When the cells were just sub 
confluent, the cells in the 6 well plate were analysed using flow cytometry as 
described in section 2.6.1 and the cells in the 10 cm plate were further sub 
cultured and frozen down as described in sections 2.3.2 and 2.3.3. The infected 
cells will express HA GLUT4 GFP for several passages. 
2.5.3 Myc-stx 16 adenovirus 
Myc stx 16 adenovirus was produced by ViraQuest Inc. North Liberty, Iowa, US, 
using the myc stx 16A in pShuttle CMV plasmid in section 2.1.4. 
To infect 3T3 L1 cells, 3T3 L1 fibroblasts were seeded in a 12 well plate and 
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of serum free DMEM was placed in each well. Between 0 and 1000 plaque 
forming units (PFU)/cell was added to each well. The cells were then incubated 
at 37 
oC for 6 hours. After incubation, 500 ml of DMEM containing 20% (v/v) FBS 
was added to each well and the cells were incubated overnight at 37 
oC. The 
next day the medium was replaced with DMEM containing 10% (v/v) FBS. The 
following day (day 8 post differentiation) the cells were lysed in 100 ml HES 
buffer (section 2.1.8) per well.  
 
2.6 Flow cytometry methods 
2.6.1 HA-GLUT4-GFP infection efficiency 
The level of HA GLUT4 GFP expression in the lentivirus infected 3T3 L1 cells was 
determined by flow cytometry. The method was suggested by Prof. C. C. Mastick 
(University of Nevada) (Muretta et al., 2008). 
Cells were detached from the 6 well plate as described in section 2.3.2. A small 
volume of complete medium was added to the cells and the cells sedimented by 
centrifugation at 183 x g for 5 minutes at 4 
oC. The cells were then washed twice 
and resuspended in ice cold PBS (section 2.1.8). The level of GFP fluorescence 
(which corresponds to the level of HA GLUT4 GFP expression) was determined 
using a Becton Dickinson FACScan machine and CellQuest software (BD 
Biosciences, Oxford, UK). The total number of cells (counts) analysed in each 
sample was set at 10,000. The cells were counted by the flow cytometer as each 
cell passed the laser. 
The mean fluorescence intensity (MFI) of the GFP fluorescence was determined 
by calculating the geometric mean. The percentage of cells positively expressing 
HA GLUT4 GFP was defined as the percentage of cells with a higher GFP 
fluorescence than the negative control cells. The percentage of cells positively 
expressing HA GLUT4 GFP was determined by calculating the area under the HA 
GLUT4 GFP infected sample curve to the right of the negative control curve. 
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2.6.2 Cell sorting 
Cell sorting was used to determine the population of 3T3 L1 adipocytes. The 
method of cell sorting is based on a paper by Prof. C. C. Mastick (University of 
Nevada) (Muretta et al., 2008). 
Wildtype 3T3 L1 adipocytes were detached from 10 cm plates by incubation with 
1 mg/ml collagenase in PBS for 5 minutes at 37 
oC. A small volume of complete 
medium was added to the cells and the cells sedimented by centrifugation at 
183 x g for 5 minutes at 4 
oC. The cells were then washed twice and resuspended 
in ice cold PBS (section 2.1.8). 
Cells were sorted using a Becton Dickinson FACSaria machine (BD Biosciences, 
Oxford, UK). The number of cells (events) sorted was set at 50,000. Cells were 
sorted on the basis of scattered light in terms of forward scatter (FSC A) and 
side scatter (SSC A) into P1 and P2 populations. FSC measures the size of the cell 
or cell volume. SSC measures the internal complexity of the cell or granularity. 
The P1 population was then sorted into P3 and P4 populations on the basis of 
autofluorescence which was measured as fluorescence in the allophycocyanin 
(APC) channel. During cell sorting, droplets containing individual cells were 
charged depending on which population they belonged to. Then each droplet 
was deflected into the correct container using an electrostatic deflection 
system.  
Sorted cells were viewed using a Zeiss Axiovert microscope (Carl Zeiss Ltd, 
Hetrfordshire, UK), with a x 32 lens, numerical aperture 0.4. 
2.6.3 HA-GLUT4-GFP surface labelling assay 
To determine the level of HA GLUT4 GFP translocation in 3T3 L1 adipocytes a 
flow cytometry assay was used. This assay is based on a paper by Prof. C. C. 
Mastick (University of Nevada) (Muretta et al., 2008). 
3T3 L1 adipocytes expressing HA GLUT4 GFP were incubated with serum free 
medium for 2 hours. The cells were then stimulated with or without 100 nM 
insulin for 30 minutes. After stimulation the cells were detached from the plates 
by incubation with 1 mg/ml collagenase in PBS for 5 minutes at 37 
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cells sedimented by centrifugation at 183 x g for 5 minutes at 4 
oC. The cells 
were then washed twice and resuspended in ice cold PBS (section 2.1.8). The 
cell suspension was incubated with HA.11 mouse monoclonal primary antibody or 
IgG isotype control from murine myeloma clone MOPC21 at 50 mg/ml for 60 
minutes at 4 
oC. The cells were washed three times with ice cold PBS and then 
incubated with RPE conjugated goat anti mouse secondary antibody or Cy3 
conjugated goat anti mouse secondary antibody for 60 minutes at 4 
oC. The cells 
were then washed three times and resuspended in ice cold PBS. The cells were 
analysed using a MACSQuant™ Analyzer (Miltenyi Biotec Ltd, Surrey, UK) and 
FlowJo software (Tree Star, Inc. Oregon, US). The total number of cells (events) 
analysed in each sample was set at 10,000. 
2.7 Confocal microscopy methods   
All images were taken with using a Zeiss LSM Exciter confocal microscope (Carl 
Zeiss Ltd, Hetrfordshire, UK), under oil immersion with a x 64 lens, numerical 
aperture 1.4. 
2.7.1 HA-GLUT4-GFP surface staining 
3T3 L1 cells infected with a 1 in 2 or 1 in 4 dilution of HA GLUT4 GFP lentivirus 
(section 2.5.2) were seeded onto glass coverslips in a 6 well plate. As a control 
cells infected without HA GLUT4 GFP DNA were used. The cells were allowed to 
grow to confluency and differentiated as described in section 2.3.4. At 8 days 
post differentiation the cells were incubated in serum free medium for 2 hours 
and then treated with or without 100 nM insulin for 30 minutes.  
To fix the cells, the coverslips were washed twice with PBS (section 2.1.8). Then 
800 ml 3% (w/v) paraformaldehyde was added to each coverslip and incubated 
for 20 30 minutes. The paraformaldehyde was removed and the coverslips 
washed again with PBS. To quench the paraformaldehyde the coverslips were 
washed with 20 mM glycine in PBS.  
After fixing, the cells were blocked by adding 800 ml BSA/Gly buffer (section 
2.1.8) to the each coverslip and incubating for 20 minutes. The cells were then 
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BSA/Gly buffer and incubated for 45 minutes. After staining the coverslips were 
washed 4 times with BSA/Gly. The cells were then stained with Cy3 conjugated 
goat anti mouse secondary antibody or RPE conjugated goat anti mouse 
secondary antibody at 1:200 dilution in BSA/Gly buffer and incubated for 30 
minutes. The cells were then washed 4 times with BSA/Gly. Finally the 
coverslips were dipped into PBS, dried and mounted onto a slide. 
If internal staining of HA was required the cells were permeablised after the 20 
mM glycine wash step with BSA/Gly/Sap buffer (section 2.1.8) and incubated for 
20 minutes. The staining of the coverslips was perfomed as described above 
except with BSA/Gly/Sap buffer replacing BSA/Gly buffer in all steps. 
2.8 96-well plate assays 
2.8.1 HA-GLUT4-GFP surface labelling assay 
3T3 L1 cells infected with a 1 in 4 dilution of HA GLUT4 GFP lentivirus (section 
2.5.2) were seeded in a 96 well plate (see plate diagram below). As a control 
cells infected without HA GLUT4 GFP DNA were used. The cells were allowed to 
grow to confluency and differentiated as described in section 2.3.4. At 8 days 
post differentiation the cells were incubated in serum free medium for 2 hours 
and then treated with or without 100 nM insulin for 30 minutes. 
Plate diagram: 
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To fix the cells, they were washed three times with PBS (section 2.1.8). Then 
200 ml 3% (w/v) paraformaldehyde was added to each well and incubated for 20 
30 minutes. The paraformaldehyde was removed and the cells washed again with 
PBS. To quench the paraformaldehyde the cells were washed with 20 mM glycine 
in PBS. The cells were washed again with PBS. Then the cells were stained with 
HA.11 mouse monoclonal primary antibody or IgG isotype control from murine 
myeloma clone MOPC21 at 50 mg/ml for 60 minutes. After staining the cells were 
washed with PBS and stained with Cy3 conjugated goat anti mouse secondary 
antibody for 60 minutes. Then the cells were washed with PBS and 200 ml PBS 
added to each well. The GFP and Cy3 fluorescence of the cells was determined 
using a FLUOstar OPTIMA microplate reader (BMG LABTECH Ltd, Aylesbury, UK). 
The GFP and Cy3 fluorescence of the cells were used to calculate the mean 
fluorescence ratio (MFR) of basal or insulin stimulated cells. The MFR of surface 
to total HA GLUT4 GFP was used as a measure of HA GLUT4 GFP translocation. 
 
 
 
 
 
 
 
 
 
 
 
2.8.2 HA-GLUT4-GFP recycling assay   
3T3 L1 cells infected with a 1 in 4 dilution of HA GLUT4 GFP lentivirus (section 
2.5.2) were seeded in a 96 well plate (see plate diagram below). As a control 
cells infected without HA GLUT4 GFP DNA were used. The cells were allowed to 
grow to confluency and differentiated as described in section 2.3.4. At 8 days 
post differentiation the cells were incubated in serum free medium for 2 hours 
and then treated with or without 170 nM insulin for 30 minutes. After treatment, 
the medium was replaced at specific time points with pre warmed serum free 
DMEM containing 50 mg/ml Cy3 HA.11 antibody (section 2.4.11) and with or Nicola S Hamilton, 2010    Chapter 2, 90 
without 170 nM insulin. For basal cells the time points were 0, 2, 5 and 10 hours. 
For insulin stimulated cells the time points were 0, 30, 60 and 120 minutes.  
Plate diagram: 
One plate was basal. A second plate was stimulated with 170 nM insulin. The 
plate below shows the time points for basal cells. 
 
When the cells had finished incubating with the Cy3 HA.11 antibody, the 96 well 
plates were placed on ice and then washed four times with recycling assay wash 
buffer (section 2.1.8). The cells were fixed by adding 200 ml 3% (w/v) 
paraformaldehyde to each well and incubating for 20 30 minutes. The 
paraformaldehyde was removed and the cells were washed with PBS (section 
2.1.8) and finally 200 ml PBS added to each well. The GFP and Cy3 fluorescence 
of the cells was determined using a FLUOstar OPTIMA microplate reader (BMG 
LABTECH Ltd, Aylesbury, UK).  
The GFP and Cy3 fluorescence of the cells were used to calculate the mean Cy3: 
GFP ratio at each time point of basal or insulin stimulated cells. The mean Cy3: 
GFP ratio was used as a measure of HA GLUT4 GFP recycling. 
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2.9 Yeast methods 
2.9.1 Yeast cultures 
Yeast cells were picked from a colony or a frozen glycerol stock using a pipette 
tip. The cells were put into YEPD, S D –Ura –Met or S Raf/Gal –Ura –Leu medium 
(section 2.1.8) and incubated at 30 
oC until the culture had reached the required 
OD600 (optical density at 600 nm) or overnight. 
2.9.2 Preparation of competent cells 
A 50 ml culture was prepared as described in section 2.9.1 in YEPD (section 
2.1.8). The culture was grown to an OD600 of 0.5 1.0. Yeast cells were harvested 
by centrifugation at 3000 x g for 2 minutes. The cells were resuspended in 10 ml 
LiTE Sorb (section 2.1.8) and then sedimented as above. The resulting pellet was 
resuspended in 1 ml LiTE Sorb and incubated at 30 
oC for 1 hour. After 
incubation the cells were placed on ice for 20 minutes. The cells were now ready 
for transformation. Any remaining cells not used for transformation were stored 
at  80 
oC after the addition of an equivalent volume of 40% (w/v) glycerol, 0.5% 
(w/v) NaCl. 
2.9.3 Yeast transformation 
10 mg DNA was added to 100 ml competent cells (section 2.9.2). An equivalent 
volume of 70% (w/v) PEG 3350 was added and mixed by inversion. The mixture 
was incubated for 30 45 minutes at 30 
oC and then incubated at 42 
oC for 20 
minutes to heat shock. After heat shock the cells were sedimented by 
centrifugation at 4000 x g for 2 minutes and resuspended in sterile water or 
YEPD (section 2.1.8), 1.2 M sorbitol. The transformed yeast cells were plated on Nicola S Hamilton, 2010    Chapter 2, 92 
S D –Ura –Met or S D –Ura –Leu plates (section 2.1.8) and incubated at 30 
oC for 
2 4 days. The transformed yeast cells could be stored on the plate at 4 
oC for up 
to one month. 
2.9.4 Preparation of samples for SDS-PAGE analysis 
To prepare samples of yeast cells, a 10 ml overnight culture was prepared as 
described in section 2.9.1. The next day the OD600 of the culture was 
determined. A volume corresponding to 10 OD600 was centrifuged at 4000 x g for 
2 minutes and resuspended in 100 ml TWIRL buffer (section 2.1.8). The samples 
were then incubated at 65 
oC for 10 minutes before analysis by SDS PAGE as 
described in sections 2.4.4, 2.4.5 and 2.4.6.  
2.9.5 Ste3p-myc endocytosis assay 
A 10 ml overnight culture was prepared as described in section 2.9.1 in S 
Raf/Gal –Ura –Leu medium (section 2.1.8) for each strain. The OD600 of the 
cultures was checked the next day. Each culture was diluted into 50 ml S 
Raf/Gal –Ura –Leu medium to an OD600 of 0.2 and then incubated at 30 
oC until 
the OD600 reached 0.4. Once the OD600 had reached this value, (D) glucose was 
added to a final concentration of 3 % (w/v) to repress the GAL1 promoter and 
inhibit expression of Ste3p myc. 4 ml of culture was harvested at 0, 20, 40, 60 
and 80 minutes after the addition of (D) glucose. At each time point the OD600 of 
the remaining culture was also measured. To harvest the cells, 4 ml of culture 
was added to 40 ml of 1 M sodium azide and the cells placed on ice for 5 
minutes. The cells were then sedimented by centrifugation at 6000 x g for 5 
minutes at 4 
oC. The supernatant was decanted and the pellet was resuspended 
and transferred to a 1.5 ml microcentrifuge tube. The cells were sedimented by 
centrifugation at 2500 x g for 2 minutes. The supernatant was removed by 
aspiration. The pellet was resuspended in TWIRL buffer (section 2.1.8) in a 
volume corresponding to the OD600 of the culture when the cells were harvested. 
The samples were then incubated at 65 
oC for 10 minutes. Nicola S Hamilton, 2010    Chapter 2, 93 
2.9.6 KCl osmotic stress assay 
A 10 ml overnight culture was prepared as described in section 2.9.1 in S D –Ura 
–Met medium (section 2.1.8) for each strain. The OD600 of each strain was 
determined the next day and the cultures were diluted to 1 OD600/ml. Ten fold 
serial dilutions were made of each culture. 5 ml aliquots of the 1 OD600/ml 
culture and the serial dilutions were spotted onto S D –Ura –Met plates with or 
without 1.5 M KCl. The plates were incubated at 30 
oC for 2 4 days. 94 
Chapter 3 Effect of syntaxin 16 on GLUT4 
trafficking 
3.1 Introduction 
In adipocytes insulin stimulates the translocation of GLUT4 from unique 
intracellular storage sites to the cell surface (Bryant et al., 2002). In type II 
diabetes this translocation is impaired. The translocation of GLUT4 is an 
example of regulated membrane trafficking and involves the fusion of vesicles 
with specific target membranes. This is mediated by SNARE proteins (Hong, 
2005). 
Stx 16 is a t SNARE found in the TGN and is known to mediate transport between 
the early endosome and the TGN (Mallard et al., 2002). There is a lot of data to 
suggest that stx 16 has a role in GLUT4 trafficking. Firstly stx 16 colocalises with 
GLUT4 in a subdomain of the TGN and is highly enriched in GLUT4 vesicles. Also 
insulin stimulates the translocation of stx 16 to the cell surface (Shewan et al., 
2003). Recent data from our lab has shown that overexpression of the cytosolic 
domain of stx 16 significantly slows the reversal of insulin stimulated glucose 
transport. Also depletion of stx 16 by RNAi reduces insulin stimulated glucose 
transport over a range of insulin concentrations. It was also noted in these cells 
that the total GLUT4 cellular levels were reduced by 30% (Proctor et al., 2006). 
This suggests that GLUT4 may be missorted to a degradation pathway in stx 16 
depleted cells. The above data suggests that stx 16 may control sequestration of 
GLUT4 in its storage site(s). 
3.2 Aims of this chapter 
In this chapter the effect of stx 16 on GLUT4 trafficking was investigated. In 
order to blockade stx 16 function a shRNA approach was used to produce 3T3 L1 
adipocytes stably depleted of stx 16. The level of GLUT4 and a number of other 
proteins was examined in these cells. Also the distribution of GLUT4 and other 
insulin responsive proteins was investigated. Finally a myc tagged human stx 16 
(which is resistant to the shRNA constructs) was expressed in the stx 16 depleted 
cells to rescue the stx 16 knockdown.  Nicola S Hamilton, 2010    Chapter 3, 95 
3.3 Results 
3.3.1 Knockdown of stx 16 expression in 3T3-L1 adipocytes  
As mentioned in section 3.1 stx 16 seems to play a role in GLUT4 trafficking. In 
order to further investigate the role of stx 16 in GLUT4 trafficking, the 
expression of stx 16 was knocked down using a shRNA approach.  This method 
was used to generate 3T3 L1 cells which were stably depleted of stx 16. Four 
different stx 16 targeting shRNAs were used and scrambled shRNA was used as a 
negative control. After infection with the shRNA retroviruses membrane extracts 
from the 3T3 L1 adipocytes were blotted for the presence of stx 16.  
As shown in figure 3.1, compared with the negative control the level of stx 16 is 
reduced in cells infected with shRNAs 1 4 to varying degrees, whereas the level 
of the unrelated SNARE SNAP 23 is not affected.  In particular shRNA4 gave the 
greatest reduction of 96.74 ± 2.22% (mean ± S.D.) (P < 0.001).  
3.3.2 Effect of stx 16 knockdown on the expression of other 
SNARE proteins 
Stx 16 is a t SNARE found in the TGN and it forms a t SNARE complex with stx 6 
and Vti1a (Mallard et al., 2002). Stx 16 is also known to interact with the SM 
protein mVps45 (Dulubova et al., 2002). Therefore the effect of stx 16 
knockdown on these important proteins was investigated.  
Figure 3.2 shows that in shRNA4 infected cells the levels of stx 6 and mVps45 
were significantly reduced compared with the negative control. Stx 6 was 
reduced by 83.01 ± 5.74% (P < 0.05) and mVps45 was reduced by 57.09 ± 32.68% 
(P < 0.05). However the level of Vti1a remained unaffected. Also the level of 
Vti1b (a closely related isotype of Vti1a) was not significantly affected. Nicola S Hamilton, 2010    Chapter 3, 96 
 
 
F(4,10) = 24.73, P < 0.0001      F(4,10) = 1.009, P = 0.4476 
 
Figure 3.1. Knockdown of syntaxin 16 expression in 3T3-L1 adipocytes. 
 
3T3 L1 fibroblasts were infected with retrovirus expressing negative control 
shRNA or shRNA targeting syntaxin (stx) 16 (1 4) as described in section 2.5.1.  
 
Upper panel: Membrane samples were prepared as described in section 2.4.1 
and blotted for stx 16 and SNAP 23 (section 2.4.4 2.4.6). Rabbit stx16 antiserum 
and rabbit SNAP23 antiserum were used at 1:1000 dilution. SNAP 23 was used as 
a loading control. The amount of protein loaded in each lane is indicated at the 
top of the blots. The numbers at the side of the blots indicate molecular weight 
in kDa. 
 
Lower panel: Mean relative expression, compared to the negative control which 
was set at 100%. The mean is calculated from 3 independent experiments. Blots 
were quantified by densitometry using ImageJ software. Error bars are S.E.M (n 
= 3). Statistical analysis was performed using the software program GraphPad 
Prism 5. The significance between groups was determined by one way ANOVA. F 
ratio and probability values are quoted. Dunnett’s multiple comparison post test 
was performed to determine which shRNA significantly differed from the 
negative control. * denotes Dunnett’s P < 0.05. *** denotes P < 0.001.Nicola S Hamilton, 2010    Chapter 3, 97 
 
 
 
F(4,10) = 3.567, P = 0.0468      F(4,10) = 0.7231, P = 0.5957 
 
F(4,10) = 2.322, P = 0.1276      F(4,10) = 3.451, P = 0.0485 
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Figure 3.2.Effect of syntaxin 16 knockdown on expression of other SNARE 
proteins. 
 
3T3 L1 fibroblasts were infected with retrovirus expressing negative control 
shRNA or shRNA targeting syntaxin (stx) 16 (1 4) as described in section 2.5.1. 
 
A. Membrane samples were prepared as described in section 2.4.1 and blotted 
for stx 16, stx 6, vti1a, vti1b and mVps45 (section 2.4.4 2.4.6). All antibodies 
were used at a 1:1000 dilution. The stx 16 blot from figure 3.1 is included as a 
reference. The amount of protein loaded in each lane is indicated at the top of 
the blots. The numbers at the side of the blots indicate molecular weight in kDa. 
 
B. Mean relative expression, compared to the negative control which was set at 
100%. The mean is calculated from 3 independent experiments. Blots were 
quantified by densitometry using ImageJ software. Error bars are S.E.M (n = 3). 
Statistical analysis was performed using the software program GraphPad Prism 5. 
The significance between groups was determined by one way ANOVA. F ratio and 
probability values are quoted. Dunnett’s multiple comparison post test was 
performed to determine which shRNA significantly differed from the negative 
control. * denotes Dunnett’s P < 0.05. 
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3.3.3 Stx 16 knockdown affects total GLUT4 cellular levels 
It was important to show whether the role of stx 16 on GLUT4 trafficking was 
specific or whether stx 16 knockdown had a general effect on proteins in the 
endosomal system. Therefore the levels of GLUT4, IRAP, which traffics in 
concert with GLUT4 (Garza and Birnbaum, 2000) and TfR were determined in the 
stx 16 depleted cells.  
As shown in figure 3.3, compared with the negative control, the level of GLUT4 
was significantly reduced in cells infected with shRNA2 and 4. The level of 
GLUT4 was reduced by 34.34 ± 3.82% (P < 0.01) in shRNA2 infected cells. The 
level of GLUT4 was reduced by 21.42 ± 5.16% (P < 0.05) in shRNA4 infected cells. 
In contrast the level of IRAP was not significantly affected. Also the level of TfR 
was unaffected. Nicola S Hamilton, 2010    Chapter 3, 100 
 
 
 
    F(4,10) = 1.833, P = 0.1992      F(4,10) = 11.23, P = 0.0010 
 
    F(4,10) = 0.5615, P = 0.6961 
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Figure 3.3.Effect of syntaxin 16 knockdown on expression of GLUT4. 
 
3T3 L1 fibroblasts were infected with retrovirus expressing negative control 
shRNA or shRNA targeting syntaxin (stx) 16 (1 4) as described in section 2.5.1.  
 
A. Membrane samples were prepared as described in section 2.4.1 and blotted 
for stx 16, transferrin receptor (TfR), glucose transporter 4 (GLUT4), and insulin 
responsive aminopeptidase (IRAP) (section 2.4.4 2.4.6). All antibodies were used 
at 1:1000 dilution. The stx 16 blot from figure 3.1 is included as a reference. 
The amount of protein loaded in each lane is indicated at the top of the blots. 
The numbers at the side of the blots indicate molecular weight in kDa. 
 
B. Mean relative expression, compared to the negative control which was set at 
100%. The mean is calculated from 3 independent experiments. Blots were 
quantified by densitometry using ImageJ software. Error bars are S.E.M (n = 3). 
Statistical analysis was performed using the software program GraphPad Prism 5. 
The significance between groups was determined by one way ANOVA. F ratio and 
probability values are quoted. Dunnett’s multiple comparison post test was 
performed to determine which shRNA significantly differed from the negative 
control. * denotes Dunnett’s P < 0.05. ** denotes P < 0.01. 
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3.3.4 Effect of stx 16 knockdown on GLUT4 cellular distribution 
After discovering a reduction in total GLUT4 cellular levels in stx 16 depleted 
cells, the distribution of GLUT4 within the cell was investigated.  3T3 L1 
adipocytes infected with negative control shRNA or shRNA4 (the highest stx 16 
knockdown) were fractionated into mitochondria/nuclei (M/N), high density 
microsome (HDM), low density microsome (LDM), plasma membrane (P/M) and 
soluble protein (Sol.) fractions.  
Figure 3.4 shows that in the shRNA4 infected cells, stx 16 was found only in the 
LDM fraction, whereas in the negative control stx 16 was found in both the HDM 
and LDM fractions. The LDM fraction represents endosomal membranes and 
GSVs. The HDM fraction represents the ER and Golgi. This suggests that in 
shRNA4 infected cells the remaining stx 16 is localised to the endosomal 
membranes and perhaps the GSVs. GLUT4 was present in both the HDM and LDM 
fractions of negative control and shRNA4 infected cells. This suggests that the 
overall localisation of GLUT4 may not be altered in stx 16 depleted cells. TfR 
was mostly found in the LDM fraction in both negative control and shRNA4 
infected cells which is expected for a protein which is localised to endosomal 
membranes. Finally SNAP23 was only present in the P/M fraction in negative 
control and shRNA4 infected cells which is where SNAP23 is normally localised. 
Perhaps stx 16 knockdown might not affect the localisation of GLUT4 but the 
level of GLUT4 in each fraction. In figure 3.5 a comparison was made of the HDM 
fractions and the LDM fractions of negative control and shRNA1 4 infected cells. 
In the HDM fractions, stx 16 is greatly reduced in shRNA3 and 4 infected cells 
compared with the negative control.  A lower level of stx 16 is also seen in the 
LDM fractions of these cells. This suggests that majority of stx 16 is depleted 
from the ER and Golgi and that the remaining stx 16 is localised to the 
endosomal membranes and perhaps the GSVs which agrees with figure 3.4.  
GLUT4 is much lower in the HDM and LDM fractions of shRNA2 and 3 infected 
cells compared with the negative control. This suggests that there is much less 
GLUT4 in the ER, Golgi, endosomal membranes and GSVs in shRNA2 and 3  
infected cells. A smaller reduction is seen in the HDM and LDM fractions of Nicola S Hamilton, 2010    Chapter 3, 103 
shRNA1 and 4 infected cells. The levels of IRAP are quite similar in the HDM 
fraction of the negative control and shRNA1, 2 and 4 infected cells. This suggests 
that there is very little change in the levels of IRAP in the ER and Golgi of those 
cells. But the levels of IRAP are very low in the shRNA3 infected cells. In the 
LDM fractions there seems to be little difference between the levels of IRAP in 
the negative control and shRNA4 infected cells, which suggests that the level of 
IRAP in the endosomal membranes and GSV in these cells is similar to that in the 
negative control. However, the levels of IRAP are a little lower in the shRNA1 3 
infected cells. Nicola S Hamilton, 2010    Chapter 3, 104 
 
 
 
Figure 3.4.Distribution of GLUT4 in stx 16-depleted 3T3-L1 adipocytes. 
 
3T3 L1 fibroblasts were infected with retrovirus expressing negative control ( ve 
control) shRNA or shRNA targeting stx 16 (shRNA4) as described in section 2.5.1. 
Lysate from two 10 cm plates of 3T3 L1 adipocytes was fractionated as 
described in section 2.4.2 into mitochondria and nuclei (M/N), heavy density 
microsome (HDM), low density microsome (LDM), plasma membrane (P/M) and 
soluble (Sol.) fractions. 1/20 of the fractions (10 ml) were blotted for stx 16, 
GLUT4, TfR and SNAP 23 (sections 2.4.4 2.4.6). All antibodies were used at a 
1:1000 dilution. The numbers at the side of the blots indicate molecular weight 
in kDa. The figure shows a representative set of blots (n = 2). 
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Figure 3.5. Level of GLUT4 in HDM and LDM fractions of stx 16-depleted 3T3-
L1 adipocytes. 
 
3T3 L1 fibroblasts were infected with retrovirus expressing negative control ( ve 
Con.) shRNA or shRNA targeting stx 16 (1 4) as described in section 2.5.1. Lysate 
from two 10 cm plates of 3T3 L1 adipocytes was fractionated as described in 
section 2.4.2 into HDM and LDM fractions. 1/20 of the fractions (10 ml) were 
blotted for stx 16, GLUT4 and IRAP (sections 2.4.4 2.4.6). All antibodies were 
used at a 1:1000 dilution. The numbers at the side of the blots indicate 
molecular weight in kDa. 
 
A.  HDM fractions. 
B.  LDM fractions. 
 
The figure shows a representative set of blots (n = 2). Nicola S Hamilton, 2010    Chapter 3, 106 
3.3.5 Expression of myc-stx 16A in stx 16 knockdown cells 
Once the knockdown of stx 16 expression in 3T3 L1 adipocytes was 
demonstrated, a way to test the results were due to the depletion of stx 16 was 
needed. Previous work in the lab had created a myc tagged human stx 16A in an 
adenoviral vector. This human stx 16 should be resistant to knockdown by the 
shRNAs which were designed to target murine stx 16 and do not align with the 
human stx 16A sequence.  
First of all the optimum PFU/cell to use for infection with the myc stx16A 
adenovirus in wild type 3T3 L1 adipocytes was determined.  Figure 3.6 shows 
that 1000 PFU/cell resulted in expression of the myc stx 16A at a similar level as 
that of endogenous stx 16. Once the optimum PFU/cell was determined, 
negative control and shRNA4 infected 3T3 L1 adipocytes were infected with or 
without 1000 PFU/cell myc stx 16A adenovirus.  As shown in figure 3.6, 
endogenous stx 16 is present in the negative control infected cells with or 
without myc stx 16A adenovirus. Endogenous stx 16 is not present in the shRNA4 
infected cells with or without adenovirus as expected. The myc stx 16A is only 
present in the cells infected with 1000 PFU/cell adenovirus and is present in 
both negative control and shRNA4 infected cells. Nicola S Hamilton, 2010    Chapter 3, 107 
 
Figure 3.6.Expression of a shRNA-resistant form of myc-stx 16A in stx 16-
depleted 3T3-L1 adipocytes. 
 
A. Wild type 3T3 L1 adipocytes were infected at day 6 post differentiation with 
adenovirus expressing myc tagged human stx 16A (Myc Stx 16) as described in 
section 2.5.3. A range of 0 1000 PFU/cell was used as indicated in the figure.  At 
day 8 post differentiation cells were lysed in HES (2.1.9) and the lysates were 
blotted for stx 16 (sections 2.4.4 2.4.6). 1/10 of the lysate (10 ml) was loaded in 
each lane. Rabbit stx 16 antiserum was used at a 1:1000 dilution. The bands 
corresponding to endogenous stx 16 (Stx 16) and Myc Stx16 are indicated by the 
arrows. The numbers at the side of the blots indicate molecular weight in kDa. 
 
B. 3T3 L1 fibroblasts were infected with retrovirus expressing negative control ( 
ve control) shRNA or shRNA targeting stx 16 (shRNA4) as described in section 
2.5.1. At day 6 post differentiation the cells were infected with or without 1000 
PFU/cell of adenovirus expressing myc stx 16A (Myc Stx 16) as described in 
section 2.5.3. At day 8 post differentiation cells were lysed in HES and the 
lysates were blotted for stx 16 (sections 2.4.4 2.4.6). 1/10 of the lysate (10 ml) 
was loaded in each lane. Rabbit stx 16 antiserum was used at a 1:1000 dilution. 
The bands corresponding to endogenous stx 16 (Stx 16) and Myc Stx16 are 
indicated by the arrows. The numbers at the side of the blots indicate molecular 
weight in kDa. Nicola S Hamilton, 2010    Chapter 3, 108 
3.4 Discussion 
Previous research has shown that stx 16 may have a role in GLUT4 trafficking 
(Proctor et al., 2006). Proctor et al. showed that knockdown of stx 16 using a 
morpholino antisense oligonucleotide resulted in a marked reduction in insulin 
stimulated glucose transport and a 30% loss in total GLUT4 cellular levels. In this 
chapter a different approach was used to knockdown stx 16 expression to 
generate 3T3 L1 cells stably depleted in stx 16. These cells were then used to 
confirm and further investigate the results of this paper. 
To knockdown expression of stx 16, a shRNA approach was used. Four different 
shRNA oligonucleotides (see table in 2.1.5) were designed to target stx 16 using 
Clontech’s online RNAi designer tools. Target sequences were selected according 
to several criteria. First of all the sequences were 19 bp in length as it has been 
shown that shRNAs with 19 bp stems give efficient knockdown (Brummelkamp et 
al., 2002). The maximum hairpin melting temperature (Tm) was set at 45 
oC to 
reduce the problem of internal hairpins in the shRNA sequence which can reduce 
the efficiency of the knockdown achieved.  Also the shRNA sequences were 
selected to have a higher thermal stability at the 5’ end of the sense strand 
compared with the 3’ end (in this case, higher thermal stability was a Tm 
difference of 1 
oC between the four bases at the 5’ end compared with the 
3’end). This is thought to promote entry of the targeting strand of the shRNA 
into the RISC complex and therefore increase efficiency of the knockdown 
(Schwarz et al., 2003). Clontech’s own studies suggested additional criteria for 
shRNA sequence selection.  Sequences were selected to have an optimal GC 
content of 45%. Also all sequences with stretches of five or more of the same 
base (polyN) and sequences with a low complexity (alternating sequences or 
sequences without one of the four bases) were ignored. Finally the sequences 
were selected according to two position  specific criteria.  All selected 
sequences had an A at position 6 and at least one A or T at residues 18 and 19 
(Reynolds et al., 2004). The criteria described above were used to increase the 
efficiency of the knockdown of stx 16 expression in 3T3 L1 adipocytes. Four 
different target sequences were selected from the list generated by Clontech’s 
RNAi Target Sequence Selector. The sequences were chosen to target different 
regions of the stx 16 sequence in the hope that at least one of the four shRNA 
sequences would knockdown stx 16 expression with high efficiency.   Nicola S Hamilton, 2010    Chapter 3, 109 
Once the four shRNA sequences were selected, the full oligonucleotides were 
designed using Clontech’s shRNA sequence designer. In this step, the other 
sequences required for cloning and expression of the shRNA sequence were 
added to the oligonucleotide sequence. Each oligonucleotide contained the 
following elements; a BamH I overhang at the 5’ end, the 19 nucleotides of the 
shRNA sense strand, a hairpin loop sequence, the 19 nucloetides of the shRNA 
antisense strand, a Pol III termination site of 6 consecutive thymidine residues, a 
Mlu I site to allow verification of the cloned inserts and an EcoR I overhang at 
the 3’ end of the oligonucleotide. Also if the shRNA sequence did not start with 
a guanine or adenine, then an extra guanine was added to the 5’ end of the 
shRNA sense strand to allow initiation of Pol III transcription.  Once the 
oligonucleotides had been designed, they were cloned into the RNAi Ready 
pSIREN RetroQ vector (section 2.5.1). The cloned vectors were then transfected 
into EcoPack2 293 packing cells, which produced retroviral particles. The 
retroviral particles were then used to infect 3T3 L1 fibroblasts. The retroviral 
method of shRNA delivery was chosen as it provided a highly efficient way to 
stably express the shRNAs in 3T3 L1 adipocytes. 
Knockdown of stx 16 using shRNA resulted in a reduction of approximately 95% in 
stx 16 levels using the shRNA4 construct (P < 0.001) (Fig. 3.1). This knockdown is 
similar to the levels achieved by Proctor et al. (Proctor et al., 2006).  
The knockdown of stx 16 was quantified by densitometry of western blots 
produced using HRP and ECL. This is one of the most commonly used methods of 
protein detection and offers rapid and sensitive results with a good signal to 
noise ratio. However film has a limited linear dynamic range, therefore it was 
important that several exposures were taken to help ensure that the signal from 
the blot fell within the linear range. 
As stx 16 is part of a t SNARE complex it was important to investigate the effect 
of stx 16 knockdown on the levels of other SNARE proteins. Figure 3.2 shows that 
knockdown of stx 16 by shRNA4 led to a reduction in the level of stx 6 compared 
with the negative control. Cells infected with shRNA4 showed an approximately 
80% reduction in stx 6 (P < 0.05). This result contradicts the data of Proctor et 
al. which showed that stx 16 knockdown by a morpholino antisense 
oligonucleotide did not affect the levels of stx 6 or stxs 4, 8 and 12 (Proctor et Nicola S Hamilton, 2010    Chapter 3, 110 
al., 2006). This may be due to the differences between the methods of 
knockdown of stx 16. In the current study, 3T3 L1 fibroblasts were depleted of 
stx 16 by stable expression of shRNA targeted to stx 16. Antibiotic selection 
ensured that only cells expressing shRNA remained and the cells were cultured 
for at least a week post  infection with the shRNA expressing retrovirus. The 
shRNA expressing cells were then differentiated to adipocytes and membranes 
were prepared and the level of stx 16 and the other proteins tested was 
determined. This method ensures that all the cells tested were expressing the 
shRNA and no non infected cells could alter the result. Also as the cells were 
cultured for at least a week post infection and then differentiated, the long 
term effects of stx 16 knockdown could be determined. This would allow any 
changes in expression of other proteins as a consequence of stx 16 knockdown to 
occur. As a retroviral expression system was used, it meant that the shRNA 
expression construct was integrated into the cells’ DNA and shRNA was 
continually expressed over the course of the experiment which allowed the long 
term effects of stx 16 knockdown to be examined. 
The method used by Proctor et al. involved electroporating 3T3 L1 adipocytes 
with morpholino antisense oligonucleotide. Lysates were then prepared from the 
cells 48 hours later and the level of stxs, 4, 8, 12 and 16 was determined. This 
method does not select for cells containing the morpholino antisense 
oligonucleotide and so cells which have not been successfully electroporated 
may affect the results obtained. Also the cells were tested only 48 hours post 
electroporation which may not allow time for changes of expression due to stx 
16 knockdown to occur. The stability of the morpholino antisense 
oligonucleotide over a long period of time has not been tested so it is not known 
how long the morpholino antisense oligonucleotide exerts its effect on stx 16 
expression. 
Recent data has also shown that knockdown of stx 16 leads to a reduction in stx 
6 levels (Ganley et al., 2008). HEK293 cells transfected with short interfering 
RNA (siRNA) against stx 16 showed an 80% reduction in stx 6. Also cells 
transfected with siRNA against stx 6 showed a 30% reduction in stx 16. The 
authors suggest that the majority of stx 6 may be complexed to stx 16 in the cell 
and that stx 16 is an important stabiliser of stx 6. The siRNA sequence used to 
knockdown stx 16 by Ganley et al. was not the same as any of the shRNA Nicola S Hamilton, 2010    Chapter 3, 111 
sequences used in this study (see table in 2.1.5). This is probably because the 
siRNA sequence was designed to be used against human stx 16 rather than 
murine stx 16. Vti1a levels were unaffected which suggests that stx 16 is not 
required to stabilise the levels of Vti1a. Also the level of the related Vti1b was 
not significantly affected.  
As knockdown of stx 16 leads to a reduction in the levels of stx 6 it is possible 
that some of the effects observed in stx 16 depleted cells are due to the lower 
levels of stx 6. Stx 6 is part of the same t SNARE complex as stx 16 with Vti1a 
(Mallard et al., 2002).Therefore any reduction in the level of stx 6 will have an 
effect on the trafficking pathways involving that t SNARE complex. However stx 
6 is also a part of several other t SNARE complexes and seems to be involved in a 
number of different trafficking pathways involving those complexes (Wendler 
and Tooze, 2001). This means that the reduction in stx 6 caused by knockdown 
of stx 16 may have effects other than those involving stx 16. Therefore in order 
to determine whether the effects observed in stx 16 depleted cells were specific 
for stx 16, myc tagged human stx 16A was expressed in negative control and 
shRNA4 infected cells (Fig. 3.6). If expression of myc  tagged human stx 16 
rescues the effects observed in stx 16 depleted cells, the effects should be 
specific to the function of stx 16 (see discussion of Fig. 3.6 later in this section).  
Interestingly, stx 16 knockdown with shRNA4 resulted in an approximately 60% 
reduction in mVps45 levels (P < 0.05). mVps45 is a  SM protein which binds to stx 
16 and regulates t SNARE assembly (Dulubova et al., 2002). The data in figure 
3.2 suggests that stx 16 depletion leads to a reduction in the recruitment of 
mVps45 to the membrane. 
As mentioned earlier, Proctor et al. showed that stx 16 knockdown resulted in a 
30% reduction in GLUT4 cellular levels. Figure 3.3 shows that in cells infected 
with shRNA2 and 4 the level of GLUT4 was reduced by approximately 35% (P < 
0.01) and 20% (P < 0.05) respectively. This suggests that in cells depleted of stx 
16, GLUT4 is missorted into a degradative pathway. It would be interesting to 
investigate whether this loss of GLUT4 was proteasome dependent using a 
proteasome inhibitor. Interestingly the levels of GLUT4 did not covary with the 
level of stx 16 knockdown observed in figure 3.1. This may be because stx 16 
expression needs to be knocked down to a high level before an effect on GLUT4 Nicola S Hamilton, 2010    Chapter 3, 112 
levels is observed. It may be that there are some compensatory mechanisms to 
preserve the level of GLUT4 in adipocytes. Alternatively, there may have been a 
problem with the differentiation of shRNA2 infected cells, as the level of GLUT4 
was reduced by 35% (P < 0.05), even though the level of stx 16 expression was 
only reduced by approximately 35% (P < 0.05). To determine if this was the case 
with the shRNA2 infected cells the differentiation of the cells could be tested by 
using Oil Red O staining or by blotting for factors which are upregulated during 
differentiation such as PPARg (see discussion of Fig. 3.5). 
In contrast the level of IRAP was unaffected in shRNA infected cells compared 
with the negative control. This result was unexpected as IRAP traffics in a 
similar manner to GLUT4 (Garza and Birnbaum, 2000). This suggests that stx 16 
depletion affects a pathway which is specific to GLUT4 and not IRAP or that IRAP 
is more able to compensate for a loss of stx 16 in the cell. Also in figure 3.3 it 
was noted that the level of TfR was unaffected in shRNA infected cells compared 
with the negative control. This result suggests that stx 16 depletion affects a 
pathway which is specific to GLUT4 and does not affect general endosomal 
recycling. 
After discovering an effect on the total cellular levels of GLUT4, the subcellular 
distribution of GLUT4 in stx 16 depleted cells was further investigated (Fig. 3.4). 
In the shRNA4 infected cells, stx 16 is only found in the LDM fraction which 
represents endosomal membranes and GSVs, but in negative control cells stx 16 
is found in both HDM (which represents the ER and Golgi) and LDM fractions. This 
suggests that even though stx 16 is depleted in shRNA4 infected cells the 
remaining protein is localised to the endosomal membranes and perhaps the 
GSVs. In figure 3.4 GLUT4 is found in both HDM and LDM fractions in the negative 
control and shRNA4 infected cells. As the reduction in GLUT4 in stx 16 depleted 
cells is only relatively small there may not be a big change in the distribution of 
GLUT4 in the different fractions. As the negative control and shRNA4 samples 
were on separate blots it was not possible to compare the levels of GLUT4 in the 
LDM and HDM fractions with this data. The TfR and SNAP 23 blots show that the 
fractions had been properly separated. TfR is located in the LDM fraction as 
expected and SNAP 23 is found in the P/M fraction where it is normally localised.  Nicola S Hamilton, 2010    Chapter 3, 113 
Attempts were made to further fractionate the LDM fraction of negative control 
and shRNA4 infected cells to separate the GSVs using an iodixanol gradient as 
described in (Hashiramoto and James, 2000) but were unsuccessful (data not 
shown). An in vitro budding assay was also attempted to examine the formation 
of GSVs as described in (Xu and Kandror, 2002). However initial experiments 
using wild type cells were unsuccessful (data not shown). 
To determine whether stx 16 depletion affects the level of GLUT4 in the HDM 
and LDM fractions, HDM and LDM samples from negative control and shRNA1 4 
infected cells were compared. In figure 3.5, the level of stx 16 in the HDM 
fraction of shRNA4 infected cells was very low compared with the negative 
control in agreement with figure 3.4. The level of stx 16 was also reduced in the 
LDM fraction but not to the same extent. The level of GLUT4 was slightly 
reduced in the shRNA4 HDM fraction compared with the negative control. In the 
LDM fractions GLUT4 was reduced to a greater extent in the shRNA4 fraction 
compared with the negative control. This suggests that of the 20% loss to total 
GLUT4 levels the majority is lost from the LDM fraction which may suggest that 
stx 16 depletion leads to a loss of GLUT4 from the GSVs. The level of IRAP in the 
HDM and LDM fractions of shRNA4 infected cells was similar to that of negative 
control infected cells which agrees with the results of figure 3.3 which showed 
no significant change in the level of total IRAP levels in stx 16 depleted cells. 
The shRNA3 infected cells showed very different results to that of shRNA4. The 
shRNA3 HDM and LDM samples had very low levels of stx 16 like shRNA4, however 
the shRNA3 samples had very low levels of GLUT4 and IRAP in the HDM fraction 
and also low levels of GLUT4 and IRAP in the LDM fractions. This result was seen 
in all experiments of this type. These results are much lower than expected 
considering that in total membrane samples the reduction of GLUT4 levels in the 
shRNA3 infected cells was approximately 10% and was not significant (Fig. 3.3). 
A possible explanation for this is that the shRNA3 infected cells had not fully 
differentiated, which would lead to a low level of GLUT4 and IRAP in the cells. 
There was not time to fully address this problem. But this problem was one of 
the reasons why the shRNA3 infected cells were not used in future experiments. 
One way to avoid this problem in the future would be to test the differentiation 
of all the shRNA infected cells to ensure that full differentiation had occurred. 
As mentioned previously, this could be done by using Oil Red O staining or by 
blotting for factors which are upregulated during differentiation such as PPARg. Nicola S Hamilton, 2010    Chapter 3, 114 
If stx 16 depletion causes a reduction in GLUT4 levels in the GSVs then this may 
affect the ability of the cells to transport glucose in response to insulin. 
Therefore the effect of stx 16 knockdown on insulin stimulated glucose transport 
was investigated using a 
3H deoxyglucose assay. Unfortunately consistent and 
reliable results were not obtained (data not shown). 
To confirm that knockdown of stx 16 was responsible for the results shown 
above, myc tagged human stx 16A was expressed in negative control and 
shRNA4 infected cells (Fig. 3.6). First of all the optimum PFU/cell of myc stx16A 
adenovirus was determined. Figure 3.6 shows that 1000 PFU/cell was required to 
express myc  stx 16A in wild type 3T3 L1 adipocytes. The level of expression of 
myc stx 16A was similar to endogenous stx 16. The myc stx 16A runs at a lower 
molecular weight than endogenous stx 16. This is because human stx 16 has a 
lower molecular weight of 34 kDa compared with endogenous stx 16 which has a 
molecular weight of 37 kDa. This difference in molecular weight is due to 22 
fewer amino acids in the human stx 16A compared to endogenous murine stx 16 
(Fig. 3.7). The majority of these amino acids are missing from a region between 
the N terminal peptide that binds to mVps45 and the Habc domain (Dulubova et 
al., 2002). This is the only major difference between the amino acid sequences 
of the two proteins. The differences between the human stx 16A and murine stx 
16 should not affect the ability of human stx 16A to rescue the main functions of 
stx 16 to bind its SM protein mVps 45 and to form SNARE complexes. However 
there is the possibility that human stx 16A may not be able to fully compensate 
for a lack of endogenous stx 16 in the shRNA4 infected cells, as it will be unable 
to perform any functions that require the missing region. If this is the case, a 
shRNA4  resistant version of murine stx 16 will need to be created using site 
directed mutagenesis.  
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Figure 3.7.Alignment of human and mouse syntaxin 16 amino acid sequences. 
Human syntaxin 16 (O14662 2) and mouse syntaxin 16 (Q8BVI5) amino acid 
sequences were aligned using Clustal W (http://services.uniprot.org/). Identical 
amino acids are highlighted in grey. * denotes the amino acids are identical, : 
denotes a strong similarity between the amino acids and . denotes weak 
similarity between the amino acids. 
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Once the optimum level of adenovirus was determined, it was used to infect 
negative control and shRNA4 infected cells. Figure 3.6 shows that shRNA4 
infected cells have depleted levels of endogenous stx 16 compared with negative 
control infected cells. However the shRNA4 infected cells are able to express 
the myc stx 16A, which shows that shRNA4 does not target myc stx 16A. The 
samples in figure 3.6 were also blotted for myc to detect myc stx 16 specifically, 
however no bands were detected (data not shown). This problem was also 
encountered in previous work in the lab. It is possible that the myc tag is not 
correctly folded and therefore the antibody is unable to detect it. Fortunately 
the myc stx 16A has a sufficiently different molecular weight for it to be 
distinguished from endogenous stx 16 in a stx 16 blot. It was hoped that the 
myc stx 16A adenovirus would be used in the 
3H deoxyglucose assay, however 
there was not sufficient time or stock of adenovirus to perform the experiments. 
In summary the data in this chapter shows that shRNA can be used to generate 
3T3 L1 adipocytes stably depleted of stx 16. The level of knockdown produced 
by shRNA4 is comparable to that produced by a morpholino antisense 
oligonucleotide (Proctor et al., 2006). Stx 16 depletion affects the levels of its t 
SNARE partner stx 6 and the SM protein mVps45 in membrane samples. 
Also stx 16 knockdown by shRNA4 reduces total GLUT4 cellular levels by 
approximately 20% (P < 0.05) which is similar to the level seen in previous work 
(Proctor et al., 2006). In particular stx 16 knockdown by shRNA4 reduces the 
level of GLUT4 in the LDM fraction which suggests that stx 16 may affect the 
level of GLUT4 in GSVs. Finally it was shown that knockdown of stx 16 can be 
rescued by expression of myc tagged human stx 16A. 117 
Chapter 4 HA-GLUT4-GFP trafficking assays 
4.1 Introduction 
The translocation of GLUT4 in response to insulin is an example of regulated 
membrane trafficking (Bryant et al., 2002). GLUT4 occupies two interrelated, 
overlapping endosomal cycles (Fig.1.3). A fast trafficking cycle, involving the 
plasma membrane and early endosome serves to internalise GLUT4 in the 
absence of insulin. Once in the endosome, GLUT4 is further sorted into a slow 
trafficking pathway, involving the endosome, the TGN and a population of 
vesicles known as GSVs. It is thought that GLUT4 in the GSVs translocates to the 
cell surface in response to insulin.  
A role for stx 16 in GLUT4 trafficking has been previously described (Proctor et 
al., 2006). It is important to determine where in the trafficking itinerary of 
GLUT4, stx 16 functions. It has been proposed that stx 16 functions to control 
entry of GLUT4 into the slow trafficking pathway into the GSVs. One way to 
examine the role of stx 16 in GLUT4 trafficking is to determine the effect stx 16 
has on GLUT4 trafficking kinetics. In order to do this the trafficking of HA 
GLUT4 GFP was examined. 
HA GLUT4 GFP is a GLUT4 molecule with two tags. It has a HA tag in the first 
exofacial loop of GLUT4 and a GFP tag at the C terminus. The HA tag allows any 
GLUT4 at the cell surface to be labelled and the GFP tag allows total HA GLUT4 
GFP expression in the cell to be determined. This allows translocation or 
recycling to be normalised for levels of HA GLUT4 GFP expression using a HA: 
GFP ratio. The use of HA GLUT4 GFP as a reporter was first described in primary 
rat adipose cells (Dawson et al., 2001). This paper showed that HA GLUT4 GFP 
localisation and trafficking were identical to that of endogenous GLUT4.  Since 
then HA GLUT4 GFP has been used in a number of studies (Zeigerer et al., 
2002;Karylowski et al., 2004;Zeigerer et al., 2004;Martin et al., 2006;Muretta et 
al., 2008). 
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4.2 Aims of this chapter 
The aims of this chapter were to develop an assay, which would allow 
translocation and recycling of GLUT4 to be examined. Initially this involved using 
a flow cytometry method, but later the assay was developed to be performed in 
a 96 well plate format for use with a fluorescence plate reader. 
4.3 Results 
4.3.1 Expression of HA-GLUT4-GFP in 3T3-L1 fibroblasts 
In order to investigate GLUT4 trafficking, HA GLUT4 GFP needed to be expressed 
in 3T3 L1 fibroblasts. To express HA GLUT4 GFP, 3T3 L1 fibroblasts were 
infected with lentivirus expressing HA GLUT4 GFP as described in section 2.5.2. 
Cells were infected with a 2 fold serial dilution and the level of HA GLUT4 GFP 
expression was determined as the level of GFP fluorescence, using flow 
cytometry as described in section 2.6.1. Figure 4.1A is the flow cytometry data 
showing the GFP fluorescence of fibroblasts infected with each serial dilution 
compared with negative control cells, which were mock infected. As shown in 
figure 4.1A the GFP fluorescence of the HA GLUT4 GFP infected cells was higher 
than the negative control at each serial dilution. As the dilution increased the 
level of GFP fluorescence decreased. The results in figure 4.1A were quantified 
in terms of mean fluorescence intensity (MFI) (Fig.4.1B) and in terms of the 
percentage of cells positively expressing HA GLUT4 GFP (Fig.4.1C). Figure 4.1B 
shows that the 1 in 2 dilution of lentivirus resulted in the highest level of GFP 
fluorescence. Also the GFP fluorescence decreased by approximately a factor of 
2 with each dilution.  Figure 4.1C shows that the 1 in 2 and 1 in 4 dilutions of 
lentivirus gave the highest levels of infection compared with the negative 
control. Nicola S Hamilton, 2010    Chapter 4, 119 
 
 
Figure 4.1. Expression of HA-GLUT4-GFP in 3T3-L1 fibroblasts. 
 
A. 3T3 L1 fibroblasts were infected with a 2 fold serial dilution of lentivirus 
expressing HA GLUT4 GFP as described in section 2.5.2. Expression levels are 
proportional to the level of GFP fluorescence, which was determined by flow 
cytometry as described in section 2.6.1. GFP fluorescence (FL1 H) is shown on 
the x axis and the number of cells (counts) is shown on the y axis. Mock infected 
cells were used as a negative control ( ve control). Each panel shows one serial Nicola S Hamilton, 2010    Chapter 4, 120 
dilution (1 in 2 to 1 in 16) of HA GLUT4 GFP lentivirus (shown in red) compared 
with the negative control (shown in grey). 
 
B.  Quantification of the data shown in A. The level of GFP fluorescence is 
expressed in terms of the MFI which is shown on the y axis (n = 1). 
 
C. Quantification of the data shown in A. The percentage of cells positively 
expressing HA GLUT4 GFP is shown on the y axis. If the negative control cells 
are considered to be not expressing HA GLUT4 GFP, any cells with a higher GFP 
fluorescence can be considered to be positively expressing HA GLUT4 GFP. The 
percentage of cells positively expressing HA GLUT4 GFP was determined by 
calculating the area under the red curve to the right of the negative control (n = 
1). 
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4.3.2 Cell sorting of 3T3-L1 adipocytes. 
Recently Muretta et al. published a method by which HA GLUT GFP trafficking in 
3T3 L1 adipocytes could be examined using flow cytometry (Muretta et al., 
2008). In this paper they also demonstrated that 3T3 L1 adipocytes could be 
distinguished using flow cytometry from 3T3 L1 fibroblasts and debris. Therefore 
before analysing HA GLUT4 GFP trafficking, wild type 3T3 L1 adipocytes were 
sorted on the basis on forward scatter (FSC), side scatter (SSC) and 
autofluorescence in the allophycocyanin (APC) channel into adipocytes, 
fibroblasts and debris (Fig. 4.2). This was to ensure that in future experiments, 
the cell populations being analysed by flow cytometry were indeed adipocytes.   
As shown in figure 4.2, 3T3 L1 adipocytes formed two populations on the basis of 
FSC and SSC. The low SSC population (P2) was fibroblasts. 3T3 L1 fibroblasts 
usually have a long and branched morphology. However, the cells in P2 in figure 
4.2 have a rounded morphology. This is probably because the cells became 
rounded during the cell sorting process and had not settled down fully on the 
microscope slide. The high SSC population (P1) was further sorted on the basis of 
autofluorescence in the APC channel. This resulted in two populations. The high 
autofluorescence population (P4) was debris. The debris has a granular and mis 
shapened morphology. The low autofluorescence population (P3) was 
adipocytes. 3T3 L1 adipocytes contain several lipid droplets of varying size 
within their cytoplasm. Nicola S Hamilton, 2010    Chapter 4, 122 
 
Figure 4.2. Sorting of 3T3-L1 adipocytes. 
 
3T3 L1 adipocytes were sorted as described in section 2.6.2 (n = 1). Cells were 
sorted on the basis of forward scatter (FSC A), which represents cell size, and 
side scatter (SSC A), which represents cell granularity, into P1 and P2 
populations. The P1 population was then sorted into P3 and P4 populations on 
the basis of autofluorescence in the APC channel (APC A). The sorted cells were 
viewed on a Zeiss Axiovert microscope using a x 32 objective lens to determine 
which was the 3T3 L1 adipocyte population. P2 is 3T3 L1 fibroblasts. P3 is 3T3 
L1 adipocytes. P4 is debris. The images shown are representative of the multiple 
fields of view recorded. 
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4.3.3 Surface labelling of HA-GLUT4-GFP 
To measure the translocation of HA GLUT4 GFP, 3T3 L1 adipocytes infected with 
a 1 in 2 dilution of lentivirus were stimulated with or without insulin for 30 
minutes. Then the cells were kept on ice and labelled for HA GLUT4 GFP at the 
cell surface using a HA primary antibody and a R Phycoerythrin (RPE) conjugated 
secondary antibody. The RPE and GFP fluorescence of the cells was measured 
using flow cytometry as described in section 2.6.3. 
Figure 4.3A shows an example of a flow cytometry analysis for one sample.  The 
cells were gated for high SSC and low autofluorescence in a similar manner to 
the cell sorting of 3T3 L1 adipocytes in figure 4.2. The top left panel of figure 
4.3A shows the FSC and SSC of all the 10,000 cells analysed in the sample. The 
cells were gated for high SSC as shown by the position of the oval in the top left 
panel. These gated cells were then analysed in the top right panel. The top right 
panel of figure 4.3A shows the SSC and autofluorescence in the APC channel of 
the gated cells. The cells in the top right panel were further gated for low 
autofluorescence in the APC channel as shown by the position of the oval in the 
top right panel. The panel at the bottom of figure 4.3A shows the RPE 
fluorescence of the gated cells (from the top right panel) which represents the 
level of HA GLUT4 GFP at the surface. Figure 4.3B shows a comparison of the 
RPE fluorescence of basal and insulin stimulated cells. Both basal and insulin 
stimulated cells, which were labelled with the isotype control, have low levels 
of RPE fluorescence. The peaks of both isotype samples are just above 10
0. The 
level of RPE fluorescence of basal and insulin stimulated cells labelled with the 
HA antibody is much higher than the isotype controls. However, there is little 
difference between the basal HA sample and the insulin stimulated HA sample. 
Both HA labelled samples have a peak at approximately 10
2. Nicola S Hamilton, 2010    Chapter 4, 124 
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Figure 4.3 Surface labelling of HA-GLUT-GFP. 
 
3T3 L1 adipocytes infected with a 1 in 2 dilution of HA GLUT4 GFP lentivirus 
(section 2.5.2) were labelled for surface levels of HA GLUT4 GFP as described in 
section 2.6.3. Cells were labelled with a HA.11 mouse monoclonal primary 
antibody or an IgG1 isotype control from murine myeloma clone MOPC21 and a 
RPE conjugated goat anti mouse secondary antibody. The cells were then 
analysed by flow cytometry.  
 
A. An example of the flow cytometry analysis for one sample. The cells were 
gated for high side scatter (SSC A) and then low autofluorescence on the APC 
channel (FL4 A APC A). The level of RPE fluorescence which represents the 
surface level of HA GLUT4 GFP was then determined. The ovals show where the 
populations have been gated and the numbers give the percentage of events 
(cells) in that gated population. 
 
B. A representative comparison of surface levels of HA GLUT4 GFP (represented 
by RPE fluorescence) in basal and insulin stimulated adipocytes expressing HA 
GLUT4 GFP (n=2). 
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4.3.4 Comparison of HA-GLUT4-GFP expression with endogenous 
GLUT4 expression 
In the previous experiment, the level of surface HA GLUT4 GFP in basal cells was 
as high as the level in insulin stimulated cells. This suggested that HA GLUT4 
GFP was on the surface of the cell at high levels in basal conditions. One 
possibility was that the level of HA GLUT4 GFP expression was too high and HA 
GLUT4 GFP was able to escape the basal retention mechanisms in the cell. 
Therefore, the level of HA GLUT4 GFP in membrane samples was determined in 
cells infected with a 1 in 2 and a 1 in 4 dilution of the lentivirus and this was 
compared with the level of endogenous GLUT4 in mock infected negative control 
cells. Figure 4.4A shows that the level of HA GLUT4 GFP in the 1 in 2 infected 
cells was much higher than the level of endogenous GLUT4 in the negative 
control cells. However, in the 1 in 4 infected cells the level of HA GLUT4 GFP 
was similar to endogenous GLUT4 levels. Figure 4.4B shows that HA GLUT4 GFP 
is only expressed in the infected cells and not in the negative control cells. 
Figure 4.4B also confirms that the band at approximately 83 kDa in the GLUT4 
blot in figure 4.4A is HA GLUT4 GFP. Nicola S Hamilton, 2010    Chapter 4, 127 
 
 
 
Figure 4.4 Comparison of HA-GLUT4-GFP expression in 3T3-L1 adipocytes 
with endogenous GLUT4. 
 
Membranes were prepared as described in section 2.4.1 from 3T3 L1 adipocytes 
infected with a 1 in 2 or a 1 in 4 dilution of HA GLUT4 GFP lentivirus (section 
2.5.2). As a control membranes were also prepared from cells which had been 
mock infected (No DNA) (n =1). The membrane samples were separated on a 10% 
(v/v) SDS PAGE gel as described in section 2.4.4. 10 mg of protein was loaded in 
each lane. The proteins were transferred to nitrocellulose as described in 
section 2.4.5 and then blotted as described in section 2.4.6. The numbers at the 
side of the blots indicate molecular weight in kDa. 
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Upper panel. Western blot of GLUT4 using a rabbit anti GLUT4 C terminus 
primary antibody at a 1:1000 dilution. 
 
Lower panel. Western blot of HA GLUT4 GFP using a rabbit anti GFP primary 
antibody at a 1:1000 dilution. 
 
Bands corresponding to GLUT4 and HA GLUT4 GFP are indicated by the arrows. 
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4.3.5 Localisation of HA-GLUT4-GFP 
It was also important to confirm that HA GLUT4 GFP was properly localised in 
basal and insulin stimulated cells. Cells infected with 1 in 2 and 1 in 4 dilutions 
of lentivirus were stimulated with or without insulin. To stain for surface HA 
GLUT4 GFP, the cells were left unpermeabilised and were stained using a HA 
primary antibody and a Cy3 conjgated secondary antibody. Cy3 fluorescence and 
GFP fluorescence were then determined by confocal microscopy. Figure 4.5A 
shows that in the 1 in 4 infected cells, under basal conditions there is little or no 
HA GLUT4 GFP at the cell surface. However insulin stimulation results in much 
higher levels of HA GLUT4 GFP at the cell surface. In contrast, in the 1 in 2 
infected cells, HA GLUT4 GFP was present at the cell surface in basal cells and 
the level at the surface did not increase much with insulin stimulation. 
 
To show that the HA staining represented the location of HA GLUT4 GFP, the 
cells were permeablised and then stained for HA. In figure 4.5C GFP and Cy3 
fluorescence colocalised in the 1 in 2 and 1 in 4 infected cells in both basal and 
insulin stimulated conditions. To confirm that there was no non specific staining 
due to the Cy3 conjugated secondary antibody, permeabilised cells were also 
stained without the HA primary antibody. Figure 4.5B shows that the staining 
was specific. Nicola S Hamilton, 2010    Chapter 4, 130 
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Figure 4.5. Localisation of HA-GLUT4-GFP in 3T3-L1 adipocytes. 
 
3T3 L1 adipocytes were infected with a 1 in 4 or a 1 in 2 dilution of HA GLUT4 
GFP lentivirus as described in section 2.5.2. Basal and insulin stimulated cells 
were stained for HA as described in section 2.7.1 (n = 2). 
 
A.  Unpermeabilised cells were stained with a HA.11 mouse monoclonal 
primary antibody and a Cy3 conjugated goat anti mouse secondary 
antibody. 
B.  Permablised cells without HA staining and a Cy3 conjugated goat anti 
mouse secondary antibody. 
C.  Permeabilised cells were stained with a HA.11 mouse monoclonal primary 
antibody and a Cy3  conjugated goat anti mouse secondary antibody. 
All images were taken with using a Zeiss LSM Exciter confocal microscope under 
oil immersion with a x 64 lens. Gain and brightness settings were the same for 
all images. Scale bar is 20 mm. 
 Nicola S Hamilton, 2010    Chapter 4, 132 
4.3.6 Surface labelling of HA-GLUT4-GFP with 1 in 4-infected cells 
The experiments of the previous two sections demonstrated that cells infected 
with a 1 in 4 dilution of lentivirus had more appropriate levels of HA GLUT4 GFP 
and the HA GLUT4 GFP in these cells responded normally to insulin. Therefore, 
the flow cytometry experiment from section 4.3.3 was repeated using the 1 in 4 
infected cells. Figure 4.6 shows a comparison of the RPE fluorescence of basal 
and insulin stimulated cells. The results look similar to the results of figure 4.3B. 
The isotype controls have low levels of RPE fluorescence and peak at about 10
0.4. 
The RPE fluorescence of the basal and insulin stimulated cells labelled with HA 
antibody is much higher than the isotype controls. The basal peak is at 10
2 and 
the insulin peak is at 10
1.7. 
4.3.7 Confocal staining with RPE-conjugated secondary antibody 
The results of the previous section suggested that there was still a problem with 
the flow cytometry surface labelling assay. One possibility was that the RPE 
conjugated secondary antibody used in the flow cytometry assay was not 
labelling the cells properly. Cells infected with a 1 in 2 and 1 in 4 dilution of 
lentivirus were stained for surface levels of HA GLUT4 GFP as described in 
section 4.3.5, except the RPE conjugated secondary antibody was used instead 
of a Cy3 conjugated secondary antibody. Figure 4.7 shows that staining with the 
RPE secondary antibody was not as strong or as clean as the staining with the 
Cy3 conjugated secondary antibody (Fig. 4.5). For the insulin stimulated cells in 
particular, the ring of staining for HA GLUT4 GFP at the surface was not as 
strong or defined. Nicola S Hamilton, 2010    Chapter 4, 133 
 
Figure 4.6. Surface labelling of HA-GLUT4-GFP. 
 
3T3 L1 adipocytes infected with a 1 in 4 dilution of HA GLUT4 GFP lentivirus 
(section 2.5.2) were labelled for surface levels of HA GLUT4 GFP as described in 
section 2.6.3. Cells were labelled with a HA.11 mouse monoclonal primary 
antibody or an IgG1 isotype control from murine myeloma clone MOPC21 and a 
RPE conjugated goat anti mouse secondary antibody. The cells were then 
analysed by flow cytometry. 
 
The figure shows a comparison of the surface levels of HA GLUT4 GFP 
(represented by RPE fluorescence) in basal and insulin stimulated adipocytes 
expressing HA GLUT4 GFP (n = 1).  
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Figure 4.7. HA staining with a RPE secondary antibody. 
 
3T3 L1 adipocytes were infected with a 1 in 4 or a 1 in 2 dilution of HA GLUT4 
GFP lentivirus as described in section 2.5.2. Basal and insulin stimulated 
unpermeablised cells were stained for HA as described in section 2.7.1 with a 
HA.11 mouse monoclonal primary antibody and a RPE conjugated goat anti 
mouse secondary antibody (n = 1).  
 
All images were taken with using a Zeiss LSM Exciter confocal microscope under 
oil immersion with a x 64 lens. Gain and brightness settings were the same for 
all images. Scale bar is 20 mm. 
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4.3.8 Surface labelling of HA-GLUT4-GFP with Cy3-conjugated 
secondary antibody 
The flow cytometry surface labelling assay was repeated as described in section 
4.3.6 except a Cy3 conjugated secondary antibody was used to label the cells. 
Figure 4.8 shows a comparison of the RPE fluorescence (nearest channel to Cy3) 
of basal and insulin stimulated cells. The isotype controls had low levels of RPE 
fluorescence, with peaks at 10
0. The basal cells labelled with HA antibody also 
had low RPE fluorescence and the peak was almost identical to the isotype 
controls. The insulin stimulated cells labelled with HA antibody had a slightly 
higher level of RPE fluorescence with a peak at 10
0.1. 
4.3.9 Surface labelling of HA-GLUT4-GFP 96-well plate assay 
The difference between basal and insulin stimulated levels of surface HA GLUT4 
GFP in the previous experiment was not as big as hoped. It was then decided to 
try the experiment in a 96 well plate format and use a fluorescence plate reader 
to measure surface levels of HA GLUT4 GFP as described in section 2.8.1. In this 
experiment cells infected with a 1 in 4 dilution of lentivirus were stimulated 
with or without insulin and then stained for surface levels of HA GLUT4 GFP 
using a HA primary antibody and the Cy3 conjugated secondary antibody. Figure 
4.9 shows that in response to insulin the level of HA GLUT4 GFP on the cell 
surface increased by over four fold (P < 0.01). The mean fluorescence ratio 
(MFR) (surface: total) of basal cells was 2.17 ± 0.213 (mean ± S.D.) and the MFR 
of insulin stimulated cells was 9.14 ± 3.48. Nicola S Hamilton, 2010    Chapter 4, 136 
 
Figure 4.8. Surface labelling of HA-GLUT4-GFP. 
 
3T3 L1 adipocytes infected with a 1 in 4 dilution of HA GLUT4 GFP lentivirus 
(section 2.5.2) were labelled for surface levels of HA GLUT4 GFP as described in 
section 2.6.3. Cells were labelled with a HA.11 mouse monoclonal primary 
antibody or an IgG1 isotype control from murine myeloma clone MOPC21 and a 
Cy3 conjugated goat anti mouse secondary antibody. The cells were then 
analysed by flow cytometry.   
 
The figure shows a comparison of the surface levels of HA GLUT4 GFP 
represented by RPE fluorescence (nearest channel to Cy3) in basal and insulin 
stimulated adipocytes expressing HA GLUT4 GFP (n = 1). RPE has an Ex/Em of 
480/580. Cy3 has an Ex/Em of 550/580. To detect RPE the cells were excited 
using a 488 nm laser and the emission was detected by channel FL 3 which uses 
a 585/40 bandpass filter. 
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Figure 4.9 Translocation of HA-GLUT4-GFP in response to insulin. 
 
3T3 L1 adipocytes infected with a 1 in 4 dilution of HA GLUT4 GFP lentivirus 
(section 2.5.2) were labelled for surface levels of HA GLUT4 GFP as described in 
section 2.8.1. Basal or insulin stimulated cells were labelled with a HA.11 mouse 
monoclonal primary antibody or an IgG1 isotype control from murine myeloma 
clone MOPC21 and a Cy3 conjugated goat anti mouse secondary antibody. The 
MFR of surface to total HA GLUT4 GFP was used as a measure of HA GLUT4 GFP 
translocation. The MFR was calculated by determining the MFI of HA GLUT4 GFP 
at the cell surface (HA/Cy3 fluorescence corrected for isotype/Cy3 fluorescence) 
and dividing by the MFI of total HA GLUT4 GFP expression (GFP fluorescence 
corrected for cells not expressing HA GLUT4 GFP). The MFR is calculated from 5 
independent experiments. Error bars are S.E.M (n = 5) ** denotes Student’s T 
test P < 0.01. 
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4.3.10 Recycling of HA-GLUT4-GFP 
The results of the previous experiment demonstrated that the 96 well plate 
assay could be used to measure translocation of HA GLUT4 GFP to the cell 
surface. Another aspect of GLUT4 trafficking that was important to study was 
the recycling of GLUT4 through intracellular compartments. For this experiment, 
basal or insulin stimulated cells infected with a 1 in 4 dilution of HA GLUT4 GFP 
lentivirus were incubated at 37
 oC with Cy3 conjugated HA antibody for various 
time periods. As the HA epitope is inserted into the first exofacial loop of 
GLUT4, when Cy3 HA antibody is added to the culture medium, cells expressing 
HA GLUT4 GFP accumulate the antibody with time. Any Cy3 HA antibody left on 
the surface after incubation was washed away and the level of intracellular HA 
GLUT4 GFP was determined using a fluorescence plate reader as described in 
section 2.8.2.  
Figure 4.10 shows that under basal conditions the Cy3: GFP ratio increases over 
time and plateaus at 10 hours. In insulin stimulated conditions, the Cy3: GFP 
ratio increases slightly more quickly and starts to plateau at 2 hours. The 
plateau of the insulin stimulated cells is lower than the plateau for the basal 
cells. The basal plateau was at 0.936 and the insulin plateau was at 0.574. The 
data from figure 4.10 suggests that in insulin stimulated cells the rate of HA 
GLUT4 GFP recycling is slightly higher than the rate in basal cells. Also the data 
suggests that the level of HA GLUT4 GFP recycled in insulin stimulated cells is 
lower than in basal cells. Nicola S Hamilton, 2010    Chapter 4, 139 
 
 
Figure 4.10 Recycling of HA-GLUT4-GFP in response to insulin. 
 
3T3 L1 adipocytes infected with a 1 in 4 dilution of HA GLUT4 GFP lentivirus 
(section 2.5.2) were labelled for recycling HA GLUT4 GFP as described in section 
2.8.2. Basal or insulin stimulated cells were incubated with pre warmed serum 
free DMEM containing 50 mg/ml Cy3 HA.11 and with or without 170 nM insulin for 
the time periods shown (in minutes). The mean Cy3: GFP ratio at each time 
point is used as a measure of HA GLUT4 GFP recycling. The Cy3: GFP ratio is 
calculated by determining the Cy3 MFI of the HA GLUT4 GFP infected cells 
(HA/Cy3 fluorescence corrected for uninfected/Cy3 fluorescence) and dividing 
by the MFI of total HA GLUT4 GFP expression (GFP fluorescence corrected for 
cells not expressing HA GLUT4 GFP). Error bars are S.E.M (n = 3). 
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4.4 Discussion 
As mentioned in section 4.1, insulin stimulated GLUT4 translocation is an 
example of regulated membrane trafficking (Bryant et al., 2002). It has been 
proposed that stx 16 has a role in GLUT4 trafficking (Proctor et al., 2006). In this 
chapter a flow cytometry assay and 96 well plate assays were used to examine 
the trafficking of HA GLUT4 GFP in 3T3 L1 adipocytes with the hope that these 
assays could be used to investigate the role of stx 16 in GLUT4 trafficking. 
To determine the trafficking of HA GLUT4 GFP, initially a flow cytometry assay 
was used which was based on the work of Muretta et al. (Muretta et al., 2008). 
First of all 3T3 L1 fibroblasts were infected with lentivirus expressing HA GLUT4 
GFP. A 1 in 2 and a 1 in 4 dilution of lentivirus gave the greatest infection rate, 
but the 1 in 2 dilution gave the greatest level of HA GLUT4 GFP expression (Fig. 
4.1). Therefore, the cells infected with a 1 in 2 dilution of lentivirus were used 
in further experiments.  
In the flow cytometry assay used by Muretta et al. only 3T3 L1 adipocytes 
wanted to be analysed for GLUT4 trafficking. However, after differentiation, 
some fibroblasts remain and the process of removing the adipocytes from their 
plates results in the formation of debris. To ensure that the cells being analysed 
by flow cytometry were only adipocytes, wild type 3T3 L1 adipocytes were 
sorted on the basis of FSC, SSC and autofluorescence in the APC channel 
(Fig.4.2). First of all, the cells were sorted on the basis of cell size by FSC and 
on the basis of cell granularity by SSC into the P1 and P2 populations. The P1 
population was then sorted into P3 and P4 populations on the basis of 
autofluorescence in the APC channel. The P2 population with lower FSC and SSC 
was made up of undifferentiated fibroblasts. The P3 population with higher FSC 
and SSC but lower autofluorescence in the APC channel was adipocytes. The P4 
population with higher FSC and SSC and higher autofluorescence in the APC 
channel was debris. Figure 4.2 shows that adipocytes could be distinguished 
from fibroblasts and debris by flow cytometry and that the adipocytes could be 
separated using a cell sorter.  
The results of the first surface labelling experiment using cells infected with a 1 
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expected. Figure 4.3 shows that there was a high level of RPE fluorescence for 
basal cells labelled with a HA antibody. This experiment was performed a couple 
of times and showed similar results. The high RPE fluorescence did not seem to 
be as a result of non specific binding as the isotype controls had low RPE 
fluorescence. The high levels of RPE fluorescence in the basal cells suggested 
that the cells had a high level of HA GLUT4 GFP on their cell surface. One 
possible explanation for this was that the 1 in 2 infected cells were expressing a 
level of HA GLUT4 GFP which was too high, and HA GLUT4 GFP molecules were 
escaping the retention mechanisms, which keep GLUT4 in intracellular 
compartments under basal conditions. Therefore, the level of HA GLUT4 GFP 
expression was compared in 1 in 2 and 1 in 4 infected cells and was also 
compared to the level of endogenous GLUT4 found in negative control cells. 
Figure 4.4 shows that the level of HA GLUT4 GFP in the 1 in 2 infected cells was 
much higher than endogenous levels of GLUT4. Whereas, the level of HA GLUT4 
GFP expression in the 1 in 4 infected cells was similar to endogenous GLUT4 
levels.  
Confocal studies were also performed to confirm that the high level of HA 
GLUT4 GFP in the 1 in 2 infected cells was affecting the localisation of HA 
GLUT4 GFP under basal conditions. Figure 4.5 shows that the 1 in 2 infected 
cells did indeed have high levels of surface HA GLUT4 GFP under basal 
conditions and also showed that insulin stimulation did not greatly increase the 
level of HA GLUT4 GFP at the cell surface compared with basal cells. This 
confirmed that the results of surface labelling assay in figure 4.3 were probably 
due to high levels of HA GLUT4 GFP at the cell surface. In contrast, the level of 
HA GLUT4 GFP at the cell surface of basal 1 in 4 infected cells was very low and 
increased greatly with insulin stimulation.  
It was also noted that in figure 4.5, the level of GFP fluorescence in the 1 in 4 
infected cells appeared lower in basal conditions compared with insulin 
stimulated conditions. This occurred in all images obtained. It is unlikely that 
insulin stimulation for 30 minutes increased the level of HA GLUT4 GFP 
expression. Perhaps the increase in GFP fluorescence is due to the HA GLUT4 
GFP molecules being closer to the cell surface in insulin stimulated conditions, 
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The results of figure 4.4 and 4.5 suggested that cells infected with a 1 in 4 
dilution of lentivirus might be more appropriate to use for the flow cytometry 
surface labelling assay. The cells had a level of HA GLUT4 GFP expression that 
more closely matched endogenous GLUT4 levels. They also had the correct 
localisation of HA GLUT4 GFP under basal conditions and were insulin 
responsive. In addition, a 1 in 4 dilution of lentivirus produced a high infection 
rate (Fig. 4.1). Therefore, the 1 in 4 infected cells were used in all future 
experiments.  
Unfortunately, when the 1 in 4 infected cells were used in a surface labelling 
assay, the results did not improve (Fig. 4.6). They were very similar to the 
results of figure 4.3. This suggested that the expression level of HA GLUT4 GFP 
in the 1 in 2 infected cells was not the only problem with the assay. It was then 
suggested that there was a problem with the labelling, in particular with the 
RPE conjugated secondary antibody. So the RPE conjugated secondary antibody 
was used to stain surface HA GLUT4 GFP and the cells were analysed by confocal 
microscopy as described in section 4.3.7. When the data of figures 4.5 and 4.7 
were compared, the RPE staining was not as strong, clean or as consistent as the 
Cy3 staining. As the Cy3 conjugated secondary antibody gave better staining in 
confocal experiments, the flow cytometry surface labelling assay was repeated 
using the Cy3 conjugated secondary antibody. As there was no Cy3 channel on 
the flow cytometer the level of surface HA GLUT4 GFP was measured using the 
RPE channel which is the closest channel to the Cy3 excitation/emission 
wavelengths (Ex/Em). Cy3 has an Ex/Em of 550/580 and RPE has an Ex/Em of 
480/580. As shown in figure 4.8, using the Cy3 conjugated secondary antibody 
reduced the high basal fluorescence, which was now almost identical to the 
isotype control fluorescence. However the fluorescence of the insulin stimulated 
cells labelled with HA antibody was much lower than expected and was very 
close to basal values. This may be due to the fact the RPE channel was not 
specific to Cy3 fluorescence and therefore it was not as sensitive to changes in 
Cy3 fluorescence. To detect RPE the cells were excited using a 488 nm laser, 
which is much lower than the excitation wavelength of Cy3 and the emission was 
detected by channel FL 3, which uses a 585/40 bandpass filter.  
It was then decided to try the surface labelling assay in a 96 well plate format 
and use a fluorescence plate reader to measure surface levels of HA GLUT4 GFP. Nicola S Hamilton, 2010    Chapter 4, 143 
Figure 4.9 shows that insulin stimulated HA GLUT4 GFP translocation was 
successfully determined. Insulin stimulation resulted in an over four fold 
increase in surface HA GLUT4 GFP compared with basal cells (P < 0.01).  
Once an assay had been developed to measure HA GLUT4 GFP translocation to 
the cell surface, the recycling of HA GLUT4 GFP was examined using the method 
described in section 2.8.2. Initial experiments used a mouse HA.11 primary 
antibody with a Cy3 conjugated secondary antibody but they were not successful 
(data not shown). It was thought that using separate primary and secondary 
antibodies may be the reason for the poor results. So a Cy3 conjugated HA 
antibody was made using a Cy3 labelling kit as described in section 2.4.11.  
Using a conjugated antibody improved the results (Fig. 4.10). The Cy3: GFP ratio 
was used as a measure of recycling, as the time dependent increase of Cy3 
labelled HA GLUT4 GFP is a measure of the movement of unlabelled intracellular 
HA GLUT4 GFP to the cell surface. In basal cells the Cy3: GFP ratio increased 
over time until it reached a plateau at around 10 hours. This agrees with the 
results of a similar experiment by Karylowski et al. (Karylowski et al., 2004). 
The rate of recycling of HA GLUT4 GFP was slightly higher with insulin. The Cy3: 
GFP ratio increased slightly more quickly and started to plateau at 2 hours.  
The curve for insulin stimulated cells was not as steep as expected. Other work 
has shown that the Cy3: GFP ratio reaches a plateau at 45 minutes in insulin 
stimulated cells (Karylowski et al., 2004). This difference has been suggested by 
Prof. Timothy McGraw (Weill Cornell Medical College) to be due to variations in 
cell culture or experimental conditions (personal communication). Karylowski et 
al. used electroporation as a method of expressing HA GLUT4 GFP in 3T3 L1 
adipocytes rather than a lentiviral method. In addition, Karylowski et al. used 
confocal microscopy to analyse the cells (Karylowski et al., 2004). Both of these 
methods require the replating of differentiated adipocytes, which may have an 
effect on the trafficking of GLUT4 (Muretta et al., 2008). Finally, Karylowski et 
al. used adipocytes at days 5 7 post differentiation, rather than at days 8 10 
post differentiation, which may have affected the cells’ responsiveness to 
insulin (Karylowski et al., 2004). 
In addition, the level of the plateau reached in insulin stimulated cells was not 
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antibody, the level of the plateau indicates the size of the cycling pool of HA 
GLUT4 GFP.The level of recycled GLUT4 should not have been lower in insulin 
stimulated cells. In the experiments by Karylowski et al. both basal and insulin 
stimulated cells reached the same plateau (Karylowski et al., 2004). In fact, 
other work has suggested that insulin increases the amount of recycling GLUT4 in 
a dose dependent manner (Govers et al., 2004). Perhaps a higher concentration 
of insulin was needed to increase the recycling rate further, or possibly the 
concentration of Cy3 HA antibody was not saturating, which would limit the rate 
of recycling. However it has been shown that at 50mg/ml the accumulation of 
Cy3 labelled HA GLUT4 GFP is not rate limited by antibody binding (Muretta et 
al., 2008). There was not sufficient time to fully address these problems. 
Once the surface labelling assay and the recycling assay had been developed, it 
was hoped that these assay could be used to investigate the effect of stx 16 
knockdown on GLUT4 trafficking. Unfortunately there was not time perform 
those experiments. The experiments would have required cell lines, which 
expressed both the shRNA to knockdown stx 16 expression and HA GLUT4 GFP. 
This would have involved infecting 3T3 L1s with a retrovirus and a lentivirus. 
There is nothing in the literature to suggest this had been done before. It was 
not known whether the infections could be done simultaneously or sequentially. 
It would have required lots of optimisation to ensure that both constructs were 
being expressed and to select cells, which were expressing both constructs. 
Alternatively, the HA GLUT4 GFP infected cells could have been transiently 
transfected with stx 16 shRNA using an electroporation method. However, this 
method would have involved replating differentiated 3T3 L1 adipocytes, which 
may have affected HA GLUT4 GFP recycling by inhibiting static retention of HA 
GLUT4 GFP (Muretta et al., 2008).  
In summary the data in this chapter shows the development of a surface 
labelling assay to measure translocation of HA GLUT4 GFP and an assay to 
measure the recycling of HA GLUT4 GFP. This chapter also illustrates the 
importance of expression levels of HA GLUT4 GFP, which can adversely affect 
trafficking. 145 
Chapter 5 Phosphorylation of syntaxin 16 
5.1 Introduction 
When insulin binds to its receptor, it results in a cascade of signalling events 
(section 1.3.2) (Kanzaki, 2006). Many of these events involve the activation of 
kinases and phosphatases. This suggests that phosphorylation status is an 
important mechanism by which insulin regulates the proteins involved in GLUT4 
trafficking. It has been shown that activation of Akt2 is sufficient to stimulate 
GLUT4 translocation to a similar extent to insulin (Ng et al., 2008). This suggests 
that phosphorylation of substrates by Akt2 is sufficient to induce GLUT4 
translocation. Also it has been shown that insulin dependent phosphorylation of 
AS160 is essential for GLUT4 translocation (Stockli et al., 2008). These examples 
demonstrate the importance of phosphorylation in regulating GLUT4 trafficking. 
 
Vesicle fusion is a highly regulated process. The assembly of cognate SNAREs into 
a trans SNARE complex is regulated in a number of ways (Gerst, 2003). Some 
SNAREs are regulated by SM proteins which regulate the availability and 
assembly of SNAREs into a trans SNARE complex. SNAREs can also be regulated 
by phosphorylation. It has been shown that (de)phosphorylation of t SNAREs is 
important for exocytosis and endocytosis in yeast (Marash and Gerst, 
2001;Gurunathan et al., 2002) Yeast cells lacking Snc1p and Snc2p (snc) are 
defective in exocytosis. Treatment of snc cells with ceramide ameliorated this 
defect and resulted in the dephosphorylation of Ssop t SNAREs and the formation 
of complexes between Ssop and Sec9p t SNAREs. Mutation of a single PKA 
phosphoryation site (Ser 79) in Sso1p to alanine was sufficient to rescue snc cells 
in the absence of ceramide. Also recombinant Sso1p phosphorylated in vitro by 
Tpk1p was unable to assemble into complexes with Sec9p (Marash and Gerst, 
2001). This data suggests that t SNARE phosphorylation by PKA inhibits SNARE 
assembly and subsequent fusion in yeast. The data also suggests a ceramide 
regulated pathway can restore exocytosis in snc cells by dephosphorylating t 
SNAREs.  
 
Yeast cells lacking Tlg1p or Tlg2p t SNAREs and the v SNAREs Snc1p and Snc2p 
are defective in endocytosis. Ceramide treatment restored endocytosis to cells 
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and Tlg2p into complexes in snc cells. Phosphorylation of Tlg1p and Tlg2p in 
vitro by Tpk1p inhibited complex assembly. Also mutation of single PKA sites in 
Tlg1p (Ser 31) or Tlg2p (Ser 90) to alanine was sufficient to restore endocytosis 
in snc cells (Gurunathan et al., 2002). This data suggests that like exocytosis, 
endocytosis is regulated by t SNARE phosphorylation in vivo. 
 
Stx 16 is phosphorylated in adipocytes under basal conditions (Perera et al., 
2003). 3T3 L1 adipocytes labelled with 
32Pi were treated with or without 1 mM 
insulin. Autoradiographs showed that stx 16 immunoprecipitated from basal cells 
was phosphorylated and
 this phosphorylation decreased by approximately 50% in 
response to insulin. It is thought that this dephosphorylation controls an 
important event in GLUT4 trafficking. Recently it has been shown that stx 16 is a 
functional homologue of Tlg2p (Struthers et al., 2009). Yeast cells lacking Tlg2p 
(Dtlg2) display multiple endocytic defects. The endocytic defects of Dtlg2 cells 
cause a delay in the degradation of the pheromone receptor Ste3p by vacuolar 
proteases (Seron et al., 1998). Also the delivery of the lipophilic dye FM4 64 to 
vacuolar membranes is delayed in these cells. Dtlg2 mutants are also sensitive to 
osmotic stress and exhibit a growth defect on high salt media (Abeliovich et al., 
1998). All of these defects were rescued by expression of HA Tlg2p or HA Stx 16, 
but not the expression of an unrelated stx, HA Stx 4. This suggests that stx 16 
can perform the same functions as Tlg2p and is therefore a functional 
homologue of Tlg2p (Struthers et al., 2009).  
Tlg2p is known to be phosphorylated at Ser 90 (Gurunathan et al., 2002). 
Previous work in the lab by Dr. Kirsty Proctor (University of Glasgow) identified 
three potential phosphorylation sites in stx 16 using a bioinformatics approach. 
First of all, NetPhos 2.0 (http://www.cbs.dtu.dk/services/NetPhos/) was used 
to analyse the stx 16A protein sequence for potential phosphorylation sites. The 
analysis suggested Ser 94 and Ser 95 as likely candidates with output scores of 
0.996 and 0.998 respectively (on a scale of 0.000 to 1.000). These sites were 
favoured over other high scoring serine residues (Ser 80, Ser 131 and Ser 224) 
because they were closest in the sequence to the Ser 90 phosphorylation site in 
Tlg2p. Analysis of the threonine residues revealed Thr 90 as another potential 
phosphorylation site with an output score of 0.601. Although the output score 
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threonine residues: Thr 3, Thr105, Thr 178 and Thr 197) it corresponded well to 
the Ser 90 phosphorylation site in Tlg2p.  
The potential phosphorylation sites, Thr 90, Ser 94 and Ser 95 were analysed 
further using the Scansite program Motif Scan which searches for motifs within 
proteins that are likely to be phosphorylated by specific protein kinases. The 
analysis focussed on identifying potential PKA sites within the stx 16A protein 
sequence, as Tlg2p is phosphorylated at Thr 90 by PKA (Gurunathan et al., 
2002). Thr 90 was identified as a potential PKA phosphorylation site. Ser 94 and 
Ser 95 were identified as potential Casein Kinase II phosphorylation sites. The 
three potential phosphorylation sites, Thr 90, Ser 94 and Ser 95 have been 
investigated in this chapter.   
 
The potential sites are at the start of the second predicted helix of the Habc 
domain in stx 16 (Dulubova et al., 2002). Therefore phosphorylation at one or 
more of these sites might regulate the ability of stx 16 to adopt a closed 
confirmation in which the Habc domain binds to the SNARE domain of stx 16 
(Struthers et al., 2009). Phosphorylation might also regulate the binding of stx 
16 to its SM protein mVps45 (Dulubova et al., 2002;Struthers et al., 2009). 
Therefore phosphorylation of stx 16 may regulate the assembly of stx 16 into 
SNARE complexes and subsequent fusion. 
5.2 Aims of this chapter 
The aim of this chapter was to determine the phosphorylation site of stx 16. Two 
complementary approaches were used to determine the phosphorylation site. 
First of all, stx 16 mutants of the three potential phosphorylation sites were 
screened in yeast cells lacking Tlg2p to determine whether expression of the stx 
16 mutants could complement the phenotypes of Dtlg2 cells. Also several 
techniques were used to determine the phosphorylation site of endogenous stx 
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5.3 Results 
5.3.1 Yeast studies 
5.3.1.1 Site-directed mutagenesis of stx 16 
Recent work which showed stx 16 was a functional homologue of Tlg2p used a 
HA tagged human stx 16A plasmid to express stx 16 in Dtlg2 yeast cells 
(Struthers et al., 2009). Single alanine mutants of the three potential stx 16 
phosphorylation sites (Thr 90, Ser 94 and Ser 95) and a triple alanine mutant had 
been made previously in the lab by Dr. Scott Shanks (University of Glasgow). 
Single phosphomimetic aspartic acid mutants of stx 16 were made by site 
directed mutagenesis as described in section 2.2.11 using the primers described 
in section 2.1.5. After mutagenesis, the plasmids were sequenced on both 
strands as described in section 2.2.7.  
5.3.1.2 Expression of Tlg2p and stx 16 mutants in D D D Dtlg2 yeast 
Dtlg2 yeast cells were transformed with stx 16 mutants and the expression of the 
HA tagged stx 16 mutants and Tlg2p was determined. Figure 5.1 shows an 
example of a set of transformations. Dtlg2 yeast cells were transformed with 
pHA Tlg2, pHA Stx 16, pHA Stx 4 or pHA Stx 16 T90A, S94A, S95A. As a control 
wild type and Dtlg2 cells were transformed with the empty vector (pVT102U). 
Figure 5.1 shows that wild type cells did not express any HA tagged proteins and 
expressed a low level of Tlg2p. Dtlg2 cells did not express any Tlg2p as 
expected. Cells transformed with pHA Stx 16, pHA Stx 4 or pHA Stx 16 T90A, 
S94A, S95A all expressed the HA tagged proteins but to different levels. The 
expression of HA Tlg2p in cells transformed with pHA Tlg2 could not be detected 
on the HA blot but a high level of Tlg2p was present in the Tlg2p blot suggesting 
that HA Tlg2p was in fact overexpressed in these cells. Nicola S Hamilton, 2010    Chapter 5, 149 
 
 
Figure 5.1. Expression of HA-Stx 16 and phosphosite mutant in yeast. 
 
RPY10 Dtlg2 (NOzY4) yeast strains were transformed as described in section 
2.9.3 with pHA Tlg2, pHA Stx 16 (pSGS025) pHA Stx 4 (pSGS036), or pHA Stx 16 
T90A, S94A, S95A. As a control wild type RPY10 and RPY10 Dtlg2 cells were 
transformed with the empty vector (pVT102U) (n = 6). 10 ml of the samples 
prepared as described in section 2.9.4 were separated on a 10% (v/v) SDS PAGE 
gel, transferred to nitrocellulose and blotted (sections 2.4.4  2.4.6). The 
samples were blotted for the HA tagged proteins using a rat anti HA primary 
antibody at a 1:1000 dilution. The samples were blotted for Tlg2p using a rabbit 
anti Tlg2p antiserum at a 1:100 dilution after blocking overnight with 5% (w/v) 
low fat milk powder. The numbers at the side of the blots indicate molecular 
weight in kDa. 
 
Lane 1: RPY10 + pVT102U 
 
Lane 2: RPY10 Dtlg2 + pVT102U 
 
Lane 3: RPY10 Dtlg2 + pHA Tlg2 
 
Lane 4: RPY10 Dtlg2 + pHA Stx 16 
 
Lane 5: RPY10 Dtlg2 + pHA Stx 4 
 
Lane 6: RPY10 Dtlg2 + pHA Stx 16 T90A, S94A, S95A Nicola S Hamilton, 2010    Chapter 5, 150 
5.3.1.3 Ste3p-myc endocytosis assay 
Yeast lacking Tlg2p have delayed endocytosis and degradation of the Ste3p 
receptor (Seron et al., 1998). This is due to delayed trafficking of Ste3p to the 
vacuole. Expression of HA Stx 16 rescues this defect (Struthers et al., 2009). 
Ste3p myc endocytosis and degradation was determined in wild type yeast cells, 
Dtlg2 cells and Dtlg2 cells expressing HA Stx 16 or HA Stx 16 T90A, S94A and 
S95A. As a control wild type and Dtlg2 yeast cells were transformed with 
pVT102U empty vector. Figure 5.2 shows that in wild type cells Ste3p myc was 
efficiently endocytosed and degraded within 80 minutes. In Dtlg2 cells the 
degradation of Ste3p myc was delayed. This is in agreement with previous work 
with Dtlg2 cells (Seron et al., 1998;Struthers et al., 2009). The level of Ste3p 
myc at the 20 minute time point and all subsequent time points was increased 
compared with wild type cells and Ste3p myc was still present after 80 minutes. 
This suggests that trafficking of Ste3p to the vacuole is impaired, resulting in the 
delayed degradation of Ste3p by vacuolar proteases. Expression of HA Stx 16 
partially rescued this effect. The rate of Ste3p myc degradation was increased 
and the amount of Ste3p myc present after 80 minutes was decreased. This 
suggests that Ste3p trafficking has been restored by expression of HA Stx 16. 
This also suggests that stx 16 can function in place of Tlg2p in Ste3p trafficking. 
However expression of HA Stx16 T90A, S94A, S95A gave a phenotype similar to 
Dtlg2 cells. The level of Ste3p myc was stabilised and only started to degrade at 
80 minutes. This suggests that Ste3p trafficking was not restored by expression 
of HA Stx16 T90A, S94A, S95A. 
5.3.1.4 KCl osmotic stress assay 
Yeast lacking Tlg2p are sensitive to osmotic stress and have reduced growth on 
high salt plates (Abeliovich et al., 1998). Expression of HA Stx 16 rescues this 
defect (Struthers et al., 2009). Wild type, Dtlg2 cells and Dtlg2 cells expressing 
HA Tlg2p, HA Stx 4, HA Stx 16, HA Stx 16 T90A, HA Stx 16 S94A or HA Stx 16 
S95A were plated on S D –Ura –Met plates with or without 1.5 M KCl. As a control 
wild type and Dtlg2 yeast cells were transformed with pVT102U empty vector. 
Figure 5.3 shows that all yeast strains grew well on S D –Ura –Met plates. All 
strains grew less well on plates containing 1.5M KCl. The Dtlg2 cells were 
particularly affected. The level of growth was reduced across all dilutions, Nicola S Hamilton, 2010    Chapter 5, 151 
particularly in the 3
rd and 4
th dilution compared with the wild type cells. This 
agrees with previous experiments on Dtlg2 cells (Abeliovich et al., 
1998;Struthers et al., 2009). The expression of HA Tlg2p in Dtlg2 cells increased 
growth at all dilutions which shows that the osmotic stress phenotype was due to 
a lack of Tlg2p expression. Expression of HA Stx 4 did not increase the growth of 
Dtlg2 cells which shows that stx 4 cannot rescue the osmotic stress phenotype. 
Expression of HA Stx 16 increased growth of Dtlg2 cells across all dilutions, 
which shows that stx 16 can rescue the osmotic stress phenotype in Dtlg2 cells. 
Also expression HA Stx 16 T90A or HA Stx 16 S94A increased growth of Dtlg2 cells 
across all dilutions. However expression of HA Stx 16 S95A did not increase 
growth of Dtlg2 cells.  Nicola S Hamilton, 2010    Chapter 5, 152 
 
Figure 5.2 Ste3p-myc endocytosis assay. 
 
RPY10 Dtlg2 (NOzY4) yeast strains were transformed as described in section 
2.9.3 with pHA Stx 16 (pSGS025) or pHA Stx 16 T90A, S94A, S95A. As a control 
wild type RPY10 and RPY10 Dtlg2 cells were transformed with the empty vector 
(pVT102U). All the strains were transformed with pSL2099 expressing the Ste3p 
myc fusion protein. Ste3p myc endocytosis was determined as described in 
section 2.9.4 (n = 1). To ensure equal loading, each sample was resuspended at 
the same OD600/ml concentration. 10 ml of the samples were separated on a 10% 
(v/v) SDS PAGE gel, transferred to nitrocellulose and blotted as described in 
sections 2.4.4, 2.4.5 and 2.4.6. The samples were blotted for Ste3p myc using a 
mouse anti myc primary antibody at a 1:250 dilution. 
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Figure 5.3 KCl osmotic stress assay. 
 
Dtlg2 (NOzY3) yeast strains were transformed as described in section 2.9.3 with 
pHA Tlg2, pHA Stx 4 (pSGS036), pHA Stx 16 (pSGS025), pHA Stx 16 T90A, pHA Stx 
16 S94A and pHA Stx 16 S95A. As a control wild type (SF838 9D) or Dtlg2 (NOzY3) 
cells were transformed with the empty vector (pVT102U). Aliquots (5 ml) of 1 
OD600/ml cultures and ten fold serial dilutions were spotted on S D –Ura –Met 
plates with or without 1.5 M KCl  in triplicate as described in section 2.9.6 (n=1). 
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5.3.2 3T3-L1 adipocyte studies 
5.3.2.1 Phosphopeptide purification kit 
Several attempts to determine the phosphorylation site of stx 16 in 3T3 L1 
adipocytes had proved unsuccessful (see section 5.4). The Fingerprint 
Proteomics unit at the University of Dundee offered a service to determine the 
phosphorylation site of protein immunoprecipitated from cell lysates. However 
this required large amounts of protein (enough protein to be visible by colloidal 
Coomassie staining).  Early attempts to immunoprecipitate the required amount 
of stx 16 to send for analysis were unsuccessful (data not shown). So a 
phosphopeptide enrichment technique was used in the hope that this would 
provide enough sample to be analysed by mass spectrometry. Stx 16 was 
immunoprecipitated from basal and insulin stimulated 3T3 L1 adipocytes as 
described section 2.4.7. The immunoprecipitated proteins were left bound to 
the Protein A agarose and were denatured and digested as described in section 
2.4.10. Two phosphopeptide enrichment methods were used to purify the 
phosphopeptides.  A TiO2 method described in section 2.4.10.1 and a SCIMAC 
method described in section 2.4.10.2. As a control an immunoprecipitation 
reaction from basal cells was run in tandem with the samples to be used for 
phosphopeptide purification. This immunoprecipitation was separated on an SDS 
PAGE gel and blotted for stx 16 to ensure that stx 16 had been correctly 
immunoprecipitated. Figure 5.4 shows immunoprecipitations performed before 
purifying for phosphopeptides using the TiO2 method and the SCIMAC method. 
The figure shows that stx 16 was successfully immunoprecipitated in both cases. 
A low level of stx 16 was present in the IgG supernatant. But no stx 16 was 
detected in the stx 16 supernatant. No stx 16 was immunoprecipitated with the 
control IgG antiserum but a large amount of stx 16 was immunoprecipitated with 
the rabbit stx 16 antiserum.  
When the samples were analysed by mass spectrometry, unfortunately no 
phosphopeptides were detected. Therefore a sample of the pre purification 
digest was sent for analysis. Again no phosphopeptides were detected. Nicola S Hamilton, 2010    Chapter 5, 155 
 
 
Figure 5.4 Immunoprecipitation of stx 16 for proteomic analysis. 
 
Endogenous stx 16 was immunoprecipitated from 3T3 L1 adipocytes as described 
in section 2.4.7. Three 10 cm plates were used for each immunoprecipitation. 
Rabbit stx 16 antiserum (Stx 16) was used to immunoprecipitate stx 16. As a 
control rabbit anti sheep IgG antiserum (IgG) was used. 20 ml (1/50) of the 
unbound supernatant after immunoprecipitation was loaded in the first two 
lanes (IgG supt., Stx 16 supt.). In the second two lanes the immunoprecipitates 
were loaded (IgG IP and Stx 16 IP). The samples were separated on a 10% (v/v) 
SDS PAGE gel, transferred to nitrocellulose and blotted for stx 16 as described in 
sections 2.4.4, 2.4.5 and 2.4.6. To blot for stx 16, rabbit stx 16 antiserum was 
used as the primary antibody at a 1:1000 dilution and a Protein A HRP secondary 
was used at a 1:2500 dilution. The numbers at the side of the blots indicate 
molecular weight in kDa. Other stx 16 immunoprecipitation reactions were run in 
parallel and used in proteomic analysis and were not put on a gel. Nicola S Hamilton, 2010    Chapter 5, 156 
A.  Stx 16 Immunoprecipitation prior to trypsin digest and phosphopeptide 
purification by TiO2. 
B.  Stx 16 Immunoprecipitation prior to trypsin digest and phosphopeptide 
purification by SCIMAC. 
 
Bands corresponding to stx 16 are indicated by the arrows. 
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5.4 Discussion 
Stx 16 is known to be phosphorylated in adipocytes under basal conditions 
(Perera et al., 2003). It is proposed that dephosphorylation of stx 16 in response 
to insulin could regulate an important event in GLUT4 trafficking. In this chapter 
the insulin regulated phosphorylation site of stx 16 was examined. The 
phosphorylation site of stx 16 was studied in both yeast and 3T3 L1 adipocytes. 
It was hoped that once the phosphorylation site had been determined, the effect 
of stx 16 phosphorylation on GLUT4 trafficking and protein interactions involving 
stx 16 could be investigated. 
In this study, the phosphorylation of stx 16 in adipocytes was not tested, as it 
had been previously shown that stx 16 is phosphorylated under basal conditions 
(Perera et al., 2003). Perera et al. showed that stx 16 immunoprecipitated from 
basal cells labelled with 
32Pi was phosphorylated and that
 this phosphorylation 
decreased by approximately 50% in response to insulin. This experiment was 
performed three times.  Other unpublished work performed by Dr. Kirsty Proctor 
(University of Glasgow) investigated the kinetics of stx 16 dephosphorylation. 
Insulin stimulated dephosphorylation was shown to be evident within 5 minutes 
of the addition of insulin and maximum dephosphorylation occurred after 15 
minutes. In addition to the experiments above, the phosphorylation of stx 16 
could also have been detected by blotting stx 16 immunoprecipitates from basal 
and insulin –stimulated adipocytes with phosphotyrosine, phosphoserine and 
phosphothreonine antibodies. Alternatively the stx 16 immunoprecipitates could 
have been stained with the Pro Q
® Diamond Phosphoprotein blot stain by 
Molecular Probes
®. 
Recently stx 16 had been shown to be a functional homologue of Tlg2p (Struthers 
et al., 2009). It was thought this would be a useful way of screening mutants of 
the potential phosphorylation sites in stx 16. Dr. Scott Shanks (University of 
Glasgow) had already made single alanine mutants of the three potential stx 16 
phosphorylation sites (Thr 90, Ser 94 and Ser 95) and a triple alanine mutant. 
Single phosphomimetic aspartic acid mutants of stx 16 were made by site 
directed mutagenesis as described in section 5.3.1.1.  Nicola S Hamilton, 2010    Chapter 5, 158 
Before the phosphorylation site mutants could be used in any experiments, their 
expression in yeast had to be confirmed. Figure 5.1 shows an example of a set of 
transformations. All of the HA tagged proteins were expressed in yeast at a 
similar level or higher level than endogenous Tlg2p in the wild type yeast strain. 
It was not possible to detect the expression of HA Tlg2p by anti HA blot but HA 
Tlg2p was detected by anti Tlg2p blot. This may be because the pHA Tlg2 
plasmid was not made in house and the HA tag had a different sequence to the 
HA tags of the other proteins. The HA antibody may not have been able to bind 
to the HA tagged Tlg2p. HA Stx 4 was to be used as a control to show that 
expression of an unrelated stx did not complement Dtlg2 yeast and therefore the 
effects seen were specific to stx 16. 
Once the expression of the phosphorylation site mutants was confirmed in yeast, 
they were used in a Ste3p myc endocytosis assay which had been previously used 
to show that stx 16 expression can complement Dtlg2 yeast (Struthers et al., 
2009). Figure 5.2 shows that while HA Stx 16 expression rescued the delayed 
Ste3p myc degradation seen in Dtlg2 cells, the expression of HA Stx 16 T90A, 
S94A, S95A did not. A control of Dtlg2 cells expressing HA Stx 4 was not used in 
this experiment as their growth was poor. This may have been due to the very 
high level of HA Stx 4 expression in the cells which was seen in figure 5.1. 
However it has already been shown that stx 4 expression does not complement 
Dtlg2 yeast in this assay (Struthers et al., 2009). The assay was repeated with 
the stx 16 single alanine mutants, however the differences in Ste3p myc 
degradation were too subtle to determine which single alanine mutants rescued 
Dtlg2 cells and which did not. 
A carboxypeptidase Y (CPY) invertase assay was then used to screen the stx 16 
mutants as this assay gave more quantitative data (Darsow et al., 2000). 
Unfortunately initial experiments involving wild type yeast cells, Dtlg2 cells and 
Dtlg2 cells expressing HA Tlg2p, HA Stx 4 or HA Stx 16 were unsuccessful. The 
results did not show any difference between wild type and Dtlg2 cells (data not 
shown). 
As the Ste3p myc assay and the CPY invertase assay had been unsuccessful in 
determining the phosphorylation site of stx 16, another assay was tried. 
Expression of stx 16 can rescue the osmotic stress phenotype of Dtlg2 yeast cells Nicola S Hamilton, 2010    Chapter 5, 159 
(Struthers et al., 2009). Figure 5.3 shows that expression of stx 16 rescued the 
growth defect of Dtlg2 cells on high salt medium. Stx 16 T90A and stx 16 S94A 
expression also rescued the growth defect of Dtlg2 cells. However stx 16 S95A 
expression did not. This result will need to be confirmed by repeat experiments 
and the phosphorylation site will also need to be confirmed in 3T3 L1 
adipocytes.  
The difference between the growth of wild type and Dtlg2 cells on high salt 
medium was not as big as that seen by Struthers et al (Struthers et al., 2009). 
The same yeast strains as those used by Struthers et al. were used in this 
experiment. However the plates did not contain 50 mM CuCl2 as the plasmids 
used to transform the yeast cells contained a constitutive ADH promoter and not 
a Cu
2+ controlled CUP1 promoter. This may account for the difference in growth 
of the strains on high salt medium.  
The Ste3p receptor endocytosis assay and the osmotic stress assay allow the 
phosphorylation site of stx 16 to be investigated. Information from these assays 
could then be used to inform experiments on stx 16 in 3T3 L1 adipocytes which 
would investigate GLUT4 trafficking. Any suggestion of a phosphorylation site 
using the Ste3p receptor assay and the osmotic stress assay would need to be 
further investigated to ensure that the effects seen in the phosphosite mutants 
were due to changes in phosphorylation and not for example, changes in protein 
folding or protein interactions.  
Ser 95 is at the start of the second predicted helix of the Habc domain in stx 16 
(Dulubova et al., 2002). So phosphorylation at Ser 95 might regulate the ability 
of stx 16 to adopt a closed confirmation (Struthers et al., 2009). Alternatively 
phosphorylation might regulate the binding of stx 16 to its SM protein mVps45 
(Dulubova et al., 2002;Struthers et al., 2009) or other SNARE proteins such as stx 
6 (Perera et al., 2003). The effect of phosphorylation of stx 16 on its 
interactions with mVps45 or stx 6 could be examined by expressing the alanine 
mutant and phosphomimetic aspartic acid mutant of Ser 95 in stx 16 depleted 
cells and then performing co immunoprecipitation assays. Alternatively the stx16 
Ser 95 mutants, mVps45 and stx 6 could be expressed in E.Coli and in vitro 
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While the phosphorylation site of stx 16 was investigated using yeast, 
experiments were also performed using 3T3 L1 adipocytes to determine the 
insulin regulated phosphorylation site of stx 16. Before starting any experiments 
to determine the site, several different alanine mutants and aspartic acid 
phosphomimetic mutants of a myc tagged stx 16 were made. It was hoped that 
these mutants could be used in future assays to examine the phosphorylation 
site of stx 16. Previously 
32Pi labelling had been used to determine the 
phosphorylation site of stx 16 using stx 16 T90A and stx 16 S94A, S95A made by 
Dr. Kirsty Proctor (University of Glasgow). Unfortunately those experiments had 
been unsuccessful.  
Therefore a different approach was taken. It was hoped that expressing the 
phosphorylation site alanine mutants of stx 16 in 3T3 L1 adipocytes, then 
purifying lysates for phosphoproteins and blotting for the myc tagged stx 16 
mutants would identify the phosphorylation site. Unfortunately initial attempts 
to use the phophosprotein kit to purify endogenous phosphorylated stx 16 as 
described in section 2.4.9 from basal and insulin stimulated wild type 3T3 L1 
adipocytes were unsuccessful. The concentration of the eluate which contained 
phosphorylated proteins was too low for endogenous stx 16 to be detected by 
western blot (data not shown).This was the case in all attempts with the kit. The 
low concentration of the eluate also meant it was not possible to detect other 
proteins known to be phosphorylated in insulin stimulated 3T3 L1 adipocytes, for 
example PKB/Akt. This would have shown whether the phosphoprotein kit was 
working correctly.   
Since the phosphoprotein purification kit had been unsuccessful, a new approach 
was taken. Instead of using stx 16 mutants, the phosphorylation site of 
endogenous stx 16 in 3T3 L1 adipocytes was investigated. The Fingerprint 
Proteomics unit at the University of Dundee offered a service to determine the 
phosphorylation site of protein immunoprecipitated from cell lysates. So stx 16 
was immunoprecipitated from basal and insulin stimulated 3T3 L1 adipocytes so 
that the insulin regulated phosphorylation site of stx 16 could be determined. 
The Fingerprint Proteomics unit required large amounts of protein to determine 
the phosphorylation site. However initial attempts at immunoprecipitating stx 16 
did not provide sufficient protein to send for analysis (data not shown). After 
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Proteomics unit, it was suggested that a phosphopeptide enrichment kit may 
compensate for the low levels of stx 16 protein immunoprecipitated. Therefore 
after immunoprecipitation, the protein bound to the Protein A agarose was 
denatured, digested and enriched for phosphopeptides as described in section 
5.3.2.1. Both TiO2 and SCIMAC phosphopeptide enrichment kits were used as the 
methods enrich different profiles of peptides (Bodenmiller et al., 2007). The 
TiO2 method tends to isolate singly phosphorylated, acidic phosphopeptides. 
Whereas, the SCIMAC method tends to isolate more doubly phosphorylated 
phosphopeptides.  As no single method can isolate the whole phosphoproteome, 
using the two different kits would give a better chance of enriching a 
phosphopeptide which contained the insulin regulated phosphorylation site of 
stx 16. 
Unfortunately when the samples were sent for analysis, no phosphopeptides 
were detected. Figure 5.4 shows that stx 16 was successfully 
immunoprecipitated before digestion and phosphopeptide enrichment. So the 
problem did not seem to be the immunoprecipitation protocol. It was thought 
that either there was a problem with the phosphopeptide enrichment kits or 
that the concentration of peptides after digestion was too low for enrichment. 
Therefore a sample of the digested immunoprecipitate prior to phosphopeptide 
enrichment was sent for analysis. In this case peptides were detected but they 
were not phosphorylated. This was unexpected as the immunoprecipitation 
protocol and buffers were designed for immunoprecipitation of phosphoproteins. 
The immunoprecipitation buffer contained several phosphatase inhibitors 
(sodium orthovanadate, sodium fluoride, sodium pyrophosphate and b glycerol 
phosphate), which should have protected any phosphorylated proteins during the 
immunoprecipitation. Perhaps there was not enough stx 16 phosphorylated under 
basal conditions for analysis. 
As the phosphopeptide kits were unsuccessful, it was decided to go back to the 
previous method of immunoprecipitating endogenous stx 16, staining by colloidal 
Coomassie to detect the band of immunoprecipitated stx 16 and sending the 
band for phosphosite analysis. As this method had been unsuccessful previously, 
it was necessary to optimise the immunoprecipitation protocol further. To 
increase the amount of stx 16 immunoprecipitated, the concentration of the cell 
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resulted in non specific binding by the control IgG antiserum (data not shown). 
The optimal concentration of lysate for stx 16 immunoprecipitation was three 10 
cm plates per immunoprecipitation. Unfortunately there was not enough stx 16 
immunoprecipitated to be visible by colloidal Coomassie staining which is the 
required level of protein for analysis.   
As the immunoprecipitation reactions using a rabbit antiserum were unsuccessful 
in precipitating sufficient quantities of stx 16 to send for analysis, an alternative 
antibody was used to immunoprecipitate stx 16. A mouse monoclonal anti stx 16 
antibody was used to immunoprecipitate stx 16 from three 10 cm plates of 3T3 
L1 adipocytes in the hope that this antibody might be more efficient at 
immunoprecipitating stx 16. Unfortunately, immunoprecipitation of stx 16 using 
the mouse monoclonal anti stx 16 antibody was not as successful as 
immunoprecipitation using the rabbit stx 16 antiserum (data not shown). There 
was still some stx 16 remaining in the stx 16 supernatant which had not been 
bound by the antibody. Also a band specific for the immunoprecipitated stx 16 
was not visible by colloidal Coomassie staining. Increasing the amount of mouse 
monoclonal antibody used in the immunoprecipitation increased the non specific 
binding of the control IgG (data not shown). 
Therefore it seems unlikely that the phosphorylation site of stx 16 will be 
determined by analysis of immunoprecipitated endogenous stx 16. Alternatively 
a tagged version of stx 16 could be overexpressed in 3T3 L1 adipocytes, 
immunoprecipitated and analysed for its phosphorylation site. This would 
require a virus, perhaps adenovirus to overexpress the tagged stx 16. If 
overexpression of a tagged stx 16 in 3T3 L1 adipocytes proves difficult, perhaps 
the phosphorylation site of stx 16 could be determined in vitro. Stx 16 protein 
could be expressed in E.Coli and then incubated with cell lysate from basal and 
insulin stimulated 3T3 L1 adipocytes before its phosphorylation site is analysed. 
Once the phosphorylation site of stx 16 has been determined, the effect of stx 
16 phosphorylation can be determined by expressing the alanine mutants and 
phosphomimetic aspartic acid mutants of the phosphorylation site in stx 16 
depleted cells. The effect of stx 16 phosphorylation on GLUT4 trafficking could 
be investigated using a 
3H deoxyglucose assay or the HA GLUT4 GFP assays 
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interactions with other proteins, for example, stx 6 or mVps45 could be 
examined by co immunoprecipitation or in vitro binding assays.  
In addition to stx 16, there are other syntaxins which have been found to be 
phosphorylated. Stx 1 is phosphorylated by several kinases including, casein 
kinase I (CKI) (Dubois et al., 2002), CKII (Bennett et al., 1993;Hirling and 
Scheller, 1996;Foster et al., 1998;Risinger and Bennett, 1999;Dubois et al., 
2002), calcium/calmodulin dependent protein kinase II (CaMKII) (Hirling and 
Scheller, 1996;Ohyama et al., 2002) and death associated protein (DAP) kinase 
(Tian et al., 2003). Also stx 4 is phosphorylated by CKII (Foster et al., 
1998;Risinger and Bennett, 1999) and PKA (Foster et al., 1998). 
Stx 1 is phosphorylated by CKI on Thr 21 (Dubois et al., 2002). This 
phosphorylation site was determined in vitro using kinase assays, trypsin 
digestion, mass spectrometry and solid phase sequencing of 
32Pi  labelled 
peptides. Stx 1 is phosphorylated by CKII on Ser 14. This site was initially 
identified by in vitro kinase assays using recombinant stx 1 fragments and 
consensus site analysis (Bennett et al., 1993;Risinger and Bennett, 1999). More 
recently the CKII phosphorylation site has been confirmed in vitro by the same 
method used for the CKI site (Dubois et al., 2002). Foletti et al. have also shown 
that stx 1 is phosphorylated at Ser 14 in vivo using a phospho specific antibody 
(Foletti et al., 2000). Phosphorylation of stx 1 by CKII enhances its interaction 
with synaptotagmin I (Risinger and Bennett, 1999). Phosphorylated stx 1 also 
associates with SNAP 25 and localises to discrete domains of axonal plasma 
membranes which may define fusion sites (Foletti et al., 2000). In addition, 
phosphorylation of stx 1 at Ser 14 decreases the N terminal interaction of stx 1 
with Munc 18 1 at the plasma membrane and reduces vesicle mobility and 
exocytosis (Rickman and Duncan, 2010). 
Stx 1 is also phosphorylated by CaMKII at Thr 161 in the linker domain (Ohyama 
et al., 2002). This site was determined by in vitro kinase assay, consensus site 
analysis and site directed mutagenesis. Phosphorylation at Thr 161 by CaMKII 
does not affect binding of CaMKII to stx 1 (Ohyama et al., 2002). In addition, stx 
1 has been found to be phosphorylated by DAP kinase. Stx 1 is phosphorylated by 
DAP kinase at Ser 188 in the linker domain of stx 1 both in vitro and in vivo in a 
Ca
2+ dependent manner (Tian et al., 2003). To determine the phosphorylation Nicola S Hamilton, 2010    Chapter 5, 164 
site, recombinant stx 1 fragments were incubated with DAP kinase, and then 
site directed mutagenesis was used to make alanine mutants of potential serine 
and threonine residues. The S188A mutant was not phosphorylated in vitro. To 
test that phosphorylation by DAP kinase occurred in vivo back phosphorylation 
assays were performed in HEK 293T cells co transfected with stx 1 and DAP 
kinase cDNAs. A decrease in the in vitro back phosphorylation of stx 1 in Ca
2+ 
stimulated cell lysates was observed, which reflects in vivo phosphorylation of 
stx 1 by DAP kinase in response to Ca
2+. Stx 1 phosphorylation by DAP kinase 
decreases stx 1 binding to Munc 18 1 (Tian et al., 2003). 
Stx 4 phosphorylation by CKII was determined by in vitro kinase assays (Foster et 
al., 1998;Risinger and Bennett, 1999). No phosphorylation site was determined, 
however phosphoamino acid analysis performed by acidic hydrolysis followed by 
thin layer chromatography revealed that stx 4 was phosphorylated on a Thr 
residue (Risinger and Bennett, 1999). Stx 4 is also phosphorylated by PKA in vitro 
(Foster et al., 1998). No phosphorylation site was determined, but it was shown 
that phosphorylation of stx 4 by PKA disrupted its binding to SNAP 23. The 
authors suggest that PKA may modulate stx 4 dependent SNARE complex 
formation to regulate exocytosis in non neuronal cells. 
The studies described above, suggest that an in vitro method might be more 
successful in determining the phosphorylation site of stx 16. The studies also 
suggest that phosphorylation of stx 16 may affect its interactions with other 
SNAREs, for example stx 6 and its SM protein mVps45. In addition 
phosphorylation may affect vesicle trafficking in the stx 16 pathway, which may 
lead to changes in GLUT4 trafficking.  
In summary the data in this chapter shows an investigation into the 
phosphorylation site of stx 16. Further work is needed to determine the insulin 
regulated phosphorylation site of stx 16 in 3T3 L1 adipocytes. 165 
Chapter 6 Discussion 
In fat and muscle cells, under basal conditions the level of GLUT4 at the cell 
surface is very low. Insulin stimulation greatly increases the level of GLUT4 at 
the cell surface by stimulating the translocation of GLUT4 from unique 
intracellular storage sites to the plasma membrane (Suzuki and Kono, 
1980;Cushman and Wardzala, 1980).The translocation of GLUT4 is an example of 
regulated membrane trafficking (Bryant et al., 2002). GLUT4 occupies two 
interrelated, overlapping endosomal cycles. A fast trafficking cycle involving the 
early endosome serves to internalise GLUT4 in the absence of insulin. Once in 
the endosome GLUT4 is further sorted into a slow trafficking pathway involving 
the endosome, TGN and GSVs. It is thought that GLUT4 in the GSVs translocates 
to the cell surface in response in insulin (Fig. 1.3). 
How is this process regulated and what are the proteins involved? How is basal 
retention of GLUT4 achieved? One place to look for answers to these questions is 
the proteins involved in the membrane trafficking of GLUT4. Membrane 
trafficking involves the fusion of vesicles with specific target membranes. This 
process is mediated by SNARE proteins (Hong, 2005). The SNAREs involved in the 
fusion of GLUT4 vesicles with the plasma membrane have been previously 
described (Thurmond and Pessin, 2001).GSVs contain the v SNARE VAMP2 (Martin 
et al., 1996) which has been shown to be important for insulin stimulated 
translocation of GSVs to the plasma membrane (Martin et al., 1998). VAMP2 
binds to the t SNAREs stx 4 and SNAP 23 present on the plasma membrane. Once 
bound, the resulting fusion leads to insertion of GLUT4 into the plasma 
membrane. The assembly of the trans SNARE complex between VAMP2, stx 4 and 
SNAP 23 is regulated by the SM protein Munc18c (Brandie et al., 2008).  
However the SNAREs involved in the intracellular trafficking of GLUT4 remain 
poorly understood. The t SNARE stx 6 has been implicated in GLUT4 trafficking. 
Stx 6 is highly enriched in GLUT4 vesicles and colocalises with GLUT4 in a 
subdomain of the TGN. Stx 6 also translocates to the cell surface in response to 
insulin (Shewan et al., 2003). Overexpression of the cytosolic domain of stx 6 
increases basal glucose transport and cell surface levels of GLUT4. Also stx 6 
cytosolic domain slows the reversal of insulin stimulated glucose transport and 
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cytosolic domain also perturbs subendosomal sorting of GLUT4 into GSVs (Perera 
et al., 2003). These data suggest that stx 6 may be involved in trafficking of 
GLUT4 into its storage site(s). 
Another SNARE which had been identified to have a role in GLUT4 trafficking is 
stx 16. Stx 16 has been shown to bind stx 6 (Perera et al., 2003) and is known to 
function in the same trafficking step from the early endosome to the TGN 
(Mallard et al., 2002).There is a lot of data to support a role for stx 16 in GLUT4 
trafficking. Like stx 6, stx 16 colocalises with GLUT4 in a subdomain of the TGN 
and is highly enriched in GLUT4 vesicles. Also insulin stimulation results in the 
translocation of stx 16 to the cell surface (Shewan et al., 2003). More recent 
data has shown that overexpression of the cytosolic domain of stx 16 
significantly slows the reversal of insulin stimulated glucose transport. Also 
depletion of stx 16 using a morpholino antisense oligonucleotide reduces insulin 
stimulated glucose transport over a range of insulin concentrations. It was also 
observed in these cells that the total cellular levels of GLUT4 were reduced by 
30% which suggested that GLUT4 was being missorted into a degradative 
pathway (Proctor et al., 2006). The above data suggests that stx 16 may control 
GLUT4 sequestration in its storage site(s). 
The aim of this thesis was to further investigate the role of stx 16 in GLUT4 
trafficking. 
In chapter 3 a different approach was used to knockdown stx 16 expression in 
3T3 L1 adipocytes. 3T3 L1 fibroblasts were infected with retrovirus expressing 
one of four different shRNAs which targeted stx 16 to generate cells which were 
stably depleted of stx 16. This is very different to the method of knockdown 
employed by Proctor et al. in which 3T3 L1 adipocytes were transiently depleted 
of stx 16 by electroporation with a morpholino antisense oligonucleotide 
(Proctor et al., 2006). Of the four shRNAs designed, shRNA4 resulted in the 
greatest level of stx 16 knockdown of 95% (Fig. 3.1). This level of knockdown is 
comparable to the level of knockdown achieved by Proctor et al. (Proctor et al., 
2006).  
It was observed in the shRNA4 infected cells that the level of the t SNARE stx 6 
was reduced by 80% (Fig.3.2). This is in contrast to the data of Proctor et al. 
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oligonucleotide did not affect the levels of stx 6 or stxs 4, 8 and 12 (Proctor et 
al., 2006). This contradiction may be due to the differences in the knockdown 
methods used. Other more recent data has also shown that stx 16 knockdown 
results in a reduction in stx 6 levels (Ganley et al., 2008). HEK293 cells 
transfected with siRNA against stx 16 showed an 80% reduction in stx 6, which is 
the same reduction seen in figure 3.2. The results of Ganley et al. and the data 
in figure 3.2 suggest that stx 16 is an important stabiliser of stx 6. In addition to 
affecting stx 6 levels, stx 16 knockdown also seemed to reduce the level of 
mVps45 recruited to the membrane. Figure 3.3 showed that membrane samples 
from shRNA4 infected cells had approximately 60% less mVps45 compared with 
the negative control infected cells.  
Cells infected with shRNA4 also exhibited a 20% reduction in total cellular levels 
of GLUT4 (Fig 3.3). This is similar to the 30% reduction in GLUT4 levels seen in 
stx 16 depleted cells by Proctor et al. (Proctor et al., 2006). This suggests that 
GLUT4 is missorted into a degradative pathway in stx 16 depleted cells. A 
proteasome inhibitor would reveal whether the loss of GLUT4 is proteasome 
dependent. Further study into the loss of GLUT4 showed that the majority of the 
loss occurred from the LDM fraction (Fig 3.5). The LDM fraction contains the 
GSVs, so stx 16 depletion may lead to a loss of GLUT4 from the GSVs. Further 
fractionation of the LDM fraction using an iodixanol gradient to separate the 
GSVs as described by Hashiramoto et al. (Hashiramoto and James, 2000) would 
reveal whether the loss of GLUT4 in stx 16 depleted cells is occurring from the 
GSVs. Also the formation of GSVs could be examined in stx 16 depleted cells 
using the in vitro budding assay described by Xu et al. (Xu and Kandror, 2002). 
Unfortunately initial attempts at these experiments were unsuccessful. 
Further work is required to confirm whether the loss of GLUT4 in stx 16 depleted 
cells affects insulin stimulated glucose transport. Proctor et al. showed that 
depletion of stx 16 by a morpholino antisense oligonucleotide resulted in a 
reduction in insulin stimulated glucose transport (Proctor et al., 2006). 
Therefore a similar effect would be expected in shRNA4 infected cells. The 
reversal of insulin stimulated glucose transport could also be tested. Expression 
of myc stx 16A in the stx 16 depleted cells would confirm whether all the results 
described above were due to stx 16 depletion.   Nicola S Hamilton, 2010    Chapter 6, 168 
In order to investigate the effect of stx 16 on GLUT4 trafficking, assays were 
developed to measure the translocation and recycling of HA GLUT4 GFP. 
Infection of 3T3 L1 fibroblasts with a 1 in 4 dilution of lentivirus expressing HA 
GLUT4 GFP resulted in adipocytes which expressed HA GLUT4 GFP to a similar 
level as endogenous GLUT4 (Fig. 4.4). These cells had the correct localisation of 
HA GLUT4 GFP under basal conditions and exhibited insulin stimulated 
translocation of HA GLUT4 GFP to the cell surface (Fig. 4.5). A flow cytometry 
method was unsuccessful in determining HA GLUT4 GFP translocation in these 
cells (Fig.4.8). This may have been due to problems with the Cy3 conjugated 
secondary antibody and the specificity of the channels in the flow cytometer.  
An alternative method using a 96 well plate successfully determined HA GLUT4 
GFP translocation in response to insulin (Fig. 4.9). Insulin stimulation resulted in 
an over four fold increase in surface HA GLUT4 GFP compared with basal cells. 
The recycling of HA GLUT4 GFP was also examined. In basal cells the Cy3: GFP 
ratio increased over time until it reached a plateau at around 10 hours (Fig. 
4.10). The recycling of HA GLUT4 GFP under basal conditions was similar to that 
seen in an experiment by Karylowski et al. (Karylowski et al., 2004). However 
the recycling of HA GLUT4 GFP in insulin stimulated conditions was not as 
expected. The rate of HA GLUT4 GFP recycling was higher with insulin but it was 
not as high as that seen by Karylowski et al. In figure 4.10 the Cy3: GFP ratio 
increased until it reached a plateau at 2 hours. However the plateau was 
reached at around 45 minutes in insulin stimulated cells in experiments by 
Karylowski et al. (Karylowski et al., 2004). Also the level of the plateau reached 
in insulin stimulated cells was not as high as the level reached by basal cells 
(Fig. 4.10). These problems may have been due to variations in cell culture or 
experimental conditions or perhaps the concentration of the Cy3 HA antibody 
was not saturating.  
Further work is needed to solve the problems with the HA GLUT4 GFP recycling 
assay. Once the problems have been rectified, the assays can be used to 
investigate the role of stx 16 on GLUT4 trafficking kinetics.  
Stx 16 is phosphorylated in adipocytes under basal conditions (Perera et al., 
2003). Insulin stimulation decreases the phosphorylation of stx 16. It is thought 
that this dephosphorylation regulates an important event in GLUT4 trafficking. 
Recently it has been shown that stx 16 is a functional homologue of Tlg2p Nicola S Hamilton, 2010    Chapter 6, 169 
(Struthers et al., 2009). Tlg2p is phosphorylated at Ser 90 by PKA (Gurunathan et 
al., 2002). Previous work in the lab by Dr. Kirsty Proctor (University of Glasgow) 
identified three potential phosphorylation sites in stx 16 using a bioinformatics 
approach to identify potential PKA phosphorylation sites. They are Thr 90, Ser 94 
and Ser 95. In chapter 5 the insulin regulated phosphorylation site of stx 16 was 
examined. Two complementary approaches were used to investigate the 
phosphorylation site of stx 16. Stx 16 mutants of the three potential 
phosphorylation sites were screened in yeast cells lacking Tlg2p to determine 
whether expression of the stx 16 mutants could complement the phenotypes of 
Dtlg2 cells. Also several techniques were used to determine the phosphorylation 
site of endogenous stx 16 in 3T3 L1 adipocytes. 
Screening of a stx 16 triple alanine mutant in Dtlg2 yeast using a Ste3p myc 
endocytosis assay confirmed that phosphorylation at one or more of the 
potential phosphorylation sites is important for stx 16 function (Fig. 5.2). 
Further work screening the single alanine mutants in a KCl osmotic stress assay, 
suggested that Ser 95 may be the site of stx 16 phosphorylation (Fig. 5.3). This 
result needs to be confirmed by repeat experiments and the phosphorylation site 
will also need to be confirmed in 3T3 L1 adipocytes. Several attempts were 
made to determine the phosphorylation site of endogenous stx 16 in 3T3 L1 
adipocytes. Phosphoprotein and phosphopeptide purification kits and 
immunoprecipitation methods were employed but unfortunately none of them 
were successful. 
Ser 95 is at the start of the second predicted helix of the Habc domain in stx 16 
(Dulubova et al., 2002). So phosphorylation at Ser 95 might regulate the ability 
of stx 16 to adopt a closed confirmation (Struthers et al., 2009). Alternatively 
phosphorylation might regulate the binding of stx 16 to its SM protein mVps45 
(Dulubova et al., 2002;Struthers et al., 2009) or other SNARE proteins such as stx 
6 (Perera et al., 2003). 
Further work is required to determine the phosphorylation site of endogenous 
stx 16. As previous attempts to obtain samples for proteomic analysis were 
unsuccessful, alternative methods to purify stx 16 from basal and insulin 
stimulated adipocytes are required. A tagged version of stx 16 could be 
overexpressed in 3T3 L1 adipocytes, immunoprecipitated and analysed for its Nicola S Hamilton, 2010    Chapter 6, 170 
phosphorylation site. Alternatively the phosphorylation site of stx 16 could be 
determined in vitro. Stx 16 protein could be expressed in E.Coli and then 
incubated with cell lysate from basal and insulin stimulated 3T3 L1 adipocytes 
before its phosphorylation site is analysed. Once the phosphorylation site of stx 
16 has been determined the effect of alanine mutants and phosphomimetic 
aspartic acid mutants on GLUT4 trafficking could be determined using a 
3H 
deoxyglucose assay or the HA GLUT4 GFP assays. Also the effect of 
phosphorylation of stx 16 on its interactions with other proteins, for example, 
stx 6 or mVps45 could be examined by co immunoprecipitation or in vitro 
binding assays. 
In summary this thesis presents a further investigation into the role of stx 16 in 
GLUT4 trafficking. Blockade of stx 16 function by shRNA knockdown results in a 
loss of GLUT4 from the cell, which may represent a depletion of GLUT4 in the 
GSVs due to missorting of GLUT4 to a degradative pathway.  
 
The data in the thesis and in the current literature suggest the following model 
for stx 16 function in GLUT4 trafficking. Stx 16 is localised in a subdomain of the 
TGN and mediates trafficking of vesicles from the early endosome to the TGN. 
This would suggest that stx 16 mediates entry of GLUT4 into the slow trafficking 
pathway (Fig. 1.3) by fusion of GLUT4 vesicles with the stx 16/stx 6 t SNAREs in 
the TGN subdomain. Enriched GLUT4 in the TGN is then packaged into GSVs 
which translocate and fuse with the plasma membrane in response to insulin. Stx 
16 and stx 6 are also packaged into the GSVs during this process which would 
explain the translocation of stx 16 and stx 6 to the plasma membrane in 
response to insulin (Shewan et al., 2003). This enrichment of stx 16 and stx 6 in 
the GSVs may be part of the maturation process for the GSVs.  
 
Knockdown of stx 16 in this model would result in GLUT4 being unable to enter 
the slow trafficking pathway as the GLUT4 vesicles cannot fuse with the TGN 
subdomain and therefore cannot be packaged into GSVs. This would lead to slow 
reversal of insulin stimulated glucose transport and high basal glucose transport 
as GLUT4 is stuck in the fast trafficking cycle between the plasma membrane 
and the endsome. This agrees with data that shows that overexpression of the 
cytosolic domain of stx 6 increases basal glucose transport (Perera et al., 2003) 
and is also consistent with previous data which shows that overexpression of the Nicola S Hamilton, 2010    Chapter 6, 171 
cytosolic domain of stx 16 significantly slows the reversal of insulin stimulated 
glucose transport (Proctor et al., 2006). 
 
Also depletion of stx 16 in 3T3 L1 adipocytes would lead to a lack of GLUT4 in 
GSVs which would result in reduced glucose transport in response to insulin. 
Proctor et al. have shown that depletion of stx 16 using a morpholino antisense 
oligonucleotide reduces insulin stimulated glucose transport over a range of 
insulin concentrations (Proctor et al., 2006). In addition, the missorting of 
GLUT4 might result in its degradation, which would explain the loss of total 
GLUT4 observed in this thesis and by Proctor et al. (Proctor et al., 2006).  
 
Further work is required to investigate the impact of stx 16 knockdown on 
GLUT4 trafficking in more detail. Future studies on the role of stx 16 in GLUT4 
trafficking should attempt to elucidate its precise role in basal retention of 
GLUT4. Where in the trafficking itinerary of GLUT4 does stx 16 exert its effect? 
Does stx 16 control entry of GLUT4 into the slow trafficking pathway into the 
GSVs, or does stx 16 regulate exit of GLUT4 from the GSV compartment? Kinetic 
studies on GLUT4 trafficking using the HA GLUT4 GFP assay described in chapter 
4 and knockdown of stx 16 by shRNA will hopefully give answers to these 
questions.  
Knockdown of stx 16 also reduces stx 6 levels and mVps45 recruitment to the 
membrane which may have an impact on vesicle fusion in this pathway. The loss 
of stx 6 in stx 16 depleted cells suggests that stx 16 is an important stabiliser of 
stx 6. In normal cells the majority of stx 6 may be in complex with stx 16 and stx 
6 may be degraded if it is not bound to stx 16 in a t SNARE complex. This 
suggests that stx 16 is important for t SNARE complex formation in this pathway. 
Stx 16 knockdown also leads to a reduction in mVps45 at the membrane, which 
suggests that mVps45 is recruited to t SNARE complexes in the membrane by 
binding to stx 16. Therefore knockdown of stx 16 would result in a reduction in 
t SNARE complex and trans SNARE complex formation. It would be interesting to 
determine whether expression of the shRNA resistant, myc tagged human stx 
16A would result in stabilisation of stx 6 and increased recruitment of mVps45 to 
the membrane in stx 16 depleted cells. Other data in the lab has found that 
mVps45 depletion in 3T3 L1 adipocytes results in a significant reduction in 
insulin stimulated glucose transport and GLUT4 translocation (Roccisana, Bryant Nicola S Hamilton, 2010    Chapter 6, 172 
and Gould, unpublished). This suggests a model in which stx 16, stx 6 and 
mVps45 act in concert in the intracellular sorting of GLUT4. 
  
The data in this thesis also suggests that phosphorylation of stx 16 is important 
for its function and suggests Ser 95 as a potential site of phosphorylation. The 
phosphorylation site of stx 16 needs to be confirmed in 3T3 L1 adipocytes and its 
importance in GLUT4 trafficking further investigated.  
The data in the thesis and in the current literature suggest the following model 
for how phosphorylation may affect stx 16 function. 
Stx 16 is phosphorylated in basal conditions (Perera et al., 2003). Insulin 
decreases this phosphorylation. Dephosphorylation of SNAREs has been shown to 
lead to t SNARE complex assembly (Marash and Gerst, 2001;Gurunathan et al., 
2002). Therefore insulin stimulation may promote stx 16 t SNARE complex 
formation.  The potential phosphorylation site for stx 16 lies at the start of the 
second helix of the Habc domain (Dulubova et al., 2002), therefore 
phosphorylation of stx 16 might regulate the conformation of stx 16, for example 
its ability to adopt the closed confirmation (Struthers et al., 2009).  
 
This might lead to the following model of how stx 16 phosphorylation might 
regulate GLUT4 trafficking. Basal stx 16 is phosphorylated and is in a closed 
conformation unable to bind to other t SNAREs in its t SNARE complex for 
example stx 6. Insulin stimulation leads to stx 16 dephosphorylation (or reduced 
phosphorylation) which leads to stx 16 adopting an open conformation (this may 
occur the other way around in which the open confirmation of stx 16 leads its 
dephosphorylation.) This leads to stx 16 assembly into the a t SNARE complex 
with stx 6 and Vti1a which allows GLUT4 vesicles to fuse with the subdomain of 
the TGN and allows GLUT4 to enter GSVs which can then fuse with the plasma 
membrane. 
 
How stx 16 is regulated by the SM protein mVps45 and by phosphorylation needs 
further investigation. Also the effect of insulin on this regulation needs to be 
examined. There are several questions still remaining: Is phosphorylation of stx 
16 required for the adoption of the closed conformation?  Does 
dephosphorylation of stx 16 and/or binding of mVps45 control opening of stx 16 
to allow SNARE complex formation? Or is stx 16 dephosphorylated as a 
consequence of it adopting the open formation? Does phosphorylation of stx 16 Nicola S Hamilton, 2010    Chapter 6, 173 
affect its binding to mVps45? mVps45 binds to both the open and closed 
conformation of stx 16. (Struthers et al., 2009) Is this regulated by 
phosphorylation of stx 16? 
 
Finally, is mVps45 phosphorylated by insulin and how does this affect its binding 
to stx16? One possible mechanism could be the following: Insuiln stimulation 
leads to mVps45 phosphorylation; mVps45 dissociates from the closed 
conformation of stx 16; Stx 16 opens and mVps45 binds to the N terminus of stx 
16; Stx 16 is dephosphorylated which leads to stx 16 SNARE complex formation.  
 
These questions could be examined by using a combination of phosphorylation 
site mutations with mutations which result in the open conformation of stx 16. 
Also the phosphorylation site mutants of stx 16 could be used with mVps45 
mutants which affect its ability to bind stx 16 and its ability to be 
phosphorylated by insulin. The effects of these mutants on in vitro and in vivo 
binding of stx 16 to mVps45 and the ability of stx 16 to form SNARE complexes 
can then be determined.  
 
In addition to furthering our understanding of the role of stx 16 in GLUT4 
trafficking, and the regulation of this role, the studies described above will 
hopefully give insight into other mechanisms controlling basal retention of 
GLUT4 and how they are regulated by insulin. These studies may also bridge the 
gap in understanding between insulin signalling and GLUT4 trafficking. 
Understanding how GLUT4 trafficking events are controlled on a molecular level 
will hopefully aid in the development of novel treatments for type II diabetes. 
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